<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Pharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Pharmacol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Pharmacology</journal-title>
</journal-title-group>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32161540</article-id>
<article-id pub-id-type="pmc">7052815</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2020.00072</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Calcium Handling Defects and Cardiac Arrhythmia Syndromes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kistamás</surname>
<given-names>Kornél</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/722647" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Veress</surname>
<given-names>Roland</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/908340/bio" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Horváth</surname>
<given-names>Balázs</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/672359" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bányász</surname>
<given-names>Tamás</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/475944" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nánási</surname>
<given-names>Péter P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/680983" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eisner</surname>
<given-names>David A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/22618" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Physiology, Faculty of Medicine, University of Debrecen</institution>, <addr-line>Debrecen</addr-line>, <country>Hungary</country></aff>
<aff id="aff2"><sup>2</sup><institution>Division of Cardiovascular Sciences, School of Medical Sciences, University of Manchester</institution>, <addr-line>Manchester</addr-line>, <country>United Kingdom</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Dental Physiology, Faculty of Dentistry, University of Debrecen</institution>, <addr-line>Debrecen</addr-line>, <country>Hungary</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Ebru Arioglu Inan, Ankara University, Turkey</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Sung Joon Kim, Seoul National University College of Medicine, South Korea; Murat Oz, Health Science Center, Kuwait; Sanda Despa, University of Kentucky, United States</p>
</fn>
<corresp id="fn001">*Correspondence: Kornél Kistamás, <email xlink:href="mailto:kistamas.kornel@med.unideb.hu" xlink:type="simple">kistamas.kornel@med.unideb.hu</email></corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Cardiovascular and Smooth Muscle Pharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>72</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>11</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>1</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Kistamás, Veress, Horváth, Bányász, Nánási and Eisner</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Kistamás, Veress, Horváth, Bányász, Nánási and Eisner</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Calcium ions (Ca<sup>2+</sup>) play a major role in the cardiac excitation-contraction coupling. Intracellular Ca<sup>2+</sup> concentration increases during systole and falls in diastole thereby determining cardiac contraction and relaxation. Normal cardiac function also requires perfect organization of the ion currents at the cellular level to drive action potentials and to maintain action potential propagation and electrical homogeneity at the tissue level. Any imbalance in Ca<sup>2+</sup> homeostasis of a cardiac myocyte can lead to electrical disturbances. This review aims to discuss cardiac physiology and pathophysiology from the elementary membrane processes that can cause the electrical instability of the ventricular myocytes through intracellular Ca<sup>2+</sup> handling maladies to inherited and acquired arrhythmias. Finally, the paper will discuss the current therapeutic approaches targeting cardiac arrhythmias.</p>
</abstract>
<kwd-group>
<kwd>calcium signalling</kwd>
<kwd>cardiac arrhythmias</kwd>
<kwd>catecholaminergic polymorphic ventricular tachycardia</kwd>
<kwd>long QT syndrome</kwd>
<kwd>atrial fibrillation</kwd>
<kwd>reentry</kwd>
<kwd>early afterdepolarization</kwd>
<kwd>delayed afterdepolarization</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Nemzeti Kutatási Fejlesztési és Innovációs Hivatal<named-content content-type="fundref-id">10.13039/501100011019</named-content></funding-source>
<award-id rid="cn001">NKFIH-K115397</award-id>
</award-group>
<award-group>
<funding-source id="cn002">Emberi Eroforrások Minisztériuma<named-content content-type="fundref-id">10.13039/501100005881</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn003">Emberi Eroforrások Minisztériuma<named-content content-type="fundref-id">10.13039/501100005881</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn004">British Heart Foundation<named-content content-type="fundref-id">10.13039/501100000274</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="7"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="291"></ref-count>
<page-count count="25"></page-count>
<word-count count="13381"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Excitation-contraction coupling (E-C coupling) of the cardiac myocytes is a well studied phenomenon. We know that the calcium ion (Ca<sup>2+</sup>) plays a major role in controlling contraction and force, a feature that was originally described by Sidney Ringer more than a century ago (<xref ref-type="bibr" rid="B198">Ringer, 1883</xref>). Since this discovery, it has become clear that changes in intracellular Ca<sup>2+</sup> concentration ([Ca<sup>2+</sup>]<sub>i</sub>) have a significant role in virtually all parts of the human body. Of particular importance is the fact, that within cardiac myocytes, [Ca<sup>2+</sup>]<sub>i</sub> changes must be tightly regulated, so that the heart can beat rhythmically. This means that during the cardiac systole, [Ca<sup>2+</sup>]<sub>i</sub> has to increase to certain levels to make contraction occur and must fall in diastole, allowing the muscle to relax and prepare for the next cardiac cycle. E-C coupling has been reviewed in detail (<xref ref-type="bibr" rid="B20">Bers, 2002</xref>; <xref ref-type="bibr" rid="B63">Eisner et al., 2017</xref>), here we consider the elementary steps and the events that can lead to electrical disturbances (<xref ref-type="fig" rid="f1"><bold>Figure 1</bold></xref>).</p>
<fig id="f1" position="float">
<label>Figure 1</label>
<caption>
<p>Schematic diagram of the cardiac excitation-contraction coupling. <bold>(A)</bold> Structures involved in Ca<sup>2+</sup> transport in cardiac mycocytes. Red trace shows a typical systolic Ca<sup>2+</sup> transient. Briefly, during the Ca<sup>2+</sup>-induced Ca<sup>2+</sup> release process, Ca<sup>2+</sup> entering the cell <italic>via</italic> L-type Ca<sup>2+</sup> channels releases a larger amount of Ca<sup>2+</sup> from the sarcoplasmic reticulum to activate the contractile machinery. Ca<sup>2+</sup> extrusion requires NCX, PMCA, and SERCA. <bold>(B)</bold> Detailed section of the dyad showing the major proteins involved in Ca<sup>2+</sup> cycling. Reproduced from Eisner et al. used with permission (<xref ref-type="bibr" rid="B63">Eisner et al., 2017</xref>). β-AR, β adrenoceptor; NCX, Na<sup>+</sup>-Ca<sup>2+</sup> exchange; PMCA, plasma membrane Ca<sup>2+</sup>-ATPase; RyR, ryanodine receptor; SERCA, sarco/endoplasmic reticulum Ca<sup>2+</sup>-ATPase; CSQ, calsequestrin; PLN, phospholamban.</p>
</caption>
<graphic xlink:href="fphar-11-00072-g001"></graphic>
</fig>
<p>The normal cardiac action potential (AP) originates in the sinoatrial node and propagates through the heart. In the ventricle the initial depolarization opens voltage-gated sodium channels leading to further depolarization which, in turn, opens the L-type Ca<sup>2+</sup> channels, causing a large Ca<sup>2+</sup>-influx (<xref ref-type="fig" rid="f1"><bold>Figure 1A</bold></xref>). Some Ca<sup>2+</sup> can also enter <italic>via</italic> T-type Ca<sup>2+</sup> channels and reverse mode Na<sup>+</sup>/Ca<sup>2+</sup> exchange (NCX) (<xref ref-type="bibr" rid="B120">Kohomoto et al., 1994</xref>; <xref ref-type="bibr" rid="B226">Sipido et al., 1997</xref>). This Ca<sup>2+</sup> entry triggers a process known as calcium-induced calcium release (CICR), in which Ca<sup>2+</sup> is released from the sarcoplasmic reticulum (SR) into the cytoplasm <italic>via</italic> ryanodine receptors (RyR), allowing Ca<sup>2+</sup> to bind to the myofilament protein troponin C, activating the contractile machinery. Normal cardiac function also requires relaxation to occur; this results from a decrease of free cytoplasmic Ca<sup>2+</sup> levels. Several Ca<sup>2+</sup> transport pathways are involved in this process, as Ca<sup>2+</sup> reuptake into the SR by the SR Ca<sup>2+</sup>-ATPase (SERCA), Ca<sup>2+</sup> extrusion by the sarcolemmal NCX and plasma membrane Ca<sup>2+</sup>-ATPase (PMCA) (<xref ref-type="fig" rid="f1"><bold>Figure 1B</bold></xref>) (<xref ref-type="bibr" rid="B19">Bers, 2000</xref>). This normal cardiac function requires perfect coordination of the ion currents and intracellular processes, as any imbalance in Ca<sup>2+</sup> homeostasis of a cardiac myocyte can lead to electrical disturbances (from cellular AP prolongation to complex arrhythmic storms) (<xref ref-type="bibr" rid="B63">Eisner et al., 2017</xref>; <xref ref-type="bibr" rid="B64">Eisner, 2018</xref>).</p>
<p>Here we review the role of Ca<sup>2+</sup> in generating and maintaining cardiac arrhythmias from basic arrhythmia mechanisms to recent progresses in pharmacological challenges and possible future therapies.</p>
</sec>
<sec id="s2">
<title>Calcium in Pathophysiology, Arrhythmia Mechanisms</title>
<p>Arrhythmia mechanisms have multiscale dynamics in the heart. The lower end is the molecular scale, originating from the stochastic behavior of ion channels, resulting from thermodynamic fluctuations (<xref ref-type="bibr" rid="B193">Qu and Weiss, 2015</xref>). Next is the cellular scale, with differences in the shape of the APs originating from distant parts of the myocardium (<xref ref-type="fig" rid="f2"><bold>Figure 2A</bold></xref>). Under some diseased conditions, several mechanisms can lead to electrical disturbances at the cellular level, including early or delayed afterdepolarizations (EAD or DAD, respectively) (<xref ref-type="fig" rid="f3"><bold>Figures 3A–D</bold></xref>). Whole-cell Ca<sup>2+</sup> oscillations, developing into propagating Ca<sup>2+</sup> waves arise when the molecular and cellular dynamics merge at the tissue and organ level. The lower and higher scales tend to have a bidirectional information flow. A good example is when EADs arising during an AP due to abnormal ion currents and Ca<sup>2+</sup> dynamics, can bring an extra amount of Ca<sup>2+</sup> into the cell due to L-type Ca<sup>2+</sup> channel reopening and potentiate Ca<sup>2+</sup> waves. These multiscale dynamics can lead to life threatening complex arrhythmias.</p>
<fig id="f2" position="float">
<label>Figure 2</label>
<caption>
<p>Cellular physiological electrical activities. <bold>(A)</bold> Transmural heterogeneity in the cardiac ventricular action potential, showing (from left to right) recordings from: subendocardium, midmyocardium, and subepicardium. Note the spike-and-dome action potential configuration in the subepicardium. ENDO, subendocardial mycocyte; MID, midmyocardial “M” myocyte; EPI, subepicardial myocyte. <bold>(B)</bold> Series of typical subepicardial ventricular action potentials at normal pacing activity.</p>
</caption>
<graphic xlink:href="fphar-11-00072-g002"></graphic>
</fig>
<fig id="f3" position="float">
<label>Figure 3</label>
<caption>
<p>Cellular pathophysiological electrical activities. <bold>(A)</bold> Phase 2 early afterdepolarization (EAD), <bold>(B)</bold> Phase 3 EAD, <bold>(C)</bold> Late-phase 3 EAD, <bold>(D)</bold> Delayed afterdepolarization (DAD) manifesting triggered activity. Ca<sup>2+</sup> has an important role in generating afterdepolarizations. Underlying mechanisms are described in the relevant sections. <bold>(E)</bold> Automaticity (spontaneous membrane potential oscillations) occurs if the membrane potential of the cells shift to more positive values causing abnormal activity. <bold>(F)</bold> Cardiac voltage alternans, manifesting a long-short-long-short pattern. <bold>(G)</bold> Short term beat-to-beat variability of the action potential duration. <bold>(a)</bold>, <bold>(b)</bold>, and <bold>(c)</bold> show different time points after interventions that increase action potential duration and beat-to-beat variability leading to EAD generation. Right panel of <bold>(G)</bold> shows action potential duration at 90% of the repolarization (APD<sub>90</sub>) as a function of time.</p>
</caption>
<graphic xlink:href="fphar-11-00072-g003"></graphic>
</fig>
<p>Normal cardiac automaticity originates in the sinoatrial (SA) node. If SA node impulse generation is impaired, atrioventricular node (AV node) and Purkinje fibers can show automatic activity. These secondary pacemakers are also called latent or subsidiary pacemakers (<xref ref-type="bibr" rid="B4">Antzelevitch and Burashnikov, 2011</xref>). SA node pacemaker activity depends on interactions of membrane potential and [Ca<sup>2+</sup>]<sub>i</sub>. This “coupled-clock” pacemaker system is produced by membrane proteins, driving the AP and the intracellular Ca<sup>2+</sup> cycling molecules (<xref ref-type="fig" rid="f4"><bold>Figure 4</bold></xref>) (<xref ref-type="bibr" rid="B153">Maltsev et al., 2006</xref>; <xref ref-type="bibr" rid="B126">Lakatta, 2010</xref>; <xref ref-type="bibr" rid="B109">Joung et al., 2011</xref>).</p>
<fig id="f4" position="float">
<label>Figure 4</label>
<caption>
<p>The origin of the heartbeat: coupled-clock pacemaker system in the sinoatrial cells. The pacemaker activity of the SA node originates from the membrane and calcium clock mechanisms. The former is composed of the sarcolemmal channel proteins, and the latter results from sarcoplasmic reticulum and sarcoplasmic Ca<sup>2+</sup> turnover. At end of the SA action potential the hyperpolarization-activated I<sub>f</sub> depolarizes the membrane to a level where Ca<sup>2+</sup> channels open. In addition, during late diastole, spontaneous SR Ca<sup>2+</sup> releases further depolarize the membrane by activating I<sub>NCX</sub>. Ca<sup>2+</sup> can bind to calmodulin and activate adenylyl cyclase (AC). High constitutive activation of AC leading to high basal level of cAMP (which is needed for protein kinase A-dependent phosphorylation) in SA node cells has been suggested to contribute to the Ca<sup>2+</sup> overload state. PKA-dependent phosphorylation of phospholamban, I<sub>Ca,L</sub>, and RyR promotes spontaneous Ca<sup>2+</sup> release. Blue shows the membrane clock and red shows the calcium clock mechanism. Solid arrows show the Ca<sup>2+</sup>-induced Ca<sup>2+</sup> release process and spontaneous Ca<sup>2+</sup> release events <italic>via</italic> RyR; dashed arrows show the phosphorylation targets of the cAMP–PKA pathway. I<sub>Ca,L</sub>, L-type Ca<sup>2+</sup> current; I<sub>Ca,T</sub>, T-type Ca<sup>2+</sup> current; I<sub>NCX</sub>, Na<sup>+</sup>-Ca<sup>2+</sup> exchange; I<sub>f</sub>, funny current; I<sub>to</sub>, transient outward K<sup>+</sup> current; I<sub>Ks</sub>, slow component of delayed rectifier K<sup>+</sup> current; I<sub>Kr</sub>, rapid component of delayed rectifier K<sup>+</sup> current; I<sub>K1</sub>, inward rectifier K<sup>+</sup> current; I<sub>Kur</sub>, ultra rapid component of delayed rectifier K<sup>+</sup> current; RyR, ryanodine receptor; SERCA, sarcoplasmic reticulum Ca<sup>2+</sup>-ATPase; PLN, phospholamban; CaM, calmodulin; AC, adenylyl cyclase; PKA, protein kinase A; CICR, Ca<sup>2+</sup>-induced Ca<sup>2+</sup> release; SA, sinoatrial.</p>
</caption>
<graphic xlink:href="fphar-11-00072-g004"></graphic>
</fig>
<p>The “membrane clock” implies sarcolemmal proteins, continuously driving the membrane potential to more positive or more negative values. The most important and well-known participant is the hyperpolarization-activated funny current (I<sub>f</sub>), working mainly during early diastolic depolarization. The consequent depolarization opens Ca<sup>2+</sup> channels (I<sub>Ca,T</sub> and I<sub>Ca,L</sub>) and the pacemaker (slow type) action potential occurs. As in the case of the working myocardium, K<sup>+</sup> currents repolarize the membrane. In the last two decades it has become clear that spontaneous Ca<sup>2+</sup> release in a cardiac cell is not always pathological. In the “calcium clock” mechanism, spontaneous SR Ca<sup>2+</sup> release events, the Ca<sup>2+</sup> sparks activate I<sub>NCX</sub> and cause late diastolic membrane depolarization. Coupled clock pacemaker system comprises functional interactions between the membrane and calcium clock (<xref ref-type="fig" rid="f4"><bold>Figure 4</bold></xref>) (<xref ref-type="bibr" rid="B260">Vinogradova et al., 2006</xref>; <xref ref-type="bibr" rid="B124">Lakatta and DiFrancesco, 2009</xref>; <xref ref-type="bibr" rid="B125">Lakatta et al., 2010</xref>).</p>
<p>For physiological contraction and relaxation, not only pacemaker automaticity, but also the impulse conduction system needs to work properly. Spontaneous depolarization from the SA node propagates and depolarizes the distant parts of the cardiac muscle (<xref ref-type="fig" rid="f2"><bold>Figure 2B</bold></xref>), <italic>via</italic> the SA node, AV node, Bundle of His, Bundle branches, and Purkinje fibers pathway.</p>
<p>Cardiac arrhythmia mechanisms can be divided into two main categories: abnormal impulse formation and abnormal impulse conduction. In general, these arrhythmic events occur when the electrical activity of the heart is slower or faster than normal and/or becomes irregular.</p>
<sec id="s2_1">
<title>Abnormal Impulse Generation</title>
<p>Focal activity (enhanced or abnormal impulse generation) is an important arrhythmogenic mechanism and consists of abnormal automaticity and triggered activity.</p>
<sec id="s2_1_1">
<title>Automaticity</title>
<p>In the normal human heart, the SA node generates the propagating APs and determine the heart rate. In the case of parasystole, when the primary pacemaker is bordered by ischemic, infarcted regions the impulse cannot leave the SA node. Under these conditions, parasystolic pacemakers can take over pacemaker activity and fire APs at a lower rate compared to that of the SA node (<xref ref-type="bibr" rid="B86">Gussak et al., 2003</xref>). The AV node produces a junctional rhythm of 40 to 60 bpm and Purkinje fibers of about 20 to 40 bpm (<xref ref-type="bibr" rid="B249">Tse, 2016</xref>). In diseased hearts (e.g. heart failure, HF) membrane potential of pacemaker cells can shift to more positive values and this depolarization causes abnormal automaticity. Enhanced activity (i.e. tachycardia) increases rate of AP discharge by three mechanisms: threshold potential shifts to more negative, maximum diastolic potential shifts to more positive, and the rate of phase 4 depolarization increases (<xref ref-type="fig" rid="f3"><bold>Figure 3E</bold></xref>) (<xref ref-type="bibr" rid="B102">Jalife et al., 2009</xref>).</p>
</sec>
<sec id="s2_1_2">
<title>Early Afterdepolarization</title>
<p>Aside from the abnormal automaticity, the most common causes of focal activity are the early and delayed afterdepolarizations (EAD and DAD, respectively). EADs occur before the terminal repolarization (phase 2 and phase 3 repolarization) of the AP, while DADs occur after the repolarization when membrane potential reaches the resting levels (<xref ref-type="fig" rid="f5"><bold>Figure 5</bold></xref>).</p>
<fig id="f5" position="float">
<label>Figure 5</label>
<caption>
<p>Basic mechanisms of ectopic activity. <bold>(A)</bold> Factors involved in the generation of early afterdepolarizations (EAD). In general, EADs occur when outward currents are reduced (reduced repolarization reserve) and/or the inward currents are enhanced. The currently known types of EADs are consequencies of different etiologies, indicated on <bold>(A)</bold>. Detailed description in the text. Membrane potential recording shows a typical phase 2 EAD. <bold>(B)</bold> Delayed afterdepolarizations (DAD) originate from Ca<sup>2+</sup> overload and consequently, spontaneous SR Ca<sup>2+</sup> release which, in turn, generates a depolarizing transient inward (I<sub>ti</sub>) current. Suprathreshold depolarization can elicit triggered activity. Membrane potential recording shows a typical DAD. EAD, early afterdepolarization; DAD, delayed afterdepolarization; I<sub>Ca,L</sub>, L-type Ca<sup>2+</sup> current; I<sub>Na</sub>, Na<sup>+</sup> current; I<sub>Ks</sub>, slow component of delayed rectifier K<sup>+</sup> current; I<sub>Kr</sub>, rapid component of delayed rectifier K<sup>+</sup> current; I<sub>K1</sub>, inward rectifier K<sup>+</sup> current; I<sub>NCX</sub>, Na<sup>+</sup>-Ca<sup>2+</sup> exchange; I<sub>NS</sub>, nonselective Ca<sup>2+</sup>-sensitive cationic currents; I<sub>Cl(Ca)</sub>, Ca<sup>2+</sup>-activated chloride current; I<sub>ti</sub>, transient outward current; RyR, ryanodine receptor; SR, sarcoplasmic reticulum; SERCA, sarcoplasmic reticulum Ca<sup>2+</sup>-ATPase; TA, triggered activity.</p>
</caption>
<graphic xlink:href="fphar-11-00072-g005"></graphic>
</fig>
<p>EADs usually occur when repolarization reserve is compromised, i.e. reduced outward currents (I<sub>K1</sub>, I<sub>Kr</sub>, I<sub>Ks</sub>) and/or increased inward currents (I<sub>Na</sub>, window I<sub>Ca,L</sub>, I<sub>NCX</sub>) (<xref ref-type="bibr" rid="B48">Damiano and Rosen, 1984</xref>; <xref ref-type="bibr" rid="B227">Sipido et al., 2007</xref>; <xref ref-type="bibr" rid="B18">Benitah et al., 2010</xref>; <xref ref-type="bibr" rid="B95">Horvath et al., 2015</xref>; <xref ref-type="bibr" rid="B113">Karagueuzian et al., 2017</xref>), that is, there is a change in the net membrane current during the plateau (<xref ref-type="fig" rid="f5"><bold>Figure 5A</bold></xref>). In most of the cases these conditions cause prolongation of the AP, allowing I<sub>Ca,L</sub> to recover from inactivation (<xref ref-type="bibr" rid="B42">Chiamvimonvat et al., 2017</xref>) and as a positive feedback loop, triggering an AP (<xref ref-type="bibr" rid="B103">January and Riddle, 1989</xref>) (<xref ref-type="fig" rid="f3"><bold>Figure 3A</bold></xref>). Alternatively, at membrane potentials negative to the activation threshold for I<sub>Ca,L</sub>, spontaneous Ca<sup>2+</sup> release from the SR can activate I<sub>NCX</sub>, driving a depolarizing current by reactivating I<sub>Na</sub> (<xref ref-type="fig" rid="f3"><bold>Figure 3B</bold></xref>) (<xref ref-type="bibr" rid="B240">Szabo et al., 1994</xref>). In addition, although EADs usually occur when the AP duration (APD) is prolonged, some data suggests a novel mechanism, where even shortening of APD can be responsible for generation of EADs (late-phase 3 EAD) (<xref ref-type="bibr" rid="B30">Burashnikov and Antzelevitch, 2003</xref>). Late-phase 3 EADs occur particularly under elevated intracellular Ca<sup>2+</sup> loading (i.e. large Ca<sup>2+</sup> transient) and are considered as a hybrid between EAD and DAD (<xref ref-type="fig" rid="f3"><bold>Figure 3C</bold></xref>). At normal APD and at membrane potentials negative to the equilibrium of the I<sub>NCX</sub> (and I<sub>Cl(Ca)</sub>), these Ca<sup>2+</sup>-mediated currents are weakly inward. However, if APD is abbreviated, they become strongly inward, allowing an I<sub>NCX</sub>-driven depolarizing current, when the shorter repolarization allows a stronger (and not spontaneous) Ca<sup>2+</sup> release from the SR (<xref ref-type="bibr" rid="B31">Burashnikov and Antzelevitch, 2006</xref>). The EAD generated under these circumstances interrupts the final phase of the AP. A key difference compared to the previously described EADs (and DADs) is a non-spontaneous Ca<sup>2+</sup> release in generating late-phase 3 EADs (<xref ref-type="fig" rid="f5"><bold>Figure 5</bold></xref>). Late-phase 3 EAD also has clinical relevance, as its appearance is immediately following termination of other tachyarrhythmias, such as atrial flutter and fibrillation or ventricular tachycardia and fibrillation (<xref ref-type="bibr" rid="B31">Burashnikov and Antzelevitch, 2006</xref>).</p>
<p>The contribution of spontaneous SR Ca<sup>2+</sup> release and an inward I<sub>NCX</sub> to the generation of EADs has been described (<xref ref-type="bibr" rid="B189">Priori and Corr, 1990</xref>; <xref ref-type="bibr" rid="B262">Volders et al., 1997</xref>), furthermore, Volders et al. elegantly demonstrated in isoproterenol induced canine ventricular myocytes that early Ca<sup>2+</sup> aftertransients and their aftercontractions precede the upstroke of the subsequent EAD so that they are a primary event inducing EADs (<xref ref-type="bibr" rid="B262">Volders et al., 1997</xref>). The time course of the EAD generation is characterized by a conditional phase (in other words, an initial delay in repolarization, defined by net membrane current) and the EAD upstroke. In this regard, a significant role of I<sub>NCX</sub> has been suggested in the initial delay in repolarization, thus in the conditional phase (<xref ref-type="bibr" rid="B263">Volders et al., 2000</xref>).</p>
<p>In previous studies, distinct spatial features of afterdepolarization-associated Ca<sup>2+</sup> transients had been shown; i.e. a heterogenous pattern indicating focal, spontaneous SR Ca<sup>2+</sup> release in DADs and a homogenous pattern suggesting I<sub>Ca,L</sub>-induced Ca<sup>2+</sup> release in EADs (<xref ref-type="bibr" rid="B164">Miura et al., 1993</xref>; <xref ref-type="bibr" rid="B165">Miura et al., 1995</xref>; <xref ref-type="bibr" rid="B50">De Ferrari et al., 1995</xref>). However, it must be noted, under certain circumstances (adrenergic stimulation mediated sudden [Ca<sup>2+</sup>]<sub>i</sub> changes), Ca<sup>2+</sup> release during an EAD is not governed by sarcolemmal Ca<sup>2+</sup> influx, so that it is spontaneous, which resembles as a heterogenous pattern, just like in the case of DADs (<xref ref-type="bibr" rid="B262">Volders et al., 1997</xref>).</p>
<p>In our previous work, EADs were evoked by I<sub>Kr</sub> blockade (dofetilide), activation of Na+ current (I<sub>Na,L</sub>) (veratridine), and activation of I<sub>Ca,L</sub> (BAY K8644) at slow pacing rates. Additional application of the Ca<sup>2+</sup> chelator BAPTA-AM decreased [Ca<sup>2+</sup>]<sub>i</sub> as expected, but either reduced EAD frequency in the presence of dofetilide and veratridine or further increased EAD frequency in the presence of BAY K8644 (direct augmentation of the I<sub>Ca,L</sub> brings extra Ca<sup>2+</sup> inflow and is a substrate for increased EAD likelihood). Since BAPTA-AM decreased EAD frequency in the presence of veratridine, but failed to shorten APD, these results contradicts the exclusive role of APD in EAD generation and indicate that an increase in [Ca<sup>2+</sup>]<sub>i</sub> is a significant factor not only for generating DADs, but for evoking EADs as well (<xref ref-type="bibr" rid="B95">Horvath et al., 2015</xref>). Moreover, in another set of experiments of Kistamas et al. H<sub>2</sub>O<sub>2</sub> significantly increased APD and relative short term beat-to-beat variability (SV) (<xref ref-type="bibr" rid="B117">Kistamas et al., 2015a</xref>) and increased the occurrence of EADs on canine ventricular myocytes. Elevation of [Ca<sup>2+</sup>]<sub>i</sub> in H<sub>2</sub>O<sub>2</sub> was shown by others which can account for the increased SV and EAD incidence (<xref ref-type="bibr" rid="B80">Goldhaber, 1996</xref>; <xref ref-type="bibr" rid="B280">Xie et al., 2009</xref>; <xref ref-type="bibr" rid="B243">Szentandrassy et al., 2015</xref>; <xref ref-type="bibr" rid="B118">Kistamas et al., 2015</xref>). Furthermore, we also showed in guinea pig cardiomyocytes, that spontaneous Ca<sup>2+</sup> release from the SR mediates (I<sub>Na,L</sub>) induced EADs (<xref ref-type="bibr" rid="B94">Horvath et al., 2013</xref>). The two possible mechanisms proposed by Zaza et al. by which I<sub>Na,L</sub> promotes EAD genesis are (1) the reactivation of I<sub>Ca,L</sub> during the plateau phase of AP and (2) SR Ca<sup>2+</sup> overload (<xref ref-type="bibr" rid="B288">Zaza et al., 2008</xref>). In our experiments the first EAD occurred at a membrane potential more positive than the window Ca<sup>2+</sup> current voltage range, meaning that not the reactivation of I<sub>Ca,L</sub> was responsible for the generation of EADs. In fact, several mechanisms were addressed, showing the SR load was key in formation of the EADs: (a) anemone toxin II (ATX-II) facilitates I<sub>Na,L</sub> that caused elevated systolic Ca<sup>2+</sup> transient and SR load, (b) the spontaneous Ca<sup>2+</sup> wave precedes the first EAD, and (c) Ca<sup>2+</sup> buffering with BAPTA in the patch pipette abolished EADs (<xref ref-type="bibr" rid="B94">Horvath et al., 2013</xref>).</p>
<p>Therefore, our recent knowledge about the factors involved in the development of EADs includes changes in [Ca<sup>2+</sup>]<sub>i</sub> and the amplitude of Ca<sup>2+</sup> transient, along with the APD and beat-to-beat variability of APD, AP morphology and plateau potential, net membrane current, and the actual availability of L-type Ca<sup>2+</sup> channels. Regardless of the type of EAD mechanisms, if the depolarizing effect of the EAD on the membrane potential is sufficient to activate I<sub>Na</sub>, the result will be an abnormal impulse generation, triggered activity (<xref ref-type="bibr" rid="B92">Hoffman and Rosen, 1981</xref>).</p>
<p>EADs are more likely to develop in midmyocardial cells and Purkinje fibers than in subepi- or subendocardial cells. There is a difference in ion current composition (less I<sub>Ks</sub>, more I<sub>Na,L</sub> in midmyocardial cells), consequently these regions are more prone to AP prolongation (<xref ref-type="bibr" rid="B137">Liu and Antzelevitch, 1995</xref>; <xref ref-type="bibr" rid="B291">Zygmunt et al., 2001</xref>; <xref ref-type="bibr" rid="B241">Szabo et al., 2005</xref>). EADs are generally observed under conditions of ventricular hypertrophy and HF, injured cardiac tissue, or when the myocardium is exposed to catecholamines, hypoxia, acidosis, and pharmacologic agents (<xref ref-type="bibr" rid="B200">Roden, 2004</xref>; <xref ref-type="bibr" rid="B201">Roden, 2006</xref>). The clinical significance of EADs is clear, as they can either serve as the trigger or as the substrate for initiation and perpetuation of torsade de pointes arrhythmia (<xref ref-type="bibr" rid="B263">Volders et al., 2000</xref>). Being as a trigger, as EADs can cause new APs which will be reflected on the ECG as ectopic beats. EADs provide a substrate by causing electrical inhomogeneity in the surrounding tissues.</p>
</sec>
<sec id="s2_1_3">
<title>Delayed Afterdepolarization</title>
<p>DADs are the other common causes of focal activity and were originally described as oscillatory afterpotentials (<xref ref-type="bibr" rid="B72">Ferrier et al., 1973</xref>). They occur in diastole, after complete repolarization of the cell (<xref ref-type="fig" rid="f5"><bold>Figure 5B</bold></xref>). DADs can originate from intracellular Ca<sup>2+</sup> overload that induces spontaneous SR Ca<sup>2+</sup> release, resulting in a depolarizing current <italic>via</italic> forward mode I<sub>NCX</sub> (<xref ref-type="bibr" rid="B157">Mechmann and Pott, 1986</xref>). Other nonselective Ca<sup>2+</sup>-sensitive cationic currents (I<sub>NS</sub>) and chloride current (I<sub>Cl(Ca)</sub>) may also be involved in DAD generation (<xref ref-type="bibr" rid="B12">Asakura et al., 2014</xref>). These three depolarizing currents result in a transient inward current (I<sub>ti</sub>), which is responsible for the membrane depolarization (<xref ref-type="fig" rid="f3"><bold>Figure 3D</bold></xref>). Ca<sup>2+</sup> overload of the cardiac myocytes can occur in several diseases and also in several experimental conditions, e.g. toxic levels of digitalis (<xref ref-type="bibr" rid="B72">Ferrier et al., 1973</xref>; <xref ref-type="bibr" rid="B213">Saunders et al., 1973</xref>; <xref ref-type="bibr" rid="B202">Rosen et al., 1973</xref>), catecholamines (<xref ref-type="bibr" rid="B274">Wit and Cranefield, 1977</xref>; <xref ref-type="bibr" rid="B209">Rozanski and Lipsius, 1985</xref>; <xref ref-type="bibr" rid="B189">Priori and Corr, 1990</xref>), hypokalemia and hypercalcemia (<xref ref-type="bibr" rid="B249">Tse, 2016</xref>), hypertrophy, HF (<xref ref-type="bibr" rid="B10">Aronson, 1981</xref>; <xref ref-type="bibr" rid="B257">Vermeulen et al., 1994</xref>), and rapid heart rates. The amplitude of the generated DAD depends on the size of the Ca<sup>2+</sup> transient and on the properties of I<sub>NCX</sub> and the inward rectifier K<sup>+</sup> current (I<sub>K1</sub>) (<xref ref-type="bibr" rid="B186">Pogwizd et al., 2001</xref>; <xref ref-type="bibr" rid="B236">Sung et al., 2006</xref>; <xref ref-type="bibr" rid="B155">Maruyama et al., 2010</xref>). Subthreshold DADs [appearing as the U wave on the electrocardiogram (ECG)] are small voltage deflections, which although unable to trigger a propagating action potential, may still cause dispersion of excitability, thereby promoting regional conduction block (<xref ref-type="bibr" rid="B203">Rosen et al., 1975</xref>; <xref ref-type="bibr" rid="B237">Surawicz, 1998</xref>; <xref ref-type="bibr" rid="B57">di Bernardo and Murray, 2002</xref>). However, if DADs reach the threshold potential for the opening of Na<sup>+</sup> channels, a spontaneous AP emerges and can result in premature ventricular contraction (PVC). The clinical significance of DAD generation lies in triggered activity that contributes to arrhythmogenesis with catecholaminergic polymorphic ventricular tachycardia (CPVT), atrial fibrillation (AF), and HF. In CPVT and HF, intracellular Ca<sup>2+</sup> load combines with RyR dysfunction (“leaky” RyR). Under circumstances when the SR becomes loaded (high Ca<sup>2+</sup> load, fast heart rate, and/or increased adrenergic tone) and/or RyR becomes leaky, spontaneous Ca<sup>2+</sup> release is favored.</p>
<p>Considering the mechanism of the spontaneous Ca<sup>2+</sup> release, there are two main patterns. First, focal Ca<sup>2+</sup> release, when Ca<sup>2+</sup> signal acts locally (<xref ref-type="bibr" rid="B136">Lipp and Niggli, 1994</xref>) and secondly, when the released Ca<sup>2+</sup> leaves its focus and propagates as a global Ca<sup>2+</sup> wave through the myocyte (<xref ref-type="bibr" rid="B244">Takamatsu and Wier, 1990</xref>; <xref ref-type="bibr" rid="B272">Wier et al., 1987</xref>; <xref ref-type="bibr" rid="B40">Cheng et al., 1993</xref>).</p>
<p>Unlike the EADs, DADs are always generated at relatively rapid rates (<xref ref-type="bibr" rid="B4">Antzelevitch and Burashnikov, 2011</xref>). As mentioned earlier, late-phase 3 EADs are considered as a hybrid between EAD and DAD. A key difference is the time of the SR Ca<sup>2+</sup> release during the AP (<xref ref-type="fig" rid="f5"><bold>Figure 5</bold></xref>). Ca<sup>2+</sup> release occurs during diastole in the case of DAD, while late-phase 3 EAD is generated at the late repolarization of the AP (<xref ref-type="bibr" rid="B73">Fink and Noble, 2010</xref>).</p>
</sec>
<sec id="s2_1_4">
<title>Beat-To-Beat Variability of Action Potential Duration</title>
<p>Variations (physiological or pathological) in AP configuration can cause disturbances in Ca<sup>2+</sup> signaling and the electrical properties of cardiac muscle. In our previous experiments, we determined the beat-to-beat variability of AP duration in isolated canine left ventricular myocytes in several experimental settings (<xref ref-type="bibr" rid="B117">Kistamas et al., 2015a</xref>; <xref ref-type="bibr" rid="B118">Kistamas et al., 2015b</xref>; <xref ref-type="bibr" rid="B243">Szentandrassy et al., 2015</xref>; <xref ref-type="bibr" rid="B150">Magyar et al., 2016</xref>), as recent studies suggest the short term beat-to-beat variability (SV) of APD as a novel method for predicting imminent cardiac arrhythmias (<xref ref-type="bibr" rid="B247">Thomsen et al., 2004</xref>; <xref ref-type="bibr" rid="B1">Abi-Gerges et al., 2010</xref>). Higher variability is considered to be arrhythmic by increasing dispersion of refractoriness (<xref ref-type="fig" rid="f3"><bold>Figure 3G</bold></xref>). We established the concept of relative short term beat-to-beat variability of APD (RSV) by normalizing the changes of short term variability of APD to the concomitant changes in APD [see (<xref ref-type="bibr" rid="B173">Nanasi et al., 2017</xref>] for review). We summarized that RSV was decreased by ion currents involved in the negative feedback regulation of APD (I<sub>Ca,L</sub>, I<sub>Ks</sub> and I<sub>Kr</sub>), while it was increased by I<sub>Na</sub> and I<sub>to</sub>, and in general, increased if repolarization reserved was compromised. RSV was also increased at faster rates and at increased [Ca<sup>2+</sup>]<sub>i</sub>. Transient changes of [Ca<sup>2+</sup>]<sub>i</sub> due to Ca<sup>2+</sup> released from the SR were the dominant contributor to this process (<xref ref-type="bibr" rid="B118">Kistamas et al., 2015b</xref>). High RSV at faster rates can also be explained by the elevated [Ca<sup>2+</sup>]<sub>i</sub>, as faster pacing increases I<sub>Ca,L</sub>, ultimately overloading the cell with Ca<sup>2+</sup> which, in turn, increases RSV.</p>
</sec>
<sec id="s2_1_5">
<title>Cardiac Alternans</title>
<p>A severe form of this beat-to-beat variation is cardiac alternans, where short and long AP duration alternate (<xref ref-type="fig" rid="f3"><bold>Figure 3F</bold></xref>). Pulse and T-wave alternans can be clinically observed and are considered to be a precursor for cardiac arrhythmias (<xref ref-type="bibr" rid="B204">Rosenbaum et al., 1994</xref>; <xref ref-type="bibr" rid="B258">Verrier et al., 2011</xref>). Cardiac alternans originates from instabilities of membrane voltage or of Ca<sup>2+</sup> cycling. At the cellular level, alternans is manifested as beat-to-beat alternations in contraction amplitude (mechanical alternans), APD (electrical or APD alternans), and Ca<sup>2+</sup> transient amplitude (Ca<sup>2+</sup> alternans) at constant heart rate. However, because of the bidirectional information flow between membrane voltage and Ca<sup>2+</sup> cycling, electrical alternans is always influenced by Ca<sup>2+</sup> alternans, and vice versa (<xref ref-type="bibr" rid="B270">Weiss et al., 2006</xref>).</p>
<p>Two mechanisms have been described for Ca<sup>2+</sup>-driven alternans. One depends on the relationship between SR Ca<sup>2+</sup> content and the amount of Ca<sup>2+</sup> released from the SR (<xref ref-type="bibr" rid="B61">Eisner et al., 2000</xref>). If this relationship is steep then a small increase of SR Ca<sup>2+</sup> content will produce a large increase of the amplitude of the Ca<sup>2+</sup> transient resulting in increased Ca<sup>2+</sup> efflux <italic>via</italic> I<sub>NCX</sub> and a decreased influx <italic>via</italic> I<sub>Ca,L</sub> (Ca<sup>2+</sup>-dependent inactivation). The net result is a decrease of SR Ca<sup>2+</sup> content. The next beat therefore arises from a depleted SR resulting in a smaller Ca<sup>2+</sup> transient and decreased I<sub>NCX</sub>, so that the cell will gain Ca<sup>2+</sup> resulting in a larger SR content and Ca<sup>2+</sup> transient for the third beat (<xref ref-type="bibr" rid="B62">Eisner et al., 2006</xref>). Later, it was shown that reduced SERCA pump activity is also needed for an alternating pattern to develop (<xref ref-type="bibr" rid="B220">Shiferaw et al., 2003</xref>; <xref ref-type="bibr" rid="B194">Qu et al., 2007</xref>; <xref ref-type="bibr" rid="B279">Xie et al., 2008</xref>; <xref ref-type="bibr" rid="B134">Li et al., 2009</xref>). Another mechanism for Ca<sup>2+</sup>-driven alternans has been proposed, when on every beat, the SR load is unchanged, however the released amount of Ca<sup>2+</sup> is alternating beat-to-beat. This kind of alternans results from the refractoriness of the RyRs, without the need for SR Ca<sup>2+</sup> content alternans (<xref ref-type="bibr" rid="B184">Picht et al., 2006</xref>; <xref ref-type="bibr" rid="B223">Shkryl et al., 2012</xref>).</p>
<p>Voltage-driven or electrical alternans is determined by APD restitution. Here, the shorter the preceding diastolic interval, the less the APD (<xref ref-type="bibr" rid="B177">Nolasco and Dahlen, 1968</xref>). The steeper this relationship, the more likely is alternans to occur. There may be several causes for this APD restitution. The rapid, pacing-induced electrical alternans occurs at fast heart rates (short diastolic intervals, where recovery of I<sub>Ca,L</sub> is crucial, becoming a key factor in regulating the steepness of APD restitution (<xref ref-type="bibr" rid="B151">Mahajan et al., 2008</xref>). Another APD alternating mechanism is driven by I<sub>to</sub> at slow or normal heart rates and possibly accounts for T-wave alternans in patients with Brugada syndrome (<xref ref-type="bibr" rid="B93">Hopenfeld, 2006</xref>). The third type of electrical alternans is mediated by non-inactivating I<sub>Ca,L</sub> with I<sub>Ks</sub> at normal or slow rates and possibly cause T-wave alternans in LQTS patients (<xref ref-type="bibr" rid="B268">Wegener et al., 2008</xref>). Electrical, restitution-based alternans has been associated with the breakdown of reentry into ventricular fibrillation (VF). At the tissue level, if cellular alternanses in different regions of the ventricle occur in phase with each other (spatially concordant), T-wave alternanses is observed on the ECG. A more malignant form, the spatially discordant APD alternans, manifesting as QRS alternans on the ECG, causes large dispersion of refractoriness, a substrate for reentry. Spatially discordant alternans is a significant cause of wave break, a phenomenon that is essential to VF (<xref ref-type="bibr" rid="B77">Garfinkel, 2007</xref>). It has been shown, that interventions that lower the slope of the APD restitution curve can turn multiwave VF to single-wave monomorphic ventricular tachycardia (VT) (<xref ref-type="bibr" rid="B76">Garfinkel et al., 2000</xref>; <xref ref-type="bibr" rid="B277">Wu et al., 2002</xref>).</p>
</sec>
</sec>
<sec id="s2_2">
<title>Abnormal Impulse Conduction</title>
<p>Abnormal impulse conduction, i.e. reentry, occurs when the AP fails to terminate and has the ability to re-excite tissue regions which have already recovered. This mechanism can be divided into two main types, one with an obstacle (circus type with anatomical or functional barrier) and the other without an obstacle (phase-2 reentry and reflection). The key difference is in refractoriness. Circus movement reentry travels around an anatomic or functional obstacle and all cells are recovered from inactivation, while cells involved in reflection or phase-2 reentry show large differences in recovery from refractoriness with no obstacle in the way of the reentrant wave. In addition, classic nomenclature distinguishes between microreentry and macroreentry, where the reentrant circuit does not or does appear on the surface ECG, respectively.</p>
<p>The myocardium works as a functional syncytium (<xref ref-type="fig" rid="f6"><bold>Figure 6A</bold></xref>). The elemental components of this system are the gap junctions. Gap junctions form channels (comprised of two neighboring connexons) between adjacent cardiomyocytes and allow the cardiac AP to propagate from cell to cell and thereby initiate contraction. However, gap junction channels are unevenly distributed within the cells, expressing a larger portion of channel proteins at the longitudinal ends of the cells than at the transversal, lateral sides (<xref ref-type="bibr" rid="B51">De Maziere and Scheuermann, 1990</xref>; <xref ref-type="bibr" rid="B180">Oosthoek et al., 1993</xref>). This anisotropy allows a much larger longitudinal conduction velocity and effective electrical coupling between the adjacent cells (<xref ref-type="fig" rid="f6"><bold>Figure 6B</bold></xref>). Several conditions are reported to reduce or abolish gap junctional conductance, including increased [Ca<sup>2+</sup>]<sub>i</sub>, reduced pH, or lower ATP levels (<xref ref-type="bibr" rid="B56">Dhein, 1998</xref>). Uncoupling of the cells may lead to the formation of unidirectional conduction block and reentry type arrhythmias (<xref ref-type="fig" rid="f6"><bold>Figure 6B</bold></xref>). The hypothesis that Ca<sup>2+</sup> overload conditions have arrhythmogenic behavior is also supported by experiments in neonatal rat myocytes, where gap junctional conductance was decreased by Ca<sup>2+</sup> concentrations higher than physiological (<xref ref-type="bibr" rid="B74">Firek and Weingart, 1995</xref>), while it was proposed that elevation of [Ca<sup>2+</sup>]<sub>i</sub> by Ca<sup>2+</sup> entry was more effective in decreasing gap junctional conductance than Ca<sup>2+</sup> released from internal stores (<xref ref-type="bibr" rid="B129">Lazrak et al., 1994</xref>; <xref ref-type="bibr" rid="B38">Chanson et al., 1999</xref>). Furthermore, adequate coupling between the cells in the tissue (i.e. low longitudinal resistance) can suppress differences in APD, eliminate EADs, and reduce beat-to-beat variability (<xref ref-type="bibr" rid="B149">Magyar et al., 2015</xref>).</p>
<fig id="f6" position="float">
<label>Figure 6</label>
<caption>
<p>Role of gap junctions in propagating of the cardiac action potential. <bold>(A)</bold> The cardiac tissue is eletrically homogenous if the adjacent cells are coupled by gap junction channels. The anisotropic nature of gap junction channel distribution favors longitudinal over transversal conduction. <bold>(B)</bold> Conditions that decrease or abolish coupling between the cells may cause a unidirectional conduction block and as the electrical impulse propagates around the block it can re-excite those tissue regions due to differences in refractoriness. Insert shows cell-cell connections <italic>via</italic> gap junction channels. The main causes of uncoupling of the cells (showed in red) are elevated intracellular Ca<sup>2+</sup> concentration, reduction in H<sup>+</sup> concentration, or lower levels of ATP. Cx, connexon; ATP, adenosine triphosphate.</p>
</caption>
<graphic xlink:href="fphar-11-00072-g006"></graphic>
</fig>
<p>In the subsequent sections reentry types are discussed in detail.</p>
<sec id="s2_2_1">
<title>Reentry With Anatomical Obstacle (Ring Model)</title>
<p>Reentry was first described in 1906 by Mayer in rings of tissue cut from jellyfish (ring model) (<xref ref-type="bibr" rid="B156">Mayer, 1906</xref>). Later work by Mines showed that circus-type reentry can be initiated by electrical stimulation in cardiac muscle and was the first to define the concept of circus movement reentry around an anatomical obstacle (<xref ref-type="fig" rid="f7"><bold>Figure 7A</bold></xref>) (<xref ref-type="bibr" rid="B161">Mines, 1913</xref>; <xref ref-type="bibr" rid="B162">Mines, 1914</xref>). The anatomical barrier can be a valve, vessel or scar. The possibility that circus-type reentry can form without an anatomical obstacle was proposed by <xref ref-type="bibr" rid="B78">Garrey (1914)</xref>.</p>
<fig id="f7" position="float">
<label>Figure 7</label>
<caption>
<p>Abnormal impulse conduction. Circus movement reentry types. <bold>(A)</bold> Reentrant wave travels around an anatomical obstacle. If the cardiac tissue around the obstacle is homogenous the impulse conduction is favored in both directions. However, if the tissue is heterogenous (i.e. dispersion of refractoriness), unidirectional block can form initating a reentry circuit. Excitable gap consists of tissue regions that fully and/or partially recovered from refractory period, therefore excitable. <bold>(B)</bold> Circuit movement reentry can form in the absence of an anatomical obstacle (functional block). In the leading circle model the length of the circuit is not determined by the pathway around an obstacle, but rather by conduction velocity, refractory period, and stimulating efficacy where (in the absence of an obstacle) a shortcut of the circuit is possible. Spiral waves reentry (or scroll wave if three-dimensional) drifts through the tissue without an obstacle and the main wave can break up and radiate waves to the neighboring regions. In the model of figure-of-8 the circulating waves appear in pairs and the wavefront can circulate around the functional blocks clockwise and counterclockwise. If the intermediate area (central gray) can be activated by the colliding separated waves, reentry can form.</p>
</caption>
<graphic xlink:href="fphar-11-00072-g007"></graphic>
</fig>
<p>Initiation of reentry requires a trigger and a substrate. The trigger can be a premature contraction, while tissue substrate is the dispersion of refractoriness. On top of that, fundamental settings are needed for reentry excitation with anatomical obstacle: (1) the impulse initiating the circus movement must propagate in one direction (unidirectional block) and (2) the proportion of absolute and relative refractoriness in the tissue, that is, the reentrant circuit must be long enough to let all areas—within the circuit, distal from the stimulus—recover from refractory (excitable gap), so the circuit can return to its origin and continue as a new cycle (<xref ref-type="fig" rid="f7"><bold>Figure 7A</bold></xref>). Consequently, (3) the circulating movement would terminate in case of interruption of the reentrant circuit (<xref ref-type="bibr" rid="B161">Mines, 1913</xref>). These criteria proposed by Mines are still in use today. The above mentioned excitation is, in fact, a propagating wave. The length of this wave (wavelength) is determined by the distance between the wavefront (phase 0, AP depolarization) and waveback (phase 3, repolarization), that is, creating an arrhythmogenic excitation needs the special properties of refractoriness and conduction velocity (<xref ref-type="bibr" rid="B269">Weiss et al., 2000</xref>). If the above three criteria are not met, i.e. in sinus rhythm if the tissue around the anatomical obstacle is homogenous (and the impulse pathway is wide enough), the wavefront can simultaneously propagate in both pathways around the barrier. However, if the tissue is electrically heterogenous, due to dispersion of refractoriness, unidirectional conduction block can form caused by a PVC, i.e. initiating reentry (<xref ref-type="fig" rid="f7"><bold>Figure 7A</bold></xref>).</p>
</sec>
<sec id="s2_2_2">
<title>Reentry Without Anatomical Obstacle (Functional Block)</title>
<p>In the cases, when there is no anatomical barrier present, functional reentry can still form, maintained only by the electrical properties (dispersion of refractoriness) of the tissue. The best known examples are the leading circle, spiral wave, and figure-of-8 reentry (<xref ref-type="fig" rid="f7"><bold>Figure 7B</bold></xref>).</p>
<p>The leading circle model was described by Allessie et al., as “the head of the circulating wavefront is continuously biting in its own tail of refractoriness” (<xref ref-type="bibr" rid="B2">Allessie et al., 1977</xref>). The main differences compared to the ring model are (1) the length of the circuit is determined by conduction velocity, stimulating efficacy, and refractory period not by an anatomic obstacle, (2) while the length of the circuit is not fixed, it can be altered by changes in electrophysiological properties of the tissue. (3) There is no excitable gap in the leading circle model and (4) a shortcut of the circuit is possible and finally (5) revolution time is proportional to refractory period, while in the ring model, revolution time is inversely related to conduction velocity (<xref ref-type="fig" rid="f7"><bold>Figure 7B</bold></xref>) (<xref ref-type="bibr" rid="B2">Allessie et al., 1977</xref>).</p>
<p>Spiral waves and rotors can be induced in small two-dimensional pieces of cardiac muscle, without an anatomical barrier, and can drift through the tissue (<xref ref-type="bibr" rid="B182">Pertsov et al., 1993</xref>). Scroll waves are the three-dimensional forms of spiral waves. Spiral waves can develop both in homogenous and heterogenous tissues and either in stable or in an unstable form (<xref ref-type="bibr" rid="B99">Ikeda et al., 1996</xref>; <xref ref-type="bibr" rid="B49">Davidenko et al., 1992</xref>). The former might result in monomorphic VT, while the latter can cause polymorphic VT or torsade de pointes (<xref ref-type="fig" rid="f7"><bold>Figure 7B</bold></xref>) (<xref ref-type="bibr" rid="B82">Gray et al., 1995</xref>).</p>
<p>Figure-of-8 type reentry was first demonstrated by el-Sherif et al. In this case the reentrant wavefront reaches a functional conduction block surrounded by regions of reduced excitability. As conduction is not favored through such tissue, the wavefront drives clockwise and counterclockwise around the two arcs of functional block and beyond the barriers of low excitability the two separated waves can collide. If the conduction is slow enough and the intermediate area can be activated, reentry can form (<xref ref-type="fig" rid="f7"><bold>Figure 7B</bold></xref>) (<xref ref-type="bibr" rid="B67">el-Sherif et al., 1985</xref>; <xref ref-type="bibr" rid="B130">Lazzara, 1988</xref>).</p>
</sec>
<sec id="s2_2_3">
<title>Phase-2 Reentry</title>
<p>In the previous reentrant mechanisms, the trigger and the substrate originated from different etiologies, while in the case of phase-2 reentry, trigger and substrate are from the same source. Phase-2 reentry occurs in ischemia (<xref ref-type="bibr" rid="B147">Lukas and Antzelevitch, 1996</xref>), Brugada syndrome (<xref ref-type="bibr" rid="B28">Brugada and Brugada, 1992</xref>) or under conditions of higher pacing rates and higher extracellular Ca<sup>2+</sup> concentration (<xref ref-type="bibr" rid="B58">Di Diego and Antzelevitch, 1994</xref>). It is caused by severe spatial dispersion of repolarization, that is, spike-and-dome configuration of AP morphology is lost at one site (predominantly at the epicardial region), while preserved at another site and is responsible for the transition to VT and VF. APs without the dome (short APD, early repolarization) can therefore be reexcited and reentry can be initiated (<xref ref-type="bibr" rid="B9">Antzelevitch, 2007</xref>). Loss of dome can be explained by a stronger transient outward current (I<sub>to</sub>) current, and overall by the competitive behavior between I<sub>Na</sub> and I<sub>to</sub> (<xref ref-type="bibr" rid="B83">Greenstein et al., 2000</xref>; <xref ref-type="bibr" rid="B241">Szabo et al., 2005</xref>; <xref ref-type="bibr" rid="B59">Dong et al., 2010</xref>). If the actual membrane potential value is more negative than the activation threshold for the I<sub>Ca,L</sub> then the AP dome vanishes. Cantalapiedra et al. showed in a simplified ionic and in a realistic cardiac model, that the origin of reexcitation is based on the presence of slow Ca<sup>2+</sup> pulse, produced by the slow inward Ca<sup>2+</sup> current (I<sub>si</sub>), so that the slow pulse propagates to the regions of short APs until it triggers a fast pulse (<xref ref-type="bibr" rid="B35">Cantalapiedra et al., 2010</xref>). Interestingly, the same research group argued that conditions (e.g. drugs) increasing the I<sub>Ca,L</sub>, to recover the dome or to prevent the loss of dome, decreases dispersion of repolarization, however, also increasing the probability of reexcitation, through the stabilizing effect of the Ca<sup>2+</sup> conductance (I<sub>Ca,L</sub>) on the slow Ca<sup>2+</sup> pulse (<xref ref-type="bibr" rid="B34">Cantalapiedra et al., 2009</xref>).</p>
</sec>
<sec id="s2_2_4">
<title>Reflection</title>
<p>Reflection is another example of non-circus movement reentry, with a one-dimensional behavior and can be the cause of PVCs or even lethal arrhythmias (<xref ref-type="bibr" rid="B275">Wit et al., 1972</xref>; <xref ref-type="bibr" rid="B205">Rosenthal, 1988</xref>; <xref ref-type="bibr" rid="B252">Van Hemel et al., 1988</xref>). Reflection describes reentry in a linear bundle of a conductive tissue. A stimulus from the proximal region travels through an inexcitable gap and elicits an AP at the distal end. Slow electrotonic currents (inexcitable region can only transmit electrotonic currents) generated by this AP can then propagate in the retrograde direction and reenter and reexcite the proximal elements (<xref ref-type="bibr" rid="B6">Antzelevitch et al., 1980</xref>). There must be an adequate conduction delay to let reflection happen (proximal end can recover from refractoriness), depending on the pacing interval and stimulus strength. It was also shown that neither EADs nor automaticity was required for reflection (<xref ref-type="bibr" rid="B33">Cabo and Barr, 1992</xref>; <xref ref-type="bibr" rid="B110">Kandel and Roth, 2015</xref>).</p>
</sec>
<sec id="s2_2_5">
<title>Biexcitability</title>
<p>A novel wave dynamic, termed biexcitability has been described in recent studies (<xref ref-type="bibr" rid="B36">Chang et al., 2012</xref>). In pacemaker regions I<sub>Ca,L</sub> causes the activation, while in working muscle cells, the upstroke of the AP is driven by I<sub>Na</sub> and I<sub>Ca,L</sub>. During biexcitability both form of activation can coexist at the same tissue. Under certain conditions, like long QT syndrome, repolarization reserve is compromised, APD prolongs, and EADs can occur. Consequently, there can be a situation where the cells develop two stable membrane potential values (−80 mV and −50 mV) and switches between them (<xref ref-type="bibr" rid="B75">Gadsby and Cranefield, 1977</xref>), resulting in a Na<sup>+</sup>- and Ca<sup>2+</sup>-mediated (fast) or a Ca<sup>2+</sup>-mediated (slow) propagating wavefront. This bi-stable behavior might serve as an explanation for the two different possible outcomes of torsade de pointes. According to Chang et al., in cases where the Ca<sup>2+</sup>-mediated slow spiral wave is terminated, leads to termination of the torsade de pointes, while if the tissue is sufficiently heterogenous, Na<sup>+</sup> and Ca<sup>2+</sup>-mediated fast spiral waves degenerate torsade de pointes to VF (<xref ref-type="bibr" rid="B36">Chang et al., 2012</xref>; <xref ref-type="bibr" rid="B37">Chang et al., 2013</xref>).</p>
<p>DADs can induce focal VT by DAD-mediated triggered activity or initiate reentry. Moreover, unstable Ca<sup>2+</sup> signaling can dynamically serve as a substrate for reentry, by promoting dispersion of excitability or promoting dispersion of refractoriness (<xref ref-type="bibr" rid="B271">Weiss et al., 2015</xref>). In those tissue regions, where subthreshold DADs do not trigger a propagating AP, the resultant small membrane depolarization can still be sufficient to depress excitability by inactivating the fast voltage gated Na<sup>+</sup> channels. This condition can lead to reentry, as the inactivated Na<sup>+</sup> channels form a regional conduction block for impulses generated by suprathreshold DADs (<xref ref-type="bibr" rid="B203">Rosen et al., 1975</xref>; <xref ref-type="bibr" rid="B144">Liu et al., 2015</xref>). In the latter case, DAD-mediated triggered activity at fast rates can promote Ca<sup>2+</sup> transient alternans, which in turn causes APD alternans, thereby increasing the dispersion of refractoriness (<xref ref-type="bibr" rid="B212">Sato et al., 2006</xref>; <xref ref-type="bibr" rid="B270">Weiss et al., 2006</xref>). As previously mentioned, subthreshold EADs can also enhance the dispersion of refractoriness, also creating a reentry substrate.</p>
<p>For more detailed reviews on conduction disorders, see <xref ref-type="bibr" rid="B193">Qu and Weiss (2015)</xref> and <xref ref-type="bibr" rid="B4">Antzelevitch and Burashnikov (2011)</xref>.</p>
<p>The following sections will provide further insights into intracellular Ca<sup>2+</sup> handling maladies in the most prevalent inherited and acquired arrhythmia syndromes, caused by channelopathies and defects in Ca<sup>2+</sup> handling genes. Ca<sup>2+</sup> handling defects also have an arrhythmogenic role in diseases, such as heart failure and cardiomyopathies, however they are beyond the scope of the present review [see recent reviews (<xref ref-type="bibr" rid="B45">Coppini et al., 2018</xref>; <xref ref-type="bibr" rid="B107">Johnson and Antoons, 2018</xref>; <xref ref-type="bibr" rid="B54">Denham et al., 2018</xref>)].</p>
</sec>
</sec>
</sec>
<sec id="s3">
<title>Inherited Syndromes</title>
<sec id="s3_1">
<title>Catecholaminergic Polymorphic Ventricular Tachycardia</title>
<p>Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a severe arrhythmogenic disorder, manifesting as a bidirectional or polymorphic VT, mainly in young patients with structurally healthy hearts after exercise or acute emotional stress (<xref ref-type="bibr" rid="B196">Reid et al., 1975</xref>). As heart rate increases as a result of exercise or emotional stress, the ectopic ventricular trigger increases in complexity, such that VT turns into VF and may lead to syncope or sudden cardiac death (<xref ref-type="bibr" rid="B46">Coumel, 1978</xref>; <xref ref-type="bibr" rid="B132">Leenhardt et al., 1995</xref>).</p>
<p>The main criteria for CPVT diagnosis are as follows: structurally normal heart (and normal coronary arteries in individuals above 40 years of age), normal QT interval, and adrenergic induced bidirectional or polymorphic VT (<xref ref-type="bibr" rid="B256">Venetucci et al., 2012</xref>). CPVT is also diagnosed in patients who carry a pathogenic mutation and in family members of a CPVT index case, fulfilling the above mentioned criteria (<xref ref-type="bibr" rid="B191">Priori et al., 2013</xref>). There are also nonspecific features, therefore not diagnostic criteria, including a prominent U wave on the ECG accompanied by sinus bradycardia (<xref ref-type="bibr" rid="B187">Postma et al., 2005</xref>).</p>
<p>In CPVT, arrhythmias are induced by Ca<sup>2+</sup> release from the SR leading to a DAD. The fundamental feature of this process is the Ca<sup>2+</sup> release unit (Ca<sup>2+</sup> sparks), where the spontaneous Ca<sup>2+</sup> release occurs. If sufficient number of release units are activated, a Ca<sup>2+</sup> wave is born, which depends on the SR Ca<sup>2+</sup> content and the SR Ca<sup>2+</sup> threshold (<xref ref-type="bibr" rid="B148">Lukyanenko et al., 1999</xref>; <xref ref-type="bibr" rid="B255">Venetucci et al., 2007</xref>). Interventions that alter RyR opening will affect SR Ca<sup>2+</sup> threshold. For example, caffeine increases the open probability of RyR, therefore it is easier to elicit spontaneous Ca<sup>2+</sup> release (<xref ref-type="bibr" rid="B248">Trafford et al., 2000</xref>), on the other hand tetracaine has an opposite effect, by reducing RyR opening, SR Ca<sup>2+</sup> release threshold is higher (<xref ref-type="bibr" rid="B181">Overend et al., 1997</xref>; <xref ref-type="bibr" rid="B254">Venetucci et al., 2006</xref>).</p>
<p>In the previous sections we detailed the normal Ca<sup>2+</sup> cycling and consequences of elevated [Ca<sup>2+</sup>]<sub>i</sub>. Briefly, the main arrhythmogenic mechanism in CPVT is due to SR Ca<sup>2+</sup> release increasing cytoplasmic Ca<sup>2+</sup> levels, NCX exchanges Ca<sup>2+</sup> with Na<sup>+</sup>, thereby generating I<sub>ti</sub>. I<sub>ti</sub> produces DADs and if DADs reach the activation threshold of Na<sup>+</sup> channels, an elicited AP causes triggered activity, which in turn can lead to an extrasystolic heartbeat. Mutations in CPVT have been shown to alter RyR function and increase the occurrence of spontaneous Ca<sup>2+</sup> release events after sympathetic stimulation (<xref ref-type="bibr" rid="B138">Liu et al., 2006</xref>). β-adrenergic activation increases SR Ca<sup>2+</sup> content, while the same process enhances RyR phosphorylation by Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMKII) and protein kinase A (PKA) (<xref ref-type="bibr" rid="B114">Kashimura et al., 2010</xref>; <xref ref-type="bibr" rid="B140">Liu et al., 2011a</xref>; <xref ref-type="bibr" rid="B256">Venetucci et al., 2012</xref>). In addition to the phosphorylation by PKA, CaMKII-mediated phosphorylation increases the I<sub>Ca,L</sub> and SERCA (by removing the inhibitory effect of phospholamban on SERCA) and activates RyR. Simultaneous activation of I<sub>Ca,L</sub>, SERCA (increases SR Ca<sup>2+</sup> content), and RyR therefore increases the possibility of spontaneous Ca<sup>2+</sup> release (<xref ref-type="bibr" rid="B152">Maier and Bers, 2007</xref>; <xref ref-type="bibr" rid="B89">Hegyi et al., 2019</xref>). Experimental data confirmed that higher RyR Ca<sup>2+</sup> sensitivity alone is not sufficient to elicit spontaneous Ca<sup>2+</sup> release and that inhibition of CaMKII in a CPVT mouse model prevents arrhythmias (<xref ref-type="bibr" rid="B255">Venetucci et al., 2007</xref>; <xref ref-type="bibr" rid="B140">Liu et al., 2011a</xref>).</p>
<p>Several CPVT subtypes have been described to date, albeit the two most common types are the CPVT-1 and CPVT-2 (<xref ref-type="table" rid="T1"><bold>Table 1</bold></xref>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Ca<sup>2+</sup> handling genes associated with inherited arrhythmogenic syndromes.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Syndrome/<break></break>Phenotype</th>
<th align="center" colspan="1" rowspan="1" valign="top">Genes</th>
<th align="center" colspan="1" rowspan="1" valign="top">Genetic<break></break>Locus</th>
<th align="center" colspan="1" rowspan="1" valign="top">Functional effect</th>
<th align="center" colspan="1" rowspan="1" valign="top">Protein</th>
<th align="center" colspan="1" rowspan="1" valign="top">Ref</th>
<th align="center" colspan="1" rowspan="1" valign="top">Syndrome<break></break>overlap</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>CPVT-1</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">RYR2</td>
<td align="left" colspan="1" rowspan="1" valign="top">1q43</td>
<td align="left" colspan="1" rowspan="1" valign="top">GoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>ryanodine receptor 2</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B123">Laitinen et al., 2001</xref>; <xref ref-type="bibr" rid="B190">Priori et al., 2001</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>CPVT-2</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CASQ2</td>
<td align="left" colspan="1" rowspan="1" valign="top">1p13.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">GoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>calsequestrin 2</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B122">Lahat et al., 2001</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>CPVT-4</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CALM1</td>
<td align="left" colspan="1" rowspan="1" valign="top">14q31–q32</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>calmodulin 1</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B178">Nyegaard et al., 2012</xref>; <xref ref-type="bibr" rid="B228">Sondergaard et al., 2015</xref>; <xref ref-type="bibr" rid="B229">Sondergaard et al., 2017</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">LQTS-14</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>CPVT-5</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">TRDN</td>
<td align="left" colspan="1" rowspan="1" valign="top">6q22.31</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>triadin</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B44">Chopra et al., 2009</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">LQTS-17</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>LQTS-4</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">ANK2</td>
<td align="left" colspan="1" rowspan="1" valign="top">4q25–q26</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>ankyrin B</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B22">Bhuiyan et al., 2013</xref>; <xref ref-type="bibr" rid="B168">Mohler et al., 2003</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>LQTS-8</bold>
<break></break>
<bold>(Timothy syndrome)</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CACNA1C</td>
<td align="left" colspan="1" rowspan="1" valign="top">12p13.33</td>
<td align="left" colspan="1" rowspan="1" valign="top">GoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>α1<sub>C</sub> subunit of LTCC</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B233">Splawski et al., 2004</xref>; <xref ref-type="bibr" rid="B246">Thiel et al., 2008</xref>; <xref ref-type="bibr" rid="B25">Boczek et al., 2015</xref>; <xref ref-type="bibr" rid="B127">Landstrom et al., 2016</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">BrS-3, SQTS-4, ERS/IVF</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>LQTS-14</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CALM1</td>
<td align="left" colspan="1" rowspan="1" valign="top">14q32.11</td>
<td align="left" colspan="1" rowspan="1" valign="top">GoF/LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>calmodulin 1</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B218">Shamgar et al., 2006</xref>; <xref ref-type="bibr" rid="B81">Gray and Behr, 2016</xref>; <xref ref-type="bibr" rid="B104">Jensen et al., 2018</xref>; <xref ref-type="bibr" rid="B276">Wren et al., 2019</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">CPVT-4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>LQTS-15</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CALM2</td>
<td align="left" colspan="1" rowspan="1" valign="top">2p21</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>calmodulin 2</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B218">Shamgar et al., 2006</xref>; <xref ref-type="bibr" rid="B81">Gray and Behr, 2016</xref>; <xref ref-type="bibr" rid="B104">Jensen et al., 2018</xref>; <xref ref-type="bibr" rid="B276">Wren et al., 2019</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>LQTS-16</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CALM3</td>
<td align="left" colspan="1" rowspan="1" valign="top">19q13.32</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>calmodulin 3</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B218">Shamgar et al., 2006</xref>; <xref ref-type="bibr" rid="B81">Gray and Behr, 2016</xref>; <xref ref-type="bibr" rid="B104">Jensen et al., 2018</xref>; <xref ref-type="bibr" rid="B276">Wren et al., 2019</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>LQTS-17</bold>
<break></break>
<bold>(Triadin Knockout Syndrome)</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">TRDN</td>
<td align="left" colspan="1" rowspan="1" valign="top">6q22.31</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>triadin</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B3">Altmann et al., 2015</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">CPVT-5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>BrS-3</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CACNA1C</td>
<td align="left" colspan="1" rowspan="1" valign="top">12p13.33</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>α1<sub>C</sub> subunit of LTCC</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B215">Schwartz et al., 1995</xref>; <xref ref-type="bibr" rid="B206">Rosero et al., 1997</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">SQTS-4, ERS/IVF</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>BrS-4</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CACNB2</td>
<td align="left" colspan="1" rowspan="1" valign="top">10p12.33–p12.31</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>β<sub>2</sub> subunit of LTCC</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B215">Schwartz et al., 1995</xref>; <xref ref-type="bibr" rid="B206">Rosero et al., 1997</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">SQTS-5, ERS/IVF</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>BrS-11</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CACNA2D1</td>
<td align="left" colspan="1" rowspan="1" valign="top">7q21.11</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>α<sub>2</sub>δ<sub>1</sub> subunit of LTCC</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B215">Schwartz et al., 1995</xref>; <xref ref-type="bibr" rid="B206">Rosero et al., 1997</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">SQTS-6, ERS/IVF</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>BrS-15</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">TRMP4</td>
<td align="left" colspan="1" rowspan="1" valign="top">19q13.33</td>
<td align="left" colspan="1" rowspan="1" valign="top">GoF/LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>transient receptor potential melastatin 4</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B142">Liu et al., 2013</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>SQTS-4</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CACNA1C</td>
<td align="left" colspan="1" rowspan="1" valign="top">12p13.33</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>α1<sub>C</sub> subunit of LTCC</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B8">Antzelevitch et al., 2007</xref>; <xref ref-type="bibr" rid="B24">Bjerregaard et al., 2010</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">BrS-3,<break></break>ERS/IVF</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>SQTS-5</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CACNB2</td>
<td align="left" colspan="1" rowspan="1" valign="top">10p12.33–p12.31</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>β<sub>2</sub> subunit of LTCC</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B8">Antzelevitch et al., 2007</xref>; <xref ref-type="bibr" rid="B24">Bjerregaard et al., 2010</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">BrS-4,<break></break>ERS/IVF</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>SQTS-6</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CACNA2D1</td>
<td align="left" colspan="1" rowspan="1" valign="top">7q21.11</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>α<sub>2</sub>δ<sub>1</sub> subunit of LTCC</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B8">Antzelevitch et al., 2007</xref>; <xref ref-type="bibr" rid="B24">Bjerregaard et al., 2010</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">BrS-11, ERS/IVF</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>ERS/IVF</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CACNA1C</td>
<td align="left" colspan="1" rowspan="1" valign="top">12p13.33</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>α1<sub>C</sub> subunit of LTCC</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B191">Priori et al., 2013</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">BrS-3, SQTS-4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CACNB2</td>
<td align="left" colspan="1" rowspan="1" valign="top">10p12.33–p12.31</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>β<sub>2</sub> subunit of LTCC</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B191">Priori et al., 2013</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">BrS-4, SQTS-5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CACNA2D1</td>
<td align="left" colspan="1" rowspan="1" valign="top">7q21.11</td>
<td align="left" colspan="1" rowspan="1" valign="top">LoF</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>α<sub>2</sub>δ<sub>1</sub> subunit of LTCC</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B191">Priori et al., 2013</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">BrS-11, SQTS-6</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>CPVT, catecholaminergic polymorphic ventricular tachycardia; LQTS, long QT syndrome; BrS, Brugada syndrome; SQTS, short QT syndrome; ERS, early repolarization syndrome; IVF, idiopathic ventricular fibrillation; LTCC, L-type Ca<sup>2+</sup> channel; GoF, gain-of-function; LoF, loss-of-function.</p>
</table-wrap-foot>
</table-wrap>
<p>CPVT-1 is caused by an autosomal dominant mutation in the RyR2 gene (<xref ref-type="bibr" rid="B238">Swan et al., 1999</xref>). This subtype is the most common, accountable for about 60% of all CPVT cases (<xref ref-type="bibr" rid="B123">Laitinen et al., 2001</xref>; <xref ref-type="bibr" rid="B190">Priori et al., 2001</xref>). RyR exists as a macromolecular complex with many other molecules, such as calsequestrin 2 (CSQ2), FK506 binding protein 1B (FKBP1B or FKBP12.6), FK506 binding protein 1B (FKBP1B or FKBP12.6), PKA, CaMKII, phosphatase 1 (PP1), phosphatase 1 (PP1), phosphatase 2A (PP2A), histidine-rich Ca<sup>2+</sup> binding protein (HRC), junctin and triadin (<xref ref-type="bibr" rid="B266">Wang et al., 1998</xref>; <xref ref-type="bibr" rid="B79">George et al., 2007</xref>; <xref ref-type="bibr" rid="B285">Yano et al., 2009</xref>; <xref ref-type="bibr" rid="B11">Arvanitis et al., 2011</xref>; <xref ref-type="bibr" rid="B242">Szabo et al., 2013</xref>). Junctin and triadin mediates interaction between RyR and CSQ2 (<xref ref-type="bibr" rid="B63">Eisner et al., 2017</xref>). Most RyR mutations in CPVT are gain-of-function mutations and thereby leading to increased Ca<sup>2+</sup> sensitivity and RyR channels may open during diastole causing Ca<sup>2+</sup> leak, particularly during adrenergic stress (<xref ref-type="bibr" rid="B108">Jones et al., 2008</xref>). Several hypotheses have been advanced to explain this phenomenon, including the role of FKBP12.6, store overload-induced Ca<sup>2+</sup> entry (SOCE) and a defective mutation in the RyR 3D conformation (<xref ref-type="bibr" rid="B197">Reiken et al., 2003</xref>; <xref ref-type="bibr" rid="B133">Lehnart et al., 2004</xref>; <xref ref-type="bibr" rid="B105">Jiang et al., 2005</xref>; <xref ref-type="bibr" rid="B281">Yamamoto et al., 2008</xref>; <xref ref-type="bibr" rid="B139">Liu et al., 2009</xref>; <xref ref-type="bibr" rid="B250">Uchinoumi et al., 2010</xref>; <xref ref-type="bibr" rid="B234">Suetomi et al., 2011</xref>; <xref ref-type="bibr" rid="B256">Venetucci et al., 2012a</xref>).</p>
<p>CPVT-2 is an autosomal recessive gene anomaly in CASQ2-encoded CSQ2 and responsible for about 3–5% of CPVT patients (<xref ref-type="bibr" rid="B122">Lahat et al., 2001</xref>). The structure of this intra-SR Ca<sup>2+</sup> buffer changes Ca<sup>2+</sup> concentration. At low SR Ca<sup>2+</sup> concentrations (&lt; 0.6 mmol/L) CSQ2 is a monomer, which is converted to a dimer (0.6–3 mmol/L) or polymer (&gt; 3 mmol/L) at higher Ca<sup>2+</sup> concentrations (<xref ref-type="bibr" rid="B163">Mitchell et al., 1988</xref>; <xref ref-type="bibr" rid="B266">Wang et al., 1998</xref>). It has been shown that, in the absence of functional CSQ2, RyR channels open spontaneously, without the need for L-type Ca<sup>2+</sup> current mediated trigger (<xref ref-type="bibr" rid="B119">Knollmann et al., 2006</xref>) and that mutation of CSQ2 destabilizes Ca<sup>2+</sup> storing capacity of the SR, which in turn alters the Ca<sup>2+</sup> sensitivity of RyR (<xref ref-type="bibr" rid="B259">Viatchenko-Karpinski et al., 2004</xref>). In all CSQ2 mutations (missense, deleterious, nonsense), level of CSQ2 protein is reduced or absent, perhaps because it is more susceptible to degradation (<xref ref-type="bibr" rid="B199">Rizzi et al., 2008</xref>; <xref ref-type="bibr" rid="B71">Faggioni et al., 2012</xref>). Impaired polymerization (<xref ref-type="bibr" rid="B13">Bal et al., 2010</xref>), reduced RyR binding and modulation (<xref ref-type="bibr" rid="B96">Houle et al., 2004</xref>; <xref ref-type="bibr" rid="B245">Terentyev et al., 2006</xref>) are generally associated with lower SR Ca<sup>2+</sup> content, higher [Ca<sup>2+</sup>]<sub>i</sub> and Ca<sup>2+</sup> leak through RyR, these effects can be augmented by β-stimulation (<xref ref-type="bibr" rid="B230">Song et al., 2007</xref>). An interesting feature of CSQ2 protein reduction is a subsequent reduction in triadin and junctin levels. Denegri et al. showed in CSQ2 knock-out animal model that viral gene transfer for <italic>in vivo</italic> replacement of CSQ2 restored normal CSQ2 levels along with triadin and junctin, and ultimately prevented arrhythmias (<xref ref-type="bibr" rid="B52">Denegri et al., 2012</xref>).</p>
<p>Other, less frequent gene mutations have also been described, such as autosomal recessive forms of CPVT, the CPVT-3 and CPVT-5, while CPVT-4 is an autosomal dominant form of the inherited syndrome. CPVT-3 subtype is related to the gene encoding trans-2,3-enoyl-CoA reductase-like protein (TECRL) and is first seen at an early age with high likelihood of infant sudden cardiac death (<xref ref-type="bibr" rid="B21">Bhuiyan et al., 2007</xref>). When CPVT-3 is studied in induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) slower Ca<sup>2+</sup> reuptake, slower Ca<sup>2+</sup> transient upstroke velocity, and increased APD has been observed, along with norepinephrine-induced DADs, which could be eliminated by flecainide (see below) (<xref ref-type="bibr" rid="B55">Devalla et al., 2016</xref>). Mutations in CALM1-encoded calmodulin (CaM) cause the CPVT-4 subtype. <italic>In vitro</italic> experiments showed that this gene anomaly in the C domain compromises Ca<sup>2+</sup> binding to CaM and impairs interaction between RyR and its CaM-binding domain, leading to an increased open state of RyR (<xref ref-type="bibr" rid="B178">Nyegaard et al., 2012</xref>; <xref ref-type="bibr" rid="B228">Sondergaard et al., 2015</xref>; <xref ref-type="bibr" rid="B229">Sondergaard et al., 2017</xref>). TRDN-encoded triadin mutation results in CPVT-5 subtype, which may cause diastolic Ca<sup>2+</sup> leak and Ca<sup>2+</sup> overload. Electron microscopy experiments uncovered fragmentation and reduced contact at the dyadic cleft, thus possibly lacking the negative feedback of SR Ca<sup>2+</sup> release on the L-type Ca<sup>2+</sup> channels, so SR Ca<sup>2+</sup> overload may arise from the uncontrolled Ca<sup>2+</sup> influx (<xref ref-type="bibr" rid="B44">Chopra et al., 2009</xref>).</p>
<p>A possible loss-of-function RyR mutation has also been proposed in a case classified as idiopathic VF, where a reduced SR Ca<sup>2+</sup> sensitivity was shown (<xref ref-type="bibr" rid="B106">Jiang et al., 2007</xref>). Moreover, exercise induced bidirectional VT has been reported in types of long QT syndromes (LQTS-4 and LQTS-7) (<xref ref-type="table" rid="T1"><bold>Table 1</bold></xref>) (<xref ref-type="bibr" rid="B167">Mohler et al., 2004</xref>; <xref ref-type="bibr" rid="B253">Vega et al., 2009</xref>).</p>
<p>Because of the hiding nature of the disease, it is difficult to diagnose CPVT, as patients have normal heart structure and show no symptoms before syncope or sudden cardiac death. However, if diagnosed, there are several therapeutic approaches to CPVT.</p>
<p>Generally speaking, life-long administration of β-blockers is the first choice as treatment. Studies showed that nadolol was clinically effective and a useful prophylactic (<xref ref-type="bibr" rid="B191">Priori et al., 2013</xref>). In countries, where nadolol is not available, propranolol was also shown to be effective (<xref ref-type="bibr" rid="B88">Hayashi et al., 2009</xref>). Carvedilol has been shown to inhibit store overload-induced Ca<sup>2+</sup> release (SOICR) and is the only β-blocker to have RyR inhibitory action, albeit it is a less potent β-blocker after all (<xref ref-type="bibr" rid="B289">Zhou et al., 2011</xref>). Patients with CPVT are recommended to remove the triggers, in other words to limit or avoid any vigorous physical activities and stressful environments (<xref ref-type="bibr" rid="B191">Priori et al., 2013</xref>). In some patients (lacking long-term studies yet) β-blocker and non–dihydropyridine Ca<sup>2+</sup>-channel blocker (verapamil) combination therapy was shown to be beneficial (<xref ref-type="bibr" rid="B239">Swan et al., 2005</xref>; <xref ref-type="bibr" rid="B207">Rosso et al., 2007</xref>).</p>
<p>Flecainide administration has been suggested on top of β-blockers to prevent arrhythmias, in CPVT patients refractory to β-blockers alone (<xref ref-type="bibr" rid="B23">Biernacka and Hoffman, 2011</xref>; <xref ref-type="bibr" rid="B188">Pott et al., 2011</xref>; <xref ref-type="bibr" rid="B251">van der Werf et al., 2011</xref>). Flecainide is a Na<sup>+</sup>-channel blocker drug, specifically a Class Ic antiarrhythmic agent. Several studies, including three retrospective cohorts in human patients with CPVT (<xref ref-type="bibr" rid="B141">Liu et al., 2011</xref>; <xref ref-type="bibr" rid="B195">Radwanski et al., 2016</xref>; <xref ref-type="bibr" rid="B112">Kannankeril et al., 2017</xref>) have shown the effectiveness of flecainide but there is still debate around the mechanism by which it exerts its antiarrhythmic effect. Watanabe et al. concluded that the most important effect of flecainide was blocking the RyR along with the Na<sup>+</sup>-channel blockade (<xref ref-type="bibr" rid="B267">Watanabe et al., 2009</xref>). They hypothesized that blocking RyR reduces the spontaneous Ca<sup>2+</sup> release events and therefore DADs, while Na<sup>+</sup>-channel blockade prevents the possibility of triggered activity from any residual DADs (<xref ref-type="bibr" rid="B91">Hilliard et al., 2010</xref>). Of the Class Ic antiarrhythmic drugs, only flecainide and propafenone was shown to inhibit RyR activity (<xref ref-type="bibr" rid="B97">Hwang et al., 2011</xref>). On the other hand, Liu et al. showed in an animal model of CPVT that although flecainide prevents VT and triggered activity, spontaneous Ca<sup>2+</sup> release and DADs were still detectable in single myocytes. They concluded that the antiarrhythmic effect of flecainide results from its Na<sup>+</sup>-channel blocker effect rather than <italic>via</italic> RyR inhibition (<xref ref-type="bibr" rid="B141">Liu et al., 2011b</xref>; <xref ref-type="bibr" rid="B14">Bannister et al., 2015</xref>). These conflicting results raise the question whether the different effects seen in the previous studies are dependent of a specific genetic mutation. In a recent study, isolated myocytes from Casq2<sup>-/-</sup> and RyR2R4496C<sup>+/-</sup> mice were compared (<xref ref-type="bibr" rid="B98">Hwang et al., 2019</xref>). It was found that the former produces a stronger proarrhythmic response upon isoproterenol stimulation, but flecainide prevented arrhythmias in both cases. Also independent from the underlying mutation, effect of flecainide decreased at high Ca<sup>2+</sup> load. An additional drug has also been tested both <italic>in vitro</italic> and <italic>in vivo</italic>. 1,4-benzothiazepine derivative K201 (JTV519) was shown to prevent arrhythmias in mouse models by reducing RyR opening, SERCA activity and I<sub>Ca,L</sub> (<xref ref-type="bibr" rid="B133">Lehnart et al., 2004</xref>; <xref ref-type="bibr" rid="B145">Loughrey et al., 2007</xref>).</p>
<p>The latest guidelines recommend implantable cardiac defibrillator (ICD) implantation in patients with diagnosis of CPVT who experience VT, syncope, or cardiac arrest despite the optimal medical treatment (<xref ref-type="bibr" rid="B191">Priori et al., 2013</xref>). However, the use of ICDs without concomitant use of β-blockers is dangerous because of the possibility of shock-related electrical storms in these patients (<xref ref-type="bibr" rid="B166">Mohamed et al., 2006</xref>; <xref ref-type="bibr" rid="B183">Pflaumer and Davis, 2012</xref>). Selective left cardiac sympathetic denervation (LCSD) can be a useful therapeutic method and may be considered in patients with uncontrollable arrhythmias (patients with contraindication to β-blockers; when ICD cannot be implanted; or when recurrent VTs manifest in patients with ICD and β-blockers treatment) (<xref ref-type="bibr" rid="B191">Priori et al., 2013</xref>). Pulmonary vein isolation (catheter ablation) was reported to be efficient in some patients with CPVT and AF (<xref ref-type="bibr" rid="B235">Sumitomo et al., 2010</xref>), while the possibility of gene therapy was suggested after successful adenoviral vector infection (CASQ2 gene) in R33Q knock-in mutant mouse with dysfunctional CSQ2 (<xref ref-type="bibr" rid="B53">Denegri et al., 2014</xref>). Family screening of first degree relatives (clinical evaluation and genetic testing) has been strongly suggested with an optional β-blocker therapy even in the absence of a positive exercise test (<xref ref-type="bibr" rid="B16">Bauce et al., 2002</xref>; <xref ref-type="bibr" rid="B88">Hayashi et al., 2009</xref>).</p>
</sec>
<sec id="s3_2">
<title>Congenital Long QT Syndrome</title>
<p>Congenital long QT syndrome (LQTS) is an inherited cardiac ion channelopathy. LQTS is characterized by a prolonged QT interval on the surface ECG, reflecting the ventricular APD prolongation, which gives rise to risk for syncope, seizures, VT or torsade de pointes and finally VF and sudden cardiac death (<xref ref-type="bibr" rid="B216">Schwartz et al., 2012</xref>). Prolongation of APD can happen in an inhomogenous pattern, resulting in an enhanced dispersion of repolarization across the tissue. Delay in repolarization can occur e.g. by genetic defects of key ion currents, namely I<sub>Ks</sub>, I<sub>Kr</sub>, or I<sub>Na</sub>. As mentioned in a previous section, EADs can form if the repolarization reserve is compromised, outward currents are reduced and/or inward currents are increased. In the case of LQTS, inhomogeneity of refractoriness combined with EADs establishes the arrhythmia substrate for VT, torsade de pointes.</p>
<p>The above mentioned conditions are illustrated in the cases of LQTS-1, LQTS-2, and LQTS-3. LQTS-1 is caused by the loss-of-function mutation of KCNQ1 gene (K<sub>v</sub>7.1) that encodes I<sub>Ks</sub> (<xref ref-type="bibr" rid="B211">Sanguinetti et al., 1996</xref>; <xref ref-type="bibr" rid="B15">Barhanin et al., 1996</xref>) while LQTS-2 is also a loss-of-function mutation, but of the KCNH2 channel gene (K<sub>v</sub>11.1), encoding I<sub>Kr</sub> (<xref ref-type="bibr" rid="B210">Sanguinetti et al., 1995</xref>). LQTS-3 is an inherited gain-of-function mutation of SCN5A Na<sup>+</sup> channel (Na<sub>v</sub>1.5) encoding I<sub>Na</sub> (<xref ref-type="bibr" rid="B265">Wang et al., 1995</xref>). All three mutations play key role in determining the length of AP and all of them points towards compromised repolarization reserve with decreased outward currents (LQTS1-2) and increased inward current (LQTS-3). LQTS-1–3 account for ~75–85% of the congenital LQTS cases (<xref ref-type="bibr" rid="B68">El-Sherif et al., 2017</xref>).</p>
<p>Mutations of several other genes have been described in LQTS patients. Mutations of structural and channel interacting proteins result in: LQTS-4, a loss-of-function mutation of ANK2-encoded ankyrin B and leads to Ca<sup>2+</sup> overload, QT prolongation, sinus bradycardia, AF, and CPVT (<xref ref-type="bibr" rid="B22">Bhuiyan et al., 2013</xref>; <xref ref-type="bibr" rid="B168">Mohler et al., 2003</xref>); LQTS-5, a loss-of-function KCNE1-encoded minK mutation, consequential reduction in I<sub>Ks</sub> (<xref ref-type="bibr" rid="B232">Splawski et al., 1997</xref>); LQTS-6, a loss-of-function mutation of KCNE2-encoded MiRP1, causing a faster inactivation time course for I<sub>Kr</sub>, enhanced I<sub>Ca,L</sub>, and reduced I<sub>f</sub> (<xref ref-type="bibr" rid="B146">Lu et al., 2003</xref>; <xref ref-type="bibr" rid="B175">Nawathe et al., 2013</xref>; <xref ref-type="bibr" rid="B143">Liu et al., 2014</xref>); LQTS-9, CAV3-encoded Caveolin 3, causing an enhanced I<sub>Na,L</sub>; and LQTS-11, a mutant A-kinase anchoring protein (AKAP9-Yotiao) results in an abnormal response upon β-stimulation, as mutation reduces interaction between AKAP9 and K<sub>v</sub>LQT1 cannel α subunit (KCNQ1, I<sub>Ks</sub>) leading to dysfunctional response to cAMP and a prolonged APD (QT) (<xref ref-type="bibr" rid="B39">Chen et al., 2007</xref>).</p>
<p>LQTS-9 and LQTS-10 (gain-of-function mutation in SCN4B-encoded Na<sup>+</sup> channel Na<sub>v</sub>β4 β-subunit) together resemble the LQTS-3 phenotype as QT prolongation is achieved by increased Na<sup>+</sup> current (<xref ref-type="bibr" rid="B158">Medeiros-Domingo et al., 2007</xref>). Mutation of SNTA1-encoded α1-syntrophin is a gain-of-function gene anomaly, causing LQTS-12 by enhancing Na<sup>+</sup> current (Na<sub>v</sub>1.5) (<xref ref-type="bibr" rid="B278">Wu et al., 2008</xref>). LQTS-7 and LQTS-13 are affecting repolarizing K<sup>+</sup> currents and channels. LQTS-7 or Andersen-Tawil type 1 syndrome is caused by the loss-of-function mutation of the KCNJ2-encoded K<sub>ir</sub>2.1 inward rectifier K<sup>+</sup> channel, responsible for I<sub>K1</sub>, and as I<sub>K1</sub> is an important player in terminal repolarization, reduction of K<sub>ir</sub>2.1 function prolongs QT interval (<xref ref-type="bibr" rid="B185">Plaster et al., 2001</xref>). In LQTS-13, a loss-of-function mutation on KCNJ5-encoded K<sub>ir</sub>3.4 causes loss of acetylcholine activated, G-protein-gated K<sup>+</sup> (I<sub>KAch</sub>) channel function. I<sub>KAch</sub> is formed by K<sub>ir</sub>3.1 and K<sub>ir</sub>3.4. Mutation in K<sub>ir</sub>3.4 function disrupts membrane targeting and stability, i.e. reduced membrane expression has been suggested as the cause of LQTS-13 (<xref ref-type="bibr" rid="B283">Yang et al., 2010</xref>).</p>
<p>Although most of the LQTS mutant genes are related to K<sup>+</sup> and Na<sup>+</sup> channels (i.e. LQTS-1–3 being ~75–85% of total congenital LQTS), there are several Ca<sup>2+</sup>-signaling proteins that are linked to the occurrence of long QT intervals, typically causing LQTS-8, LQTS-14, LQTS-15, LQTS-16, and LQTS-17 (<xref ref-type="table" rid="T1"><bold>Table 1</bold></xref>).</p>
<p>LQTS-8 is a gain-of-function mutation of the CACNA1C-encoded α1<sub>C</sub> subunit of L-type Ca<sup>2+</sup> channel (Ca<sub>v</sub>1.2) and is generally associated with Timothy syndrome. Timothy syndrome is a rare (less than 30 patients reported worldwide), but severe multisystem disorder, involving QT prolongation, syndactyly, congenital heart defects, cardiomyopathies, bradycardia (caused by AV block rather than sinus bradycardia), and autism (<xref ref-type="bibr" rid="B233">Splawski et al., 2004</xref>). LQTS-8 mutation of the Ca<sub>v</sub>1.2 leads to (1) a significant reduction in voltage-dependent inactivation of I<sub>Ca,L</sub>, (2) enhanced I<sub>Ca,L</sub>, (3) decreased current density with enhanced window current, and (4) a steeper APD restitution curve (<xref ref-type="bibr" rid="B246">Thiel et al., 2008</xref>; <xref ref-type="bibr" rid="B25">Boczek et al., 2015</xref>; <xref ref-type="bibr" rid="B127">Landstrom et al., 2016</xref>). A lesser inactivation of the steady-state current and/or increased peak current means a higher Ca<sup>2+</sup> influx, which can in turn prolong APD, therefore QT interval. A steeper APD restitution curve is proarrhythmic, being a substrate for alternans, as detailed in previous chapters. The mutation can also cause T-wave alternans on the ECG by increasing the dispersion of repolarization (<xref ref-type="bibr" rid="B290">Zhu and Clancy, 2007</xref>). In iPSC cells of a Timothy syndrome patient, a cyclin-dependent kinase inhibitor, roscovitine was found to shorten APD by partially recovering inactivation of the mutant channel (<xref ref-type="bibr" rid="B286">Yarotskyy et al., 2010</xref>; <xref ref-type="bibr" rid="B287">Yazawa et al., 2011</xref>). If Timothy syndrome/LQTS-8 is diagnosed, because of the high mortality, ICD implantation is the first choice. ICD is often supplemented with β-blockers, relying on the fact that they are generally effective in LQTS patients. Also, verapamil (<xref ref-type="bibr" rid="B101">Jacobs et al., 2006</xref>), mexiletine (<xref ref-type="bibr" rid="B121">Krause et al., 2011</xref>), and ranolazine (<xref ref-type="bibr" rid="B217">Shah et al., 2012</xref>) have been shown to shorten APD by affecting I<sub>Ca,L</sub> and reducing the risk of arrhythmias.</p>
<p>LQTS-14–16 are newly described subtypes of LQT syndrome, caused by mutations in the genes coding the ubiquitous Ca<sup>2+</sup> sensor and binder, calmodulin (CaM). Mutations in CALM1-encoding CaM1, CALM2-encoding CaM2, and CALM3-encoding CaM3 are responsible for producing LQTS-14, LQTS-15, and LQTS-16, respectively. Patients diagnosed with these conditions are usually young and have a high rate of cardiac arrest with severe QT prolongation (<xref ref-type="bibr" rid="B81">Gray and Behr, 2016</xref>). CaM is important in the inactivation of Na<sup>+</sup> channels, Ca<sup>2+</sup>-dependent inactivation of I<sub>Ca,L</sub> and also important in the trafficking, assembly, and gating of the I<sub>Ks</sub> channel, KCNQ1 (<xref ref-type="bibr" rid="B218">Shamgar et al., 2006</xref>). Gene anomalies, affecting CaM, and therefore, Ca<sup>2+</sup> binding and/or enhancing I<sub>Ca,L</sub> can lead to severe APD prolongation. To date, over 20 mutations have been reported in the disease group of calmodulinopathies (<xref ref-type="bibr" rid="B104">Jensen et al., 2018</xref>; <xref ref-type="bibr" rid="B276">Wren et al., 2019</xref>) associated with LQTS, CPVT, and idiopathic VF. LQTS mutations, e.g. CaM-D130G, CaM-D96V, CaM-N98S, and CaM-F142L are all having impaired Ca<sup>2+</sup> binding properties at the EF hand domains (<xref ref-type="bibr" rid="B47">Crotti et al., 2013</xref>). In CaM-D130G, CaM-D96V, and CaM-N98S mutations impaired CaM-dependent inhibition of RyR was reported, thereby increasing SR Ca<sup>2+</sup> release due to an increased open state of RyR (<xref ref-type="bibr" rid="B229">Sondergaard et al., 2017</xref>; <xref ref-type="bibr" rid="B104">Jensen et al., 2018</xref>). Unexpectedly, an LQTS-associated CaM mutation, CaM-F142L did not diminish, but, increased the CaM-dependent RyR gating inhibition and caused faster RyR closing at high [Ca<sup>2+</sup>]<sub>i</sub> (<xref ref-type="bibr" rid="B229">Sondergaard et al., 2017</xref>). The authors proposed that the mutation displayed both gain-of-function and loss-of-function properties. In the process of gain-of-function, F142L mutation increases the interactions between the C-domain of CaM and the CaM binding domain of RyR, therefore enhancing RyR inhibition. On the other hand, the loss-of-function effect impairs the ability of the C-domain of CaM to bind free Ca<sup>2+</sup>, i.e. decreases RyR inhibition. However, at high [Ca<sup>2+</sup>]<sub>i</sub> C-domain of CaM saturates allowing the increased RyR inhibitory effect to be the dominant one (<xref ref-type="bibr" rid="B229">Sondergaard et al., 2017</xref>). One might assume an overlap between LQTS and CPVT as diminished inhibitory effect on RyR gating is generally associated with CPVT. In mutant guinea pig cells, it was shown that decreased inhibition of RyR gating with impaired CaM effect on the CaM-dependent inactivation of I<sub>Ca,L</sub> (i.e. increased I<sub>Ca,L</sub>) may contribute to APD prolongation and that LQTS associated CaM mutations can lead to electrical alternans, a pathological feature of LQTS (<xref ref-type="bibr" rid="B135">Limpitikul et al., 2014</xref>).</p>
<p>Recently a novel mutation, LQTS-17 has been proposed, however, the nomenclature is still indistinct. Some reviews refer to LQTS-17 as a mutation in TRDN-encoded triadin, which has also been linked to CPVT-5 (<xref ref-type="bibr" rid="B128">Landstrom et al., 2017</xref>). However, Altmann et al., originally identified the autosomal recessive homozygous or compound heterozygous frameshift loss-of-function mutations in TRDN, proposed the term Triadin Knockout Syndrome (TKOS) or TRDN-mediated autosomal-recessive LQTS, rather than LQTS-17 (<xref ref-type="bibr" rid="B3">Altmann et al., 2015</xref>). As in the previous case, here is also the possibility of an overlap with CPVT, as QT prolongation and disease appearance at young age is accompanied by arrhythmias that occur during exercise. The possible cellular mechanism includes reduced negative feedback on I<sub>Ca,L</sub> (i.e. increased I<sub>Ca,L</sub>), increased spontaneous Ca<sup>2+</sup> release <italic>via</italic> RyR, and promotion of SR Ca<sup>2+</sup> loading by NCX. It is not clear yet, whether the arrhythmogenic feature is mediated by DAD or EAD, but in a TRDN-null mice model, nifedipine aborted SR Ca<sup>2+</sup> overload and spontaneous Ca<sup>2+</sup> release (<xref ref-type="bibr" rid="B44">Chopra et al., 2009</xref>).</p>
<p>Although most of the LQTSs are inherited in an autosomal dominant form, there is a relatively rare, autosomal recessive inherited form, causing the Jervell and Lange-Nielsen syndrome (KCNQ1 or KCNE1, leading to reduced I<sub>Ks</sub>) (<xref ref-type="bibr" rid="B232">Splawski et al., 1997</xref>; <xref ref-type="bibr" rid="B60">Duggal et al., 1998</xref>). LQTS-related arrhythmias can be triggered by either slow or fast heart rate or by sinus pauses, therefore the relation between the LQTSs and the sinoatrial node is an interesting topic; for details, see the mini-review from <xref ref-type="bibr" rid="B273">Wilders and Verkerk (2018)</xref>. For a detailed summary chart about LQTSs with the genetic loci, see a recent review of Landstrom et al. (<xref ref-type="bibr" rid="B128">Landstrom et al., 2017</xref>).</p>
<p>Pharmacological management of congenital LQTS starts with the administration of β-blockers, irrespective of the genotype (<xref ref-type="bibr" rid="B170">Moss et al., 2000</xref>). In one study, propranolol was shown to be the most effective β-blocker (Na<sup>+</sup> channel blockade with limited effects on K<sup>+</sup> channels) (<xref ref-type="bibr" rid="B43">Chockalingam et al., 2012</xref>). It should be noted that care is required with the use of β-blockers at low heart rate in LQTS-3 since bradycardia-dependent arrhythmias occur more often in these patients (<xref ref-type="bibr" rid="B68">El-Sherif et al., 2017</xref>). It was shown in LQTS-2 patients that besides β-blockers, application of mexiletine may also have positive effects (<xref ref-type="bibr" rid="B115">Kim et al., 2010</xref>; <xref ref-type="bibr" rid="B100">Ildarova et al., 2012</xref>). As an add-on therapy, in the case of LQTS-3 patients mexiletine (<xref ref-type="bibr" rid="B215">Schwartz et al., 1995</xref>), lidocaine, tocainide (<xref ref-type="bibr" rid="B206">Rosero et al., 1997</xref>), flecainide (<xref ref-type="bibr" rid="B171">Moss et al., 2005</xref>), phenytoin (<xref ref-type="bibr" rid="B264">Vukmir and Stein, 1991</xref>), or ranolazine (<xref ref-type="bibr" rid="B172">Moss et al., 2008</xref>) can be useful (<xref ref-type="bibr" rid="B191">Priori et al., 2013</xref>). In LQTS where mutations cause reduction in K<sup>+</sup> currents, drugs that enhance K<sup>+</sup> currents, nicorandil (<xref ref-type="bibr" rid="B221">Shimizu et al., 1998</xref>) or RPR26043 (<xref ref-type="bibr" rid="B111">Kang et al., 2005</xref>) were shown to be effective. ICD implantation is recommended for survivors of cardiac arrest or with recurrent syncope while on β-blocker (<xref ref-type="bibr" rid="B191">Priori et al., 2013</xref>). Left cardiac sympathetic denervation (LCSD) can also be performed on high-risk patients (arrhythmic events even in the presence of β-blocker/ICD). In addition to drugs or surgical procedures, lifestyle changes, such as avoidance of drugs that lengthen QT interval, identification and correlation of electrolyte abnormalities, avoidance of strenuous exercise (especially swimming in LQTS-1 patients) and abrupt loud noises (LTQS-2) are recommended for patients (<xref ref-type="bibr" rid="B191">Priori et al., 2013</xref>).</p>
</sec>
<sec id="s3_3">
<title>Brugada Syndrome</title>
<p>Brugada syndrome (BrS) is characterized by ST elevation in V1–V3 ECG leads and is associated with elevated risk of polymorphic VT, VF, and sudden cardiac death (<xref ref-type="bibr" rid="B28">Brugada and Brugada, 1992</xref>). Two hypotheses have been proposed to describe the mechanism behind BrS and how ST segment elevation is linked to VT/VF. (<xref ref-type="bibr" rid="B198">Ringer, 1883</xref>) In the repolarization hypothesis, the loss of spike-and-dome AP morphology (heterogenous shortening of AP due to predominance of I<sub>to</sub> over I<sub>Na</sub> and I<sub>Ca,L</sub>) is suggested in the epicardium of the right ventricular outflow tract, causing an enhanced transmural dispersion of repolarization, i.e. ST elevation (<xref ref-type="bibr" rid="B282">Yan and Antzelevitch, 1999</xref>). The arrhythmogenic mechanism is delivered by phase-2 reentry, when the produced extrasystole can occur on the preceding T wave (R-on-T phenomenon), finally initiating VT/VF. (<xref ref-type="bibr" rid="B20">Bers, 2002</xref>) The depolarization theory proposes a slowed conduction and delayed activation mechanism in the right ventricular outflow tract as a substrate for reentry (<xref ref-type="bibr" rid="B159">Meregalli et al., 2005</xref>).</p>
<p>To date, 23 gene (gain-of-function and also loss-of-function) mutations have been described generating BrS-1–BrS-23 (<xref ref-type="bibr" rid="B81">Gray and Behr, 2016</xref>). The most common subtype is BrS-1, mutation affects the SCN5A-encoded α-subunit of the Na<sup>+</sup> channel (Na<sub>v</sub>1.5) and is accountable for about one third of all BrS (<xref ref-type="bibr" rid="B7">Antzelevitch et al., 2005</xref>). Genes, governing Ca<sup>2+</sup>-signaling molecules are also affected in BrS and causing 10–15% of cases (<xref ref-type="bibr" rid="B32">Burashnikov et al., 2010</xref>) (<xref ref-type="table" rid="T1"><bold>Table 1</bold></xref>). Loss-of-function mutation of the CACNA1C-encoded α<sub>1C</sub>-subunit (Ca<sub>v</sub>1.2α1; BrS-3), the CACNB2-encoded β<sub>2</sub>-subunit (Ca<sub>v</sub>β2; BrS-4), and the CACNA2D1-encoded α<sub>2</sub>δ<sub>1</sub>-subunit (Ca<sub>v</sub>α2δ1; BrS-11) of the L-type Ca<sup>2+</sup> channel (governing I<sub>Ca,L</sub>) have been described with a concomitant reduction of I<sub>Ca,L</sub> (<xref ref-type="bibr" rid="B8">Antzelevitch et al., 2007</xref>). Patients harboring these Ca<sup>2+</sup> related mutations showed BrS like ECG but with shorter than normal QT intervals. Recently, a new Ca<sup>2+</sup>-related mutation has been linked to BrS, accounting for about 6% of the cases. Mutation of the TRPM4-encoded Ca<sup>2+</sup> activated non-selective cation channel transient receptor potential melastatin 4 (TRPM4; BrS-15) can either be gain-of-function or loss-of-function (<xref ref-type="bibr" rid="B142">Liu et al., 2013</xref>). TRPM4-mediated current increases APD in atrial muscle and isolated myocytes (<xref ref-type="bibr" rid="B225">Simard et al., 2013</xref>), possibly by promoting the plateau (as it is more likely to activate when Ca<sup>2+</sup> is elevated). Therefore, TRPM4 mutation may change the AP dome and be arrhythmogenic. TRMP4 may also slow down conduction by altering the availability of Na<sup>+</sup> channels (<xref ref-type="bibr" rid="B142">Liu et al., 2013</xref>).</p>
<p>There have been pharmacological attempts to manage BrS (isoproterenol, quinidine, procainamide, propafenone, pilsicainide, flecainide), some of them were effective in preventing recurrent episodes of VF or electrical storms, but did not reduce the overall risk of VF (<xref ref-type="bibr" rid="B29">Brugada et al., 2000</xref>; <xref ref-type="bibr" rid="B222">Shimizu et al., 2000</xref>; <xref ref-type="bibr" rid="B169">Morita et al., 2003</xref>; <xref ref-type="bibr" rid="B17">Belhassen et al., 2004</xref>; <xref ref-type="bibr" rid="B179">Ohgo et al., 2007</xref>). Guidelines are also recommending lifestyle changes (omit drugs that aggravate ST elevation, avoid alcohol and immediate treatment if fevered) and implantation of ICD (<xref ref-type="bibr" rid="B191">Priori et al., 2013</xref>).</p>
</sec>
<sec id="s3_4">
<title>Short QT Syndrome</title>
<p>Short QT syndrome (SQTS) is a rare inherited syndrome characterized by QT intervals essentially shorter than 360 ms and by an increased incidence of VT/VF mainly in youngsters (<xref ref-type="bibr" rid="B24">Bjerregaard et al., 2010</xref>). There are eight different gene mutations, of which three affect I<sub>Ca,L</sub> (<xref ref-type="table" rid="T1"><bold>Table 1</bold></xref>). Loss-of-function mutation of the CACNA1C-encoded α<sub>1C</sub>-subunit (Ca<sub>v</sub>1.2α1; SQTS-4), the CACNB2-encoded β<sub>2</sub>-subunit (Ca<sub>v</sub>β2; SQTS-5), and the CACNA2D1-encoded α<sub>2</sub>δ<sub>1</sub>-subunit (Ca<sub>v</sub>α2δ1; SQTS-6) of the L-type Ca<sup>2+</sup> channel, similar to the BrS-3, BrS-4, and BrS-11 phenotype. These mutations decrease I<sub>Ca,L</sub> (alter current density and activation/inactivation kinetics), cause heterogenous shortening of APD and QT interval, therefore increases dispersion of repolarization (<xref ref-type="bibr" rid="B8">Antzelevitch et al., 2007</xref>). Transmural dispersion of repolarization (shortening effect is more pronounced in the epicardium compared to endocardium and midmyocardium) finally serves as a substrate for reentry. These mutations combined with the mutation of SCN5A-encoded α-subunit of the Na<sup>+</sup> channel (Na<sub>v</sub>1.5) causes an overlapping phenotype of SQTS and BrS.</p>
</sec>
<sec id="s3_5">
<title>Early Repolarization Syndrome and Idiopathic Ventricular Fibrillation</title>
<p>Early repolarization syndrome (ERS) is characterized by J-point and ST segment elevation in two or more contiguous leads on ECG (<xref ref-type="bibr" rid="B26">Boineau, 2007</xref>). The early repolarization pattern (in the inferior and/or lateral precordial leads) had been considered harmless, but it has recently been associated with idiopathic ventricular fibrillation (IVF) (<xref ref-type="bibr" rid="B208">Rosso et al., 2008</xref>). ERS now is diagnosed in IVF survival patients, without other causes of cardiac arrest (channelopathies; structural or non-structural heart diseases, e.g. BrS; metabolic; toxicological; respiratory; and infectious) (<xref ref-type="bibr" rid="B87">Haissaguerre et al., 2008</xref>). Seven gene mutations were shown, to date, including loss-of-function mutations of CACNA1C, CACNAB2, and CACNA2D1, as seen in BrS or SQTS (<xref ref-type="table" rid="T1"><bold>Table 1</bold></xref>). L-type channel mutations account for 16% of cases (<xref ref-type="bibr" rid="B32">Burashnikov et al., 2010</xref>). CaM-F90L mutation was proposed to be linked to IVF phenotype, where the authors speculated that CaM mutations could be arrhythmogenic by altering Ca<sup>2+</sup> binding and/or binding of target proteins, thus generating a rather insensitive CaM and that the gene anomaly is more pronounced in the Purkinje system (<xref ref-type="bibr" rid="B154">Marsman et al., 2014</xref>). Recently, a novel single point mutation in RyR2 (RyR2-H29D) has been linked to IVF phenotype (<xref ref-type="bibr" rid="B41">Cheung et al., 2015</xref>). RyR2-H29D mutation was shown to be associated with short-coupled premature ventricular contractions, initiating polymorphic VT. This mutation caused diastolic Ca<sup>2+</sup> leak at rest by higher open probability and higher frequency of opening of RyR at low diastolic Ca<sup>2+</sup> levels in a non-PKA phosphorylated state, unlike the typical CPVT-related RyR mutations. Therefore, RyR dysfunction caused by RyR2-H29D mutation may play a role in short-coupled polymorphic VT.</p>
<p>J-point elevation associated malignant arrhythmias have recently been proposed with a new classification, as J-wave syndrome (<xref ref-type="bibr" rid="B5">Antzelevitch and Yan, 2010</xref>).</p>
</sec>
</sec>
<sec id="s4">
<title>Acquired Syndromes</title>
<sec id="s4_1">
<title>Acquired Long QT Syndrome</title>
<p>In addition to the congenital form, LQTS can also be acquired. The prevalence of acquired LQTS is greater than that of congenital forms (<xref ref-type="bibr" rid="B69">El-Sherif et al., 2019</xref>). It is generally caused by adverse, unwanted drug effects and/or electrolyte abnormalities and may predispose to the prolongation of the APD/QT interval, increase in dispersion of refractoriness and to a higher risk for generating EADs, being the substrates for VTs, especially for torsade de pointes VT (<xref ref-type="bibr" rid="B65">El-Sherif and Turitto, 1999</xref>).</p>
<p>The above mentioned effects are often seen for the hERG-encoded (human ether-à-go-go-related gene or KCNH2) K<sub>v</sub>11.1 channel, responsible for I<sub>Kr</sub> while effects on enhanced I<sub>Na,L</sub> has also been reported (<xref ref-type="bibr" rid="B284">Yang et al., 2014</xref>). The role of dispersion of repolarization in generating tachyarrhythmias (and the role as a preclinical proarrhythmia marker) is further supported by a series of experiments, where DL-sotalol and amiodarone were compared (<xref ref-type="bibr" rid="B160">Milberg et al., 2004</xref>). It was shown, that both hERG-blockers increased QT interval, however only DL-sotalol increased transmural dispersion of refractoriness, EADs and torsade de pointes (and caused triangulation of the AP), while amiodarone caused phase-2 prolongation of the AP without triangulation, which is otherwise considered proarrhythmic.</p>
<p>Several other causes of acquired LQTS have been described, including electrolyte disorders (<xref ref-type="bibr" rid="B66">El-Sherif and Turitto, 2011</xref>), such as hypokalemia, hypomagnesemia or hypocalcemia, hypothyroidism, hypothermia, but also antidepressant and antipsychotic treatments (<xref ref-type="bibr" rid="B224">Sicouri and Antzelevitch, 2018</xref>), female gender, and autoimmune and inflammatory diseases (<xref ref-type="bibr" rid="B131">Lazzerini et al., 2015</xref>; <xref ref-type="bibr" rid="B27">Boutjdir et al., 2016</xref>). Hypocalcemia causes QT prolongation <italic>via</italic> phase-2 prolongation of AP (<xref ref-type="bibr" rid="B70">Eryol et al., 2003</xref>), also longer and late Ca<sup>2+</sup> influx (due to reduced Ca<sup>2+</sup>-dependent inactivation of I<sub>Ca,L</sub>) can favor the formation of EADs.</p>
</sec>
<sec id="s4_2">
<title>Atrial Fibrillation</title>
<p>The most prevalent cardiac arrhythmia is atrial fibrillation (AF) and this can be classified as paroxysmal (spontaneously self-terminates into sinus rhythm in less than 7 days), persistent (lasts for more than 7 days), long-lasting persistent (AF lasts for more than a year) or permanent AF (without active rhythm control) (<xref ref-type="bibr" rid="B116">Kirchhof et al., 2016</xref>). AF is multifactorial. Basic arrhythmogenic mechanisms include Ca<sup>2+</sup> handling defects such as triggered activity (DAD, late-phase 3 EAD), conduction block (reentry), and Ca<sup>2+</sup>-driven cardiac alternans and altered Ca<sup>2+</sup> buffering (<xref ref-type="bibr" rid="B174">Nattel and Dobrev, 2016</xref>). DAD-mediated triggered arrhythmias are underlined by Ca<sup>2+</sup> handling instability in AF, namely RyR dysfunction (increased phosphorylation and open probability), increased SERCA function, increased diastolic SR Ca<sup>2+</sup> leak and spontaneous SR Ca<sup>2+</sup> release, increase in Ca<sup>2+</sup> sparks and waves, enhanced CaMKII function (with subsequent RyR hyperphosphorylation), or reduced I<sub>Ca,L</sub> (<xref ref-type="bibr" rid="B231">Sood et al., 2008</xref>; <xref ref-type="bibr" rid="B176">Neef et al., 2010</xref>; <xref ref-type="bibr" rid="B219">Shan et al., 2012</xref>; <xref ref-type="bibr" rid="B261">Voigt et al., 2012</xref>). Involvement of late-phase 3 EAD has also been shown (<xref ref-type="bibr" rid="B31">Burashnikov and Antzelevitch, 2006</xref>). As in most of the AF models APD is abbreviated, this observation can be somewhat surprising, since EADs generally occur at a prolonged APD. However, as we previously described, late-phase 3 EADs occur at shorter APD and at elevated Ca<sup>2+</sup> loading conditions (such as rapid atrial pacing). These ectopic activities can serve as a trigger for reentry which is considered to be the main arrhythmogenic mechanism in AF. Also, I<sub>Ca,L</sub> reduction in AF causes APD shortening and promotes reentrant activity (<xref ref-type="bibr" rid="B90">Heijman et al., 2014</xref>). Reduction of I<sub>Ca,L</sub> might be governed by reduction of protein and mRNA levels of the channel (alpha subunit) after rapid pacing. This transcriptional downregulation of Ca<sup>2+</sup> channel has been proposed to be mediated by activation of calcineurin by Ca<sup>2+</sup>/CaM, which in turn, regulates nuclear translocation of NFAT (<xref ref-type="bibr" rid="B192">Qi et al., 2008</xref>).</p>
<p>A novel, interesting theory has been proposed, namely, Ca<sup>2+</sup> signaling silencing, as an antiarrhythmic adaptive mechanism in AF (<xref ref-type="bibr" rid="B84">Greiser et al., 2014</xref>). The key observation was, that sustained high atrial pacing may not lead to Ca<sup>2+</sup> instability, suggesting a role of accompanying cardiovascular diseases (e.g. HF) rather than “lone AF” itself in those cases when unstable Ca<sup>2+</sup> signaling occurs in AF. Ca<sup>2+</sup> signaling silencing process includes the failure of centripetal intracellular Ca<sup>2+</sup> signal propagation (also unchanged level of Ca<sup>2+</sup> sparks and decreased amplitude of the systolic Ca<sup>2+</sup> transient), remodeling of the RyR complex (reduced protein expression and CaMKII-mediated phosphorylation), and lower Na<sup>+</sup> concentration (consequential reduction in Ca<sup>2+</sup> load) (<xref ref-type="bibr" rid="B85">Greiser, 2017</xref>). The decreased propagation was associated with an increase of cytoplasmic buffer power possibly due to increased Ca<sup>2+</sup> sensitivity of myofilaments resulting from decreased phosphorylation of troponin I (<xref ref-type="bibr" rid="B84">Greiser et al., 2014</xref>). The authors concluded that the Ca<sup>2+</sup> signaling phenotype in AF patients is a net result of factors that stabilize (i.e. Ca<sup>2+</sup> signaling silencing) or destabilize it (arrhythmogenic Ca<sup>2+</sup> instability). Therefore, future therapeutic approaches should identify the substrate (arrhythmia enhancing abnormalities or arrhythmia suppressing Ca<sup>2+</sup> signaling silencing) and tailor therapies for individual AF patients (<xref ref-type="bibr" rid="B116">Kirchhof et al., 2016</xref>; <xref ref-type="bibr" rid="B214">Schotten et al., 2016</xref>; <xref ref-type="bibr" rid="B85">Greiser, 2017</xref>).</p>
<p>For an excess review about the role of Ca<sup>2+</sup> in the pathophsiology of AF see the review of <xref ref-type="bibr" rid="B54">Denham et al. (2018)</xref>.</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusions</title>
<p>In summary, we have reviewed the roles of Ca<sup>2+</sup> in cardiac E-C-coupling focusing on those defects which lead to cardiac arrhythmias in inherited and acquired syndromes. In the last few decades there have been great advances in the understanding of these arrhythmias, however, there is still a need for more work investigating the physiology and pathophysiology of Ca<sup>2+</sup> related events. Designing drugs to treat a specific disease type has never been simple; it is enough to think of the early disappointing attempts to block the Na<sup>+</sup> or K<sup>+</sup> channels (CAST and SWORD trials, respectively). Multiple characteristics of novel therapeutic approaches have to be determined and to be considered as a complex, systems problem.</p>
<p>Along with the generally used β-blockers, newly developed selective drugs without proarrhythmic side effects are necessary. While implantable cardiac defibrillators provide longer life expectancy, they cannot prevent the onset of cardiac events. An additional helpful tool would be reliable and effective risk stratification and clinical guidance for all of the syndromes discussed. It should not be overlooked that in the future other genetic mutations may be discovered requiring novel biological therapies. Because of the diversity of inherited and acquired mutations individually tailored therapeutic approaches (gene-specific or mutation-specific pharmacological and/or gene therapy) will be required.</p>
<p>To gain a better understanding of the role of Ca<sup>2+</sup> in the cardiac arrhythmias data from basic science should meet the clinical practice; translational aspects must be key in all fields of science.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>KK conceived the review and drafted the manuscript. KK, RV, BH, TB, PN, and DE revised the manuscript critically for important intellectual content. DE contributed to the critical review of the literature, editing of the manuscript text and review of the figures. All authors approved the final version of the manuscript submitted.</p>
</sec>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>This work was funded by the National Research Development and Innovation Office (NKFIH-K115397). Further support was obtained from GINOP-2.3.2.-15-2016-00040 and EFOP-3.6.2-16-2017-00006 projects, which are co-financed by the European Union and the European Regional Development Fund. The research was financed by the Thematic Excellence Programme of the Ministry for Innovation and Technology in Hungary (ED_18-1-2019-0028), within the framework of the Space Sciences thematic program of the University of Debrecen. This work was supported by the British Heart Foundation Chair Award (grant number: CH/200004/12801).</p>
</sec>
<sec id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>KK is grateful to his wife Viktoria Csato, PhD who is expecting their twin daughters Zoe Amira and Liza Jazmin, without whom this review would have been completed much earlier. The authors wish to thank Jessica L. Caldwell for the design of <xref ref-type="fig" rid="f1"><bold>Figure 1</bold></xref>.</p>
</ack>
<sec id="s9">
<title>Abbreviations</title>
<p>AF, atrial fibrillation; AP, action potential; APD, action potential duration; AV, atrioventricular; BrS, Brugada syndrome; CaM, calmodulin; CaMKII, Ca<sup>2+</sup>/calmodulin-dependent protein kinase II; CICR, Ca<sup>2+</sup>-induced Ca<sup>2+</sup> release; CPVT, catecholaminergic polymorphic ventricular tachycardia; CSQ2, calsequestrin 2; DAD, delayed afterdepolarization; EAD, early afterdepolarization; EC, excitation-contraction coupling; ERS, early repolarization syndrome; HF, heart failure; ICD, implantable cardiac defibrillator; IVF, idiopathic ventricular fibrillation; LQTS, long QT syndrome; NCX, sodium-calcium exchange; NFAT, nuclear factor of activated T-cells; PKA, protein kinase A; PLN, phospholamban; PMCA, plasma membrane Ca<sup>2+</sup>-ATPase; PVC, premature ventricular contraction; RSV, relative short term beat-to-beat variability of action potential duration; RyR, ryanodine receptor; SA, sinoatrial; SERCA, sarco/endoplasmic reticulum Ca<sup>2+</sup>-ATPase; SOCE, store overload-induced Ca<sup>2+</sup> entry; SOICR, store overload-induced Ca<sup>2+</sup> release; SQTS, short QT syndrome; SR, sarcoplasmic reticulum; SV, short term beat-to-beat variability of action potential duration; VF, ventricular fibrillation; VT, ventricular tachycardia.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abi-Gerges</surname><given-names>N.</given-names></name><name><surname>Valentin</surname><given-names>J. P.</given-names></name><name><surname>Pollard</surname><given-names>C. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Dog left ventricular midmyocardial myocytes for assessment of drug-induced delayed repolarization: short-term variability and proarrhythmic potential</article-title>. <source/>Br. J. Pharmacol.
<volume>159</volume> (<issue>1</issue>), <fpage>77</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2009.00338.x</pub-id>
<pub-id pub-id-type="pmid">19663882</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Allessie</surname><given-names>M. A.</given-names></name><name><surname>Bonke</surname><given-names>F. I.</given-names></name><name><surname>Schopman</surname><given-names>F. J.</given-names></name></person-group> (<year>1977</year>). <article-title>Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The “leading circle” concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle</article-title>. <source/>Circ. Res.
<volume>41</volume> (<issue>1</issue>), <fpage>9</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.41.1.9</pub-id>
<pub-id pub-id-type="pmid">862147</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Altmann</surname><given-names>H. M.</given-names></name><name><surname>Tester</surname><given-names>D. J.</given-names></name><name><surname>Will</surname><given-names>M. L.</given-names></name><name><surname>Middha</surname><given-names>S.</given-names></name><name><surname>Evans</surname><given-names>J. M.</given-names></name><name><surname>Eckloff</surname><given-names>B. W.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Homozygous/compound heterozygous triadin mutations associated with autosomal-recessive long-QT syndrome and pediatric sudden cardiac arrest: elucidation of the triadin knockout syndrome</article-title>. <source/>Circulation
<volume>131</volume> (<issue>23</issue>), <fpage>2051</fpage>–<lpage>2060</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.115.015397</pub-id>
<pub-id pub-id-type="pmid">25922419</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Antzelevitch</surname><given-names>C.</given-names></name><name><surname>Burashnikov</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Overview of basic mechanisms of cardiac arrhythmia</article-title>. <source/>Cardiac Electrophysiol. Clinics
<volume>3</volume> (<issue>1</issue>), <fpage>23</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccep.2010.10.012</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Antzelevitch</surname><given-names>C.</given-names></name><name><surname>Yan</surname><given-names>G. X.</given-names></name></person-group> (<year>2010</year>). <article-title>J wave syndromes</article-title>. <source/>Heart Rhythm
<volume>7</volume> (<issue>4</issue>), <fpage>549</fpage>–<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2009.12.006</pub-id>
<pub-id pub-id-type="pmid">20153265</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Antzelevitch</surname><given-names>C.</given-names></name><name><surname>Jalife</surname><given-names>J.</given-names></name><name><surname>Moe</surname><given-names>G. K.</given-names></name></person-group> (<year>1980</year>). <article-title>Characteristics of reflection as a mechanism of reentrant arrhythmias and its relationship to parasystole</article-title>. <source/>Circulation
<volume>61</volume> (<issue>1</issue>), <fpage>182</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.61.1.182</pub-id>
<pub-id pub-id-type="pmid">7349933</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Antzelevitch</surname><given-names>C.</given-names></name><name><surname>Brugada</surname><given-names>P.</given-names></name><name><surname>Borggrefe</surname><given-names>M.</given-names></name><name><surname>Brugada</surname><given-names>J.</given-names></name><name><surname>Brugada</surname><given-names>R.</given-names></name><name><surname>Corrado</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Brugada syndrome: report of the second consensus conference: endorsed by the heart rhythm society and the european heart rhythm association</article-title>. <source/>Circulation
<volume>111</volume> (<issue>5</issue>), <fpage>659</fpage>–<lpage>670</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000152479.54298.51</pub-id>
<pub-id pub-id-type="pmid">15655131</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Antzelevitch</surname><given-names>C.</given-names></name><name><surname>Pollevick</surname><given-names>G. D.</given-names></name><name><surname>Cordeiro</surname><given-names>J. M.</given-names></name><name><surname>Casis</surname><given-names>O.</given-names></name><name><surname>Sanguinetti</surname><given-names>M. C.</given-names></name><name><surname>Aizawa</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death</article-title>. <source/>Circulation
<volume>115</volume> (<issue>4</issue>), <fpage>442</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.668392</pub-id>
<pub-id pub-id-type="pmid">17224476</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Antzelevitch</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>Heterogeneity and cardiac arrhythmias: an overview</article-title>. <source/>Heart Rhythm
<volume>4</volume> (<issue>7</issue>), <fpage>964</fpage>–<lpage>972</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2007.03.036</pub-id>
<pub-id pub-id-type="pmid">17599687</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aronson</surname><given-names>R. S.</given-names></name></person-group> (<year>1981</year>). <article-title>Afterpotentials and triggered activity in hypertrophied myocardium from rats with renal hypertension</article-title>. <source/>Circ. Res.
<volume>48</volume> (<issue>5</issue>), <fpage>720</fpage>–<lpage>727</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.48.5.720</pub-id>
<pub-id pub-id-type="pmid">6452233</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arvanitis</surname><given-names>D. A.</given-names></name><name><surname>Vafiadaki</surname><given-names>E.</given-names></name><name><surname>Sanoudou</surname><given-names>D.</given-names></name><name><surname>Kranias</surname><given-names>E. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Histidine-rich calcium binding protein: the new regulator of sarcoplasmic reticulum calcium cycling</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>50</volume> (<issue>1</issue>), <fpage>43</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2010.08.021</pub-id>
<pub-id pub-id-type="pmid">20807542</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asakura</surname><given-names>K.</given-names></name><name><surname>Cha</surname><given-names>C. Y.</given-names></name><name><surname>Yamaoka</surname><given-names>H.</given-names></name><name><surname>Horikawa</surname><given-names>Y.</given-names></name><name><surname>Memida</surname><given-names>H.</given-names></name><name><surname>Powell</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>EAD and DAD mechanisms analyzed by developing a new human ventricular cell model</article-title>. <source/>Prog. Biophys. Mol. Biol.
<volume>116</volume> (<issue>1</issue>), <fpage>11</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2014.08.008</pub-id>
<pub-id pub-id-type="pmid">25192800</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bal</surname><given-names>N. C.</given-names></name><name><surname>Sharon</surname><given-names>A.</given-names></name><name><surname>Gupta</surname><given-names>S. C.</given-names></name><name><surname>Jena</surname><given-names>N.</given-names></name><name><surname>Shaikh</surname><given-names>S.</given-names></name><name><surname>Gyorke</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>The catecholaminergic polymorphic ventricular tachycardia mutation R33Q disrupts the N-terminal structural motif that regulates reversible calsequestrin polymerization</article-title>. <source/>J. Biol. Chem.
<volume>285</volume> (<issue>22</issue>), <fpage>17188</fpage>–<lpage>17196</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.096354</pub-id>
<pub-id pub-id-type="pmid">20353949</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bannister</surname><given-names>M. L.</given-names></name><name><surname>Thomas</surname><given-names>N. L.</given-names></name><name><surname>Sikkel</surname><given-names>M. B.</given-names></name><name><surname>Mukherjee</surname><given-names>S.</given-names></name><name><surname>Maxwell</surname><given-names>C.</given-names></name><name><surname>MacLeod</surname><given-names>K. T.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>The mechanism of flecainide action in CPVT does not involve a direct effect on RyR2</article-title>. <source/>Circ. Res.
<volume>116</volume> (<issue>8</issue>), <fpage>1324</fpage>–<lpage>1335</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.305347</pub-id>
<pub-id pub-id-type="pmid">25648700</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barhanin</surname><given-names>J.</given-names></name><name><surname>Lesage</surname><given-names>F.</given-names></name><name><surname>Guillemare</surname><given-names>E.</given-names></name><name><surname>Fink</surname><given-names>M.</given-names></name><name><surname>Lazdunski</surname><given-names>M.</given-names></name><name><surname>Romey</surname><given-names>G.</given-names></name></person-group> (<year>1996</year>). <article-title>K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current</article-title>. <source/>Nature
<volume>384</volume> (<issue>6604</issue>), <fpage>78</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1038/384078a0</pub-id>
<pub-id pub-id-type="pmid">8900282</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bauce</surname><given-names>B.</given-names></name><name><surname>Rampazzo</surname><given-names>A.</given-names></name><name><surname>Basso</surname><given-names>C.</given-names></name><name><surname>Bagattin</surname><given-names>A.</given-names></name><name><surname>Daliento</surname><given-names>L.</given-names></name><name><surname>Tiso</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers</article-title>. <source/>J. Am. Coll. Cardiol.
<volume>40</volume> (<issue>2</issue>), <fpage>341</fpage>–<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1016/s0735-1097(02)01946-0</pub-id>
<pub-id pub-id-type="pmid">12106942</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Belhassen</surname><given-names>B.</given-names></name><name><surname>Glick</surname><given-names>A.</given-names></name><name><surname>Viskin</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Efficacy of quinidine in high-risk patients with Brugada syndrome</article-title>. <source/>Circulation
<volume>110</volume> (<issue>13</issue>), <fpage>1731</fpage>–<lpage>1737</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000143159.30585.90</pub-id>
<pub-id pub-id-type="pmid">15381640</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Benitah</surname><given-names>J. P.</given-names></name><name><surname>Alvarez</surname><given-names>J. L.</given-names></name><name><surname>Gomez</surname><given-names>A. M.</given-names></name></person-group> (<year>2010</year>). <article-title>L-type Ca(2+) current in ventricular cardiomyocytes</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>48</volume> (<issue>1</issue>), <fpage>26</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2009.07.026</pub-id>
<pub-id pub-id-type="pmid">19660468</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Calcium fluxes involved in control of cardiac myocyte contraction</article-title>. <source/>Circ. Res.
<volume>87</volume> (<issue>4</issue>), <fpage>275</fpage>–<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.87.4.275</pub-id>
<pub-id pub-id-type="pmid">10948060</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Cardiac excitation-contraction coupling</article-title>. <source/>Nature
<volume>415</volume> (<issue>6868</issue>), <fpage>198</fpage>–<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1038/415198a</pub-id>
<pub-id pub-id-type="pmid">11805843</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bhuiyan</surname><given-names>Z. A.</given-names></name><name><surname>Hamdan</surname><given-names>M. A.</given-names></name><name><surname>Shamsi</surname><given-names>E. T.</given-names></name><name><surname>Postma</surname><given-names>A. V.</given-names></name><name><surname>Mannens</surname><given-names>M. M.</given-names></name><name><surname>Wilde</surname><given-names>A. A.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22</article-title>. <source/>J. Cardiovasc. Electrophysiol.
<volume>18</volume> (<issue>10</issue>), <fpage>1060</fpage>–<lpage>1066</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8167.2007.00913.x</pub-id>
<pub-id pub-id-type="pmid">17666061</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bhuiyan</surname><given-names>Z. A.</given-names></name><name><surname>Al-Shahrani</surname><given-names>S.</given-names></name><name><surname>Al-Aama</surname><given-names>J.</given-names></name><name><surname>Wilde</surname><given-names>A. A.</given-names></name><name><surname>Momenah</surname><given-names>T. S.</given-names></name></person-group> (<year>2013</year>). <article-title>Congenital long QT syndrome: an update and present perspective in Saudi Arabia</article-title>. <source/>Front. Pediatr.
<volume>1</volume>, <elocation-id>39</elocation-id>. <pub-id pub-id-type="doi">10.3389/fped.2013.00039</pub-id>
<pub-id pub-id-type="pmid">24400285</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Biernacka</surname><given-names>E. K.</given-names></name><name><surname>Hoffman</surname><given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>Efficacy of flecainide in a patient with catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Europace
<volume>13</volume> (<issue>1</issue>), <fpage>129</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1093/europace/euq279</pub-id>
<pub-id pub-id-type="pmid">20798117</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bjerregaard</surname><given-names>P.</given-names></name><name><surname>Nallapaneni</surname><given-names>H.</given-names></name><name><surname>Gussak</surname><given-names>I.</given-names></name></person-group> (<year>2010</year>). <article-title>Short QT interval in clinical practice</article-title>. <source/>J. Electrocardiol.
<volume>43</volume> (<issue>5</issue>), <fpage>390</fpage>–<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1016/j.jelectrocard.2010.06.004</pub-id>
<pub-id pub-id-type="pmid">20667544</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boczek</surname><given-names>N. J.</given-names></name><name><surname>Miller</surname><given-names>E. M.</given-names></name><name><surname>Ye</surname><given-names>D.</given-names></name><name><surname>Nesterenko</surname><given-names>V. V.</given-names></name><name><surname>Tester</surname><given-names>D. J.</given-names></name><name><surname>Antzelevitch</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Novel Timothy syndrome mutation leading to increase in CACNA1C window current</article-title>. <source/>Heart Rhythm.
<volume>12</volume> (<issue>1</issue>), <fpage>211</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2014.09.051</pub-id>
<pub-id pub-id-type="pmid">25260352</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boineau</surname><given-names>J. P.</given-names></name></person-group> (<year>2007</year>). <article-title>The early repolarization variant–normal or a marker of heart disease in certain subjects</article-title>. <source/>J. Electrocardiol.
<volume>40</volume> (<issue>1</issue>), <fpage>3.e11</fpage>–<lpage>3.e16</lpage>. <pub-id pub-id-type="doi">10.1016/j.jelectrocard.2006.04.002</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boutjdir</surname><given-names>M.</given-names></name><name><surname>Lazzerini</surname><given-names>P. E.</given-names></name><name><surname>Capecchi</surname><given-names>P. L.</given-names></name><name><surname>Laghi-Pasini</surname><given-names>F.</given-names></name><name><surname>El-Sherif</surname><given-names>N.</given-names></name></person-group> (<year>2016</year>). <article-title>Potassium channel block and novel autoimmune-associated long QT syndrome</article-title>. <source/>Cardiac Electrophysiol. Clinics
<volume>8</volume> (<issue>2</issue>), <fpage>373</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccep.2016.02.002</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brugada</surname><given-names>P.</given-names></name><name><surname>Brugada</surname><given-names>J.</given-names></name></person-group> (<year>1992</year>). <article-title>Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. a multicenter report</article-title>. <source/>J. Am. Coll. Cardiol.
<volume>20</volume> (<issue>6</issue>), <fpage>1391</fpage>–<lpage>1396</lpage>. <pub-id pub-id-type="doi">10.1016/0735-1097(92)90253-j</pub-id>
<pub-id pub-id-type="pmid">1309182</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brugada</surname><given-names>R.</given-names></name><name><surname>Brugada</surname><given-names>J.</given-names></name><name><surname>Antzelevitch</surname><given-names>C.</given-names></name><name><surname>Kirsch</surname><given-names>G. E.</given-names></name><name><surname>Potenza</surname><given-names>D.</given-names></name><name><surname>Towbin</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts</article-title>. <source/>Circulation
<volume>101</volume> (<issue>5</issue>), <fpage>510</fpage>–<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.101.5.510</pub-id>
<pub-id pub-id-type="pmid">10662748</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burashnikov</surname><given-names>A.</given-names></name><name><surname>Antzelevitch</surname><given-names>C.</given-names></name></person-group> (<year>2003</year>). <article-title>Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity</article-title>. <source/>Circulation
<volume>107</volume> (<issue>18</issue>), <fpage>2355</fpage>–<lpage>2360</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000065578.00869.7C</pub-id>
<pub-id pub-id-type="pmid">12695296</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burashnikov</surname><given-names>A.</given-names></name><name><surname>Antzelevitch</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>Late-phase 3 EAD. a unique mechanism contributing to initiation of atrial fibrillation</article-title>. <source/>Pacing Clin. Electrophysiol.
<volume>29</volume> (<issue>3</issue>), <fpage>290</fpage>–<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8159.2006.00336.x</pub-id>
<pub-id pub-id-type="pmid">16606397</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burashnikov</surname><given-names>E.</given-names></name><name><surname>Pfeiffer</surname><given-names>R.</given-names></name><name><surname>Barajas-Martinez</surname><given-names>H.</given-names></name><name><surname>Delpon</surname><given-names>E.</given-names></name><name><surname>Hu</surname><given-names>D.</given-names></name><name><surname>Desai</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death</article-title>. <source/>Heart Rhythm
<volume>7</volume> (<issue>12</issue>), <fpage>1872</fpage>–<lpage>1882</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2010.08.026</pub-id>
<pub-id pub-id-type="pmid">20817017</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cabo</surname><given-names>C.</given-names></name><name><surname>Barr</surname><given-names>R. C.</given-names></name></person-group> (<year>1992</year>). <article-title>Propagation model using the DiFrancesco-Noble equations. Comparison to reported experimental results</article-title>. <source/>Med. Biol. Eng. Comput.
<volume>30</volume> (<issue>3</issue>), <fpage>292</fpage>–<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1007/bf02446967</pub-id>
<pub-id pub-id-type="pmid">1453801</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cantalapiedra</surname><given-names>I. R.</given-names></name><name><surname>Penaranda</surname><given-names>A.</given-names></name><name><surname>Mont</surname><given-names>L.</given-names></name><name><surname>Brugada</surname><given-names>J.</given-names></name><name><surname>Echebarria</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>). <article-title>Reexcitation mechanisms in epicardial tissue: role of I(to) density heterogeneities and I(Na) inactivation kinetics</article-title>. <source/>J. Theor. Biol.
<volume>259</volume> (<issue>4</issue>), <fpage>850</fpage>–<lpage>859</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtbi.2009.04.021</pub-id>
<pub-id pub-id-type="pmid">19410581</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cantalapiedra</surname><given-names>I. R.</given-names></name><name><surname>Penaranda</surname><given-names>A.</given-names></name><name><surname>Echebarria</surname><given-names>B.</given-names></name><name><surname>Bragard</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Phase-2 reentry in cardiac tissue: role of the slow calcium pulse</article-title>. <source/>Phys. Rev. E Stat. Nonlinear Soft Matter Phys.
<volume>82</volume> (<issue>1 Pt 1</issue>), <elocation-id>011907</elocation-id>. <pub-id pub-id-type="doi">10.1103/PhysRevE.82.011907</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>M. G.</given-names></name><name><surname>Sato</surname><given-names>D.</given-names></name><name><surname>de Lange</surname><given-names>E.</given-names></name><name><surname>Lee</surname><given-names>J. H.</given-names></name><name><surname>Karagueuzian</surname><given-names>H. S.</given-names></name><name><surname>Garfinkel</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Bi-stable wave propagation and early afterdepolarization-mediated cardiac arrhythmias</article-title>. <source/>Heart Rhythm
<volume>9</volume> (<issue>1</issue>), <fpage>115</fpage>–<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2011.08.014</pub-id>
<pub-id pub-id-type="pmid">21855520</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>M. G.</given-names></name><name><surname>de Lange</surname><given-names>E.</given-names></name><name><surname>Calmettes</surname><given-names>G.</given-names></name><name><surname>Garfinkel</surname><given-names>A.</given-names></name><name><surname>Qu</surname><given-names>Z.</given-names></name><name><surname>Weiss</surname><given-names>J. N.</given-names></name></person-group> (<year>2013</year>). <article-title>Pro- and antiarrhythmic effects of ATP-sensitive potassium current activation on reentry during early afterdepolarization-mediated arrhythmias</article-title>. <source/>Heart Rhythm
<volume>10</volume> (<issue>4</issue>), <fpage>575</fpage>–<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2012.12.017</pub-id>
<pub-id pub-id-type="pmid">23246594</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chanson</surname><given-names>M.</given-names></name><name><surname>Mollard</surname><given-names>P.</given-names></name><name><surname>Meda</surname><given-names>P.</given-names></name><name><surname>Suter</surname><given-names>S.</given-names></name><name><surname>Jongsma</surname><given-names>H. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Modulation of pancreatic acinar cell to cell coupling during ACh-evoked changes in cytosolic Ca2+</article-title>. <source/>J. Biol. Chem.
<volume>274</volume> (<issue>1</issue>), <fpage>282</fpage>–<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.274.1.282</pub-id>
<pub-id pub-id-type="pmid">9867842</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Marquardt</surname><given-names>M. L.</given-names></name><name><surname>Tester</surname><given-names>D. J.</given-names></name><name><surname>Sampson</surname><given-names>K. J.</given-names></name><name><surname>Ackerman</surname><given-names>M. J.</given-names></name><name><surname>Kass</surname><given-names>R. S.</given-names></name></person-group> (<year>2007</year>). <article-title>Mutation of an a-kinase-anchoring protein causes long-QT syndrome</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>104</volume> (<issue>52</issue>), <fpage>20990</fpage>–<lpage>20995</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0710527105</pub-id>
<pub-id pub-id-type="pmid">18093912</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cheng</surname><given-names>H.</given-names></name><name><surname>Lederer</surname><given-names>W. J.</given-names></name><name><surname>Cannell</surname><given-names>M. B.</given-names></name></person-group> (<year>1993</year>). <article-title>Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle</article-title>. <source/>Science
<volume>262</volume> (<issue>5134</issue>), <fpage>740</fpage>–<lpage>744</lpage>. <pub-id pub-id-type="doi">10.1126/science.8235594</pub-id>
<pub-id pub-id-type="pmid">8235594</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cheung</surname><given-names>J. W.</given-names></name><name><surname>Meli</surname><given-names>A. C.</given-names></name><name><surname>Xie</surname><given-names>W.</given-names></name><name><surname>Mittal</surname><given-names>S.</given-names></name><name><surname>Reiken</surname><given-names>S.</given-names></name><name><surname>Wronska</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Short-coupled polymorphic ventricular tachycardia at rest linked to a novel ryanodine receptor (RyR2) mutation: leaky RyR2 channels under non-stress conditions</article-title>. <source/>Int. J. Cardiol.
<volume>180</volume>, <fpage>228</fpage>–<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2014.11.119</pub-id>
<pub-id pub-id-type="pmid">25463374</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chiamvimonvat</surname><given-names>N.</given-names></name><name><surname>Chen-Izu</surname><given-names>Y.</given-names></name><name><surname>Clancy</surname><given-names>C. E.</given-names></name><name><surname>Deschenes</surname><given-names>I.</given-names></name><name><surname>Dobrev</surname><given-names>D.</given-names></name><name><surname>Heijman</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics</article-title>. <source/>J. Physiol.
<volume>595</volume> (<issue>7</issue>), <fpage>2229</fpage>–<lpage>2252</lpage>. <pub-id pub-id-type="doi">10.1113/JP272883</pub-id>
<pub-id pub-id-type="pmid">27808412</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chockalingam</surname><given-names>P.</given-names></name><name><surname>Crotti</surname><given-names>L.</given-names></name><name><surname>Girardengo</surname><given-names>G.</given-names></name><name><surname>Johnson</surname><given-names>J. N.</given-names></name><name><surname>Harris</surname><given-names>K. M.</given-names></name><name><surname>van der Heijden</surname><given-names>J. F.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol</article-title>. <source/>J. Am. Coll. Cardiol.
<volume>60</volume> (<issue>20</issue>), <fpage>2092</fpage>–<lpage>2099</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2012.07.046</pub-id>
<pub-id pub-id-type="pmid">23083782</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chopra</surname><given-names>N.</given-names></name><name><surname>Yang</surname><given-names>T.</given-names></name><name><surname>Asghari</surname><given-names>P.</given-names></name><name><surname>Moore</surname><given-names>E. D.</given-names></name><name><surname>Huke</surname><given-names>S.</given-names></name><name><surname>Akin</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>106</volume> (<issue>18</issue>), <fpage>7636</fpage>–<lpage>7641</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0902919106</pub-id>
<pub-id pub-id-type="pmid">19383796</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coppini</surname><given-names>R.</given-names></name><name><surname>Ferrantini</surname><given-names>C.</given-names></name><name><surname>Mugelli</surname><given-names>A.</given-names></name><name><surname>Poggesi</surname><given-names>C.</given-names></name><name><surname>Cerbai</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>). <article-title>Altered Ca(2+) and Na(+) homeostasis in human hypertrophic cardiomyopathy: implications for arrhythmogenesis</article-title>. <source/>Front. Physiol.
<volume>9</volume>, <elocation-id>1391</elocation-id>. <pub-id pub-id-type="doi">10.3389/fphys.2018.01391</pub-id>
<pub-id pub-id-type="pmid">30420810</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coumel</surname><given-names>P.</given-names></name></person-group> (<year>1978</year>). <article-title>Catecholaminergic-induced severe ventricular arrhythmias with adams-Stokes syndrome in children: report of four cases</article-title>. <source/>Br. Heart J.
<volume>40</volume>, <fpage>28</fpage>–<lpage>37</lpage>.
</mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Crotti</surname><given-names>L.</given-names></name><name><surname>Johnson</surname><given-names>C. N.</given-names></name><name><surname>Graf</surname><given-names>E.</given-names></name><name><surname>De Ferrari</surname><given-names>G. M.</given-names></name><name><surname>Cuneo</surname><given-names>B. F.</given-names></name><name><surname>Ovadia</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Calmodulin mutations associated with recurrent cardiac arrest in infants</article-title>. <source/>Circulation
<volume>127</volume> (<issue>9</issue>), <fpage>1009</fpage>–<lpage>1017</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.001216</pub-id>
<pub-id pub-id-type="pmid">23388215</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Damiano</surname><given-names>B. P.</given-names></name><name><surname>Rosen</surname><given-names>M. R.</given-names></name></person-group> (<year>1984</year>). <article-title>Effects of pacing on triggered activity induced by early afterdepolarizations</article-title>. <source/>Circulation
<volume>69</volume> (<issue>5</issue>), <fpage>1013</fpage>–<lpage>1025</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.69.5.1013</pub-id>
<pub-id pub-id-type="pmid">6705157</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davidenko</surname><given-names>J. M.</given-names></name><name><surname>Pertsov</surname><given-names>A. V.</given-names></name><name><surname>Salomonsz</surname><given-names>R.</given-names></name><name><surname>Baxter</surname><given-names>W.</given-names></name><name><surname>Jalife</surname><given-names>J.</given-names></name></person-group> (<year>1992</year>). <article-title>Stationary and drifting spiral waves of excitation in isolated cardiac muscle</article-title>. <source/>Nature
<volume>355</volume> (<issue>6358</issue>), <fpage>349</fpage>–<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1038/355349a0</pub-id>
<pub-id pub-id-type="pmid">1731248</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Ferrari</surname><given-names>G. M.</given-names></name><name><surname>Viola</surname><given-names>M. C.</given-names></name><name><surname>D'Amato</surname><given-names>E.</given-names></name><name><surname>Antolini</surname><given-names>R.</given-names></name><name><surname>Forti</surname><given-names>S.</given-names></name></person-group> (<year>1995</year>). <article-title>Distinct patterns of calcium transients during early and delayed afterdepolarizations induced by isoproterenol in ventricular myocytes</article-title>. <source/>Circulation
<volume>91</volume> (<issue>10</issue>), <fpage>2510</fpage>–<lpage>2515</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.91.10.2510</pub-id>
<pub-id pub-id-type="pmid">7743611</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Maziere</surname><given-names>A. M.</given-names></name><name><surname>Scheuermann</surname><given-names>D. W.</given-names></name></person-group> (<year>1990</year>). <article-title>Structural changes in cardiac gap junctions after hypoxia and reoxygenation: a quantitative freeze-fracture analysis</article-title>. <source/>Cell Tissue Res.
<volume>261</volume> (<issue>1</issue>), <fpage>183</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1007/bf00329451</pub-id>
<pub-id pub-id-type="pmid">2383884</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Denegri</surname><given-names>M.</given-names></name><name><surname>Avelino-Cruz</surname><given-names>J. E.</given-names></name><name><surname>Boncompagni</surname><given-names>S.</given-names></name><name><surname>De Simone</surname><given-names>S. A.</given-names></name><name><surname>Auricchio</surname><given-names>A.</given-names></name><name><surname>Villani</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Viral gene transfer rescues arrhythmogenic phenotype and ultrastructural abnormalities in adult calsequestrin-null mice with inherited arrhythmias</article-title>. <source/>Circ. Res.
<volume>110</volume> (<issue>5</issue>), <fpage>663</fpage>–<lpage>668</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.263939</pub-id>
<pub-id pub-id-type="pmid">22298808</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Denegri</surname><given-names>M.</given-names></name><name><surname>Bongianino</surname><given-names>R.</given-names></name><name><surname>Lodola</surname><given-names>F.</given-names></name><name><surname>Boncompagni</surname><given-names>S.</given-names></name><name><surname>De Giusti</surname><given-names>V. C.</given-names></name><name><surname>Avelino-Cruz</surname><given-names>J. E.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age</article-title>. <source/>Circulation
<volume>129</volume> (<issue>25</issue>), <fpage>2673</fpage>–<lpage>2681</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.006901</pub-id>
<pub-id pub-id-type="pmid">24888331</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Denham</surname><given-names>N. C.</given-names></name><name><surname>Pearman</surname><given-names>C. M.</given-names></name><name><surname>Caldwell</surname><given-names>J. L.</given-names></name><name><surname>Madders</surname><given-names>G. W. P.</given-names></name><name><surname>Eisner</surname><given-names>D. A.</given-names></name><name><surname>Trafford</surname><given-names>A. W.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Calcium in the pathophysiology of atrial fibrillation and heart failure</article-title>. <source/>Front. Physiol.
<volume>9</volume>, <elocation-id>1380</elocation-id>. <pub-id pub-id-type="doi">10.3389/fphys.2018.01380</pub-id>
<pub-id pub-id-type="pmid">30337881</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Devalla</surname><given-names>H. D.</given-names></name><name><surname>Gelinas</surname><given-names>R.</given-names></name><name><surname>Aburawi</surname><given-names>E. H.</given-names></name><name><surname>Beqqali</surname><given-names>A.</given-names></name><name><surname>Goyette</surname><given-names>P.</given-names></name><name><surname>Freund</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT</article-title>. <source/>EMBO Mol. Med.
<volume>8</volume> (<issue>12</issue>), <fpage>1390</fpage>–<lpage>1408</lpage>. <pub-id pub-id-type="doi">10.15252/emmm.201505719</pub-id>
<pub-id pub-id-type="pmid">27861123</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dhein</surname><given-names>S.</given-names></name></person-group> (<year>1998</year>). <article-title>Gap junction channels in the cardiovascular system: pharmacological and physiological modulation</article-title>. <source/>Trends Pharmacol. Sci.
<volume>19</volume> (<issue>6</issue>), <fpage>229</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1016/s0165-6147(98)01192-4</pub-id>
<pub-id pub-id-type="pmid">9666714</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>di Bernardo</surname><given-names>D.</given-names></name><name><surname>Murray</surname><given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>Origin on the electrocardiogram of U-waves and abnormal U-wave inversion</article-title>. <source/>Cardiovasc. Res.
<volume>53</volume> (<issue>1</issue>), <fpage>202</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1016/s0008-6363(01)00439-4</pub-id>
<pub-id pub-id-type="pmid">11744029</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Di Diego</surname><given-names>J. M.</given-names></name><name><surname>Antzelevitch</surname><given-names>C.</given-names></name></person-group> (<year>1994</year>). <article-title>High [Ca2+]o-induced electrical heterogeneity and extrasystolic activity in isolated canine ventricular epicardium. Phase 2 reentry</article-title>. <source/>Circulation
<volume>89</volume> (<issue>4</issue>), <fpage>1839</fpage>–<lpage>1850</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.89.4.1839</pub-id>
<pub-id pub-id-type="pmid">7511994</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dong</surname><given-names>M.</given-names></name><name><surname>Yan</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Niklewski</surname><given-names>P. J.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Chenault</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Role of the transient outward current in regulating mechanical properties of canine ventricular myocytes</article-title>. <source/>J. Cardiovasc. Electrophysiol.
<volume>21</volume> (<issue>6</issue>), <fpage>697</fpage>–<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8167.2009.01708.x</pub-id>
<pub-id pub-id-type="pmid">20132386</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duggal</surname><given-names>P.</given-names></name><name><surname>Vesely</surname><given-names>M. R.</given-names></name><name><surname>Wattanasirichaigoon</surname><given-names>D.</given-names></name><name><surname>Villafane</surname><given-names>J.</given-names></name><name><surname>Kaushik</surname><given-names>V.</given-names></name><name><surname>Beggs</surname><given-names>A. H.</given-names></name></person-group> (<year>1998</year>). <article-title>Mutation of the gene for IsK associated with both jervell and lange-nielsen and romano-ward forms of long-QT syndrome</article-title>. <source/>Circulation
<volume>97</volume> (<issue>2</issue>), <fpage>142</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.97.2.142</pub-id>
<pub-id pub-id-type="pmid">9445165</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eisner</surname><given-names>D. A.</given-names></name><name><surname>Choi</surname><given-names>H. S.</given-names></name><name><surname>Diaz</surname><given-names>M. E.</given-names></name><name><surname>O'Neill</surname><given-names>S. C.</given-names></name><name><surname>Trafford</surname><given-names>A. W.</given-names></name></person-group> (<year>2000</year>). <article-title>Integrative analysis of calcium cycling in cardiac muscle</article-title>. <source/>Circ. Res.
<volume>87</volume> (<issue>12</issue>), <fpage>1087</fpage>–<lpage>1094</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.87.12.1087</pub-id>
<pub-id pub-id-type="pmid">11110764</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eisner</surname><given-names>D. A.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>O'Neill</surname><given-names>S. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Alternans of intracellular calcium: mechanism and significance</article-title>. <source/>Heart Rhythm
<volume>3</volume> (<issue>6</issue>), <fpage>743</fpage>–<lpage>745</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2005.12.020</pub-id>
<pub-id pub-id-type="pmid">16731482</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eisner</surname><given-names>D. A.</given-names></name><name><surname>Caldwell</surname><given-names>J. L.</given-names></name><name><surname>Kistamas</surname><given-names>K.</given-names></name><name><surname>Trafford</surname><given-names>A. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Calcium and excitation-contraction coupling in the heart</article-title>. <source/>Circ. Res.
<volume>121</volume> (<issue>2</issue>), <fpage>181</fpage>–<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1161/circresaha.117.310230</pub-id>
<pub-id pub-id-type="pmid">28684623</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eisner</surname><given-names>D. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Ups and downs of calcium in the heart</article-title>. <source/>J. Physiol.
<volume>596</volume> (<issue>1</issue>), <fpage>19</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1113/jp275130</pub-id>
<pub-id pub-id-type="pmid">29071725</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>El-Sherif</surname><given-names>N.</given-names></name><name><surname>Turitto</surname><given-names>G.</given-names></name></person-group> (<year>1999</year>). <article-title>The long QT syndrome and torsade de pointes</article-title>. <source/>Pacing Clin. Electrophysiol.
<volume>22</volume> (<issue>1 Pt 1</issue>), <fpage>91</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8159.1999.tb00305.x</pub-id>
<pub-id pub-id-type="pmid">9990606</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>El-Sherif</surname><given-names>N.</given-names></name><name><surname>Turitto</surname><given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>Electrolyte disorders and arrhythmogenesis</article-title>. <source/>Cardiol. J.
<volume>18</volume> (<issue>3</issue>), <fpage>233</fpage>–<lpage>245</lpage>.
<pub-id pub-id-type="pmid">21660912</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>el-Sherif</surname><given-names>N.</given-names></name><name><surname>WB</surname><given-names>G.</given-names></name><name><surname>RH</surname><given-names>Z.</given-names></name><name><surname>Hariman</surname><given-names>R.</given-names></name></person-group> (<year>1985</year>). <article-title>Reentrant ventricular arrhythmias in the late myocardial infarction period. 12. spontaneous versus induced reentry and intramural versus epicardial circuits</article-title>. <source/>J. Am. Coll. Cardiol.
<volume>6</volume> (<issue>1</issue>), <fpage>124</fpage>–<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1016/s0735-1097(85)80263-1</pub-id>
<pub-id pub-id-type="pmid">4008769</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>El-Sherif</surname><given-names>N.</given-names></name><name><surname>Turitto</surname><given-names>G.</given-names></name><name><surname>Boutjdir</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Congenital Long QT syndrome and torsade de pointes</article-title>. <source/>Ann. Noninvasive Electrocardiol.: Off. J. Int. Soc. Holter Noninvasive Electrocardiol. Inc.
<volume>22</volume> (<issue>6</issue>), <elocation-id>e12481</elocation-id>. <pub-id pub-id-type="doi">10.1111/anec.12481</pub-id>
</mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>El-Sherif</surname><given-names>N.</given-names></name><name><surname>Turitto</surname><given-names>G.</given-names></name><name><surname>Boutjdir</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Acquired long QT syndrome and electrophysiology of torsade de pointes</article-title>. <source/>Arrhythmia Electrophysiol. Rev.
<volume>8</volume> (<issue>2</issue>), <fpage>122</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.15420/aer.2019.8.3</pub-id>
</mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eryol</surname><given-names>N. K.</given-names></name><name><surname>Colak</surname><given-names>R.</given-names></name><name><surname>Ozdogru</surname><given-names>I.</given-names></name><name><surname>Tanriverdi</surname><given-names>F.</given-names></name><name><surname>Unal</surname><given-names>S.</given-names></name><name><surname>Topsakal</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Effects of calcium treatment on QT interval and QT dispersion in hypocalcemia</article-title>. <source/>Am. J. Cardiol.
<volume>91</volume> (<issue>6</issue>), <fpage>750</fpage>–<lpage>752</lpage>. <pub-id pub-id-type="doi">10.1016/s0002-9149(02)03423-9</pub-id>
<pub-id pub-id-type="pmid">12633817</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Faggioni</surname><given-names>M.</given-names></name><name><surname>Kryshtal</surname><given-names>D. O.</given-names></name><name><surname>Knollmann</surname><given-names>B. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Pediatr. Cardiol.
<volume>33</volume> (<issue>6</issue>), <fpage>959</fpage>–<lpage>967</lpage>. <pub-id pub-id-type="doi">10.1007/s00246-012-0256-1</pub-id>
<pub-id pub-id-type="pmid">22421959</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ferrier</surname><given-names>G. R.</given-names></name><name><surname>Saunders</surname><given-names>J. H.</given-names></name><name><surname>Mendez</surname><given-names>C.</given-names></name></person-group> (<year>1973</year>). <article-title>A cellular mechanism for the generation of ventricular arrhythmias by acetylstrophanthidin</article-title>. <source/>Circ. Res.
<volume>32</volume> (<issue>5</issue>), <fpage>600</fpage>–<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.32.5.600</pub-id>
<pub-id pub-id-type="pmid">4713202</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fink</surname><given-names>M.</given-names></name><name><surname>Noble</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>Pharmacodynamic effects in the cardiovascular system: the modeller's view</article-title>. <source/>Basic Clin. Pharmacol. Toxicol.
<volume>106</volume> (<issue>3</issue>), <fpage>243</fpage>–<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-7843.2009.00534.x</pub-id>
<pub-id pub-id-type="pmid">20470255</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Firek</surname><given-names>L.</given-names></name><name><surname>Weingart</surname><given-names>R.</given-names></name></person-group> (<year>1995</year>). <article-title>Modification of gap junction conductance by divalent cations and protons in neonatal rat heart cells</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>27</volume> (<issue>8</issue>), <fpage>1633</fpage>–<lpage>1643</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-2828(95)90623-1</pub-id>
<pub-id pub-id-type="pmid">8523426</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gadsby</surname><given-names>D. C.</given-names></name><name><surname>Cranefield</surname><given-names>P. F.</given-names></name></person-group> (<year>1977</year>). <article-title>Two levels of resting potential in cardiac Purkinje fibers</article-title>. <source/>J. Gen. Physiol.
<volume>70</volume> (<issue>6</issue>), <fpage>725</fpage>–<lpage>746</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.70.6.725</pub-id>
<pub-id pub-id-type="pmid">591921</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garfinkel</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>Y. H.</given-names></name><name><surname>Voroshilovsky</surname><given-names>O.</given-names></name><name><surname>Qu</surname><given-names>Z.</given-names></name><name><surname>Kil</surname><given-names>J. R.</given-names></name><name><surname>Lee</surname><given-names>M. H.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Preventing ventricular fibrillation by flattening cardiac restitution</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>97</volume> (<issue>11</issue>), <fpage>6061</fpage>–<lpage>6066</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.090492697</pub-id>
<pub-id pub-id-type="pmid">10811880</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garfinkel</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Eight (or more) kinds of alternans</article-title>. <source/>J. Electrocardiol.
<volume>40</volume> (<issue>6 Suppl</issue>), <fpage>S70</fpage>–<lpage>S74</lpage>. <pub-id pub-id-type="doi">10.1016/j.jelectrocard.2007.06.011</pub-id>
<pub-id pub-id-type="pmid">17993333</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garrey</surname><given-names>W. E.</given-names></name></person-group> (<year>1914</year>). <article-title>The nature of fibrillary contraction of the heart.—its relation to tissue mass and form</article-title>. <source/>Am. J. Physiology-Legacy Content
<volume>33</volume> (<issue>3</issue>), <fpage>397</fpage>–<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1152/ajplegacy.1914.33.3.397</pub-id>
</mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>George</surname><given-names>C. H.</given-names></name><name><surname>Jundi</surname><given-names>H.</given-names></name><name><surname>Thomas</surname><given-names>N. L.</given-names></name><name><surname>Fry</surname><given-names>D. L.</given-names></name><name><surname>Lai</surname><given-names>F. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>42</volume> (<issue>1</issue>), <fpage>34</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2006.08.115</pub-id>
<pub-id pub-id-type="pmid">17081562</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goldhaber</surname><given-names>J. I.</given-names></name></person-group> (<year>1996</year>). <article-title>Free radicals enhance Na+/Ca2+ exchange in ventricular myocytes</article-title>. <source/>Am. J. Physiol.
<volume>271</volume> (<issue>3 Pt 2</issue>), <fpage>H823</fpage>–<lpage>H833</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.1996.271.3.H823</pub-id>
<pub-id pub-id-type="pmid">8853314</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gray</surname><given-names>B.</given-names></name><name><surname>Behr</surname><given-names>E. R.</given-names></name></person-group> (<year>2016</year>). <article-title>New insights into the genetic basis of inherited arrhythmia syndromes</article-title>. <source/>Circ. Cardiovasc. Genet.
<volume>9</volume> (<issue>6</issue>), <fpage>569</fpage>–<lpage>577</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.116.001571</pub-id>
<pub-id pub-id-type="pmid">27998945</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gray</surname><given-names>R. A.</given-names></name><name><surname>Jalife</surname><given-names>J.</given-names></name><name><surname>Panfilov</surname><given-names>A. V.</given-names></name><name><surname>Baxter</surname><given-names>W. T.</given-names></name><name><surname>Cabo</surname><given-names>C.</given-names></name><name><surname>Davidenko</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>1995</year>). <article-title>Mechanisms of cardiac fibrillation</article-title>. <source/>Science
<volume>270</volume> (<issue>5239</issue>), <fpage>1222</fpage>–<lpage>1223</lpage>; author reply 4–5. <pub-id pub-id-type="doi">10.1126/science.270.5239.1222</pub-id>
<pub-id pub-id-type="pmid">7502055</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Greenstein</surname><given-names>J. L.</given-names></name><name><surname>Wu</surname><given-names>R.</given-names></name><name><surname>Po</surname><given-names>S.</given-names></name><name><surname>Tomaselli</surname><given-names>G. F.</given-names></name><name><surname>Winslow</surname><given-names>R. L.</given-names></name></person-group> (<year>2000</year>). <article-title>Role of the calcium-independent transient outward current I(to1) in shaping action potential morphology and duration</article-title>. <source/>Circ. Res.
<volume>87</volume> (<issue>11</issue>), <fpage>1026</fpage>–<lpage>1033</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.87.11.1026</pub-id>
<pub-id pub-id-type="pmid">11090548</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Greiser</surname><given-names>M.</given-names></name><name><surname>Kerfant</surname><given-names>B. G.</given-names></name><name><surname>Williams</surname><given-names>G. S.</given-names></name><name><surname>Voigt</surname><given-names>N.</given-names></name><name><surname>Harks</surname><given-names>E.</given-names></name><name><surname>Dibb</surname><given-names>K. M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes</article-title>. <source/>J. Clin. Invest.
<volume>124</volume> (<issue>11</issue>), <fpage>4759</fpage>–<lpage>4772</lpage>. <pub-id pub-id-type="doi">10.1172/JCI70102</pub-id>
<pub-id pub-id-type="pmid">25329692</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Greiser</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Calcium signalling silencing in atrial fibrillation</article-title>. <source/>J. Physiol.
<volume>595</volume> (<issue>12</issue>), <fpage>4009</fpage>–<lpage>4017</lpage>. <pub-id pub-id-type="doi">10.1113/JP273045</pub-id>
<pub-id pub-id-type="pmid">28332202</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Gussak</surname><given-names>I.</given-names></name><name><surname>Antzelevitch</surname><given-names>C.</given-names></name><name><surname>Hammill</surname><given-names>S. C.</given-names></name><name><surname>Shen</surname><given-names>W. K.</given-names></name><name><surname>Bjerregaard</surname><given-names>P.</given-names></name></person-group> (<year>2003</year>). <source/>Cardiac Repolarization - Bridging Basic and Clinical Science. Contemporary Cardiology. (<publisher-loc>Totowa, New Jersey</publisher-loc>: <publisher-name>Humana Press</publisher-name>).
</mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haissaguerre</surname><given-names>M.</given-names></name><name><surname>Derval</surname><given-names>N.</given-names></name><name><surname>Sacher</surname><given-names>F.</given-names></name><name><surname>Jesel</surname><given-names>L.</given-names></name><name><surname>Deisenhofer</surname><given-names>I.</given-names></name><name><surname>de Roy</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Sudden cardiac arrest associated with early repolarization</article-title>. <source/>New Engl. J. Med.
<volume>358</volume> (<issue>19</issue>), <fpage>2016</fpage>–<lpage>2023</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa071968</pub-id>
<pub-id pub-id-type="pmid">18463377</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>M.</given-names></name><name><surname>Denjoy</surname><given-names>I.</given-names></name><name><surname>Extramiana</surname><given-names>F.</given-names></name><name><surname>Maltret</surname><given-names>A.</given-names></name><name><surname>Buisson</surname><given-names>N. R.</given-names></name><name><surname>Lupoglazoff</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Circulation
<volume>119</volume> (<issue>18</issue>), <fpage>2426</fpage>–<lpage>2434</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.829267</pub-id>
<pub-id pub-id-type="pmid">19398665</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hegyi</surname><given-names>B.</given-names></name><name><surname>Bers</surname><given-names>D. M.</given-names></name><name><surname>Bossuyt</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>CaMKII signaling in heart diseases: Emerging role in diabetic cardiomyopathy</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>127</volume>, <fpage>246</fpage>–<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2019.01.001</pub-id>
<pub-id pub-id-type="pmid">30633874</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heijman</surname><given-names>J.</given-names></name><name><surname>Voigt</surname><given-names>N.</given-names></name><name><surname>Nattel</surname><given-names>S.</given-names></name><name><surname>Dobrev</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression</article-title>. <source/>Circ. Res.
<volume>114</volume> (<issue>9</issue>), <fpage>1483</fpage>–<lpage>1499</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.114.302226</pub-id>
<pub-id pub-id-type="pmid">24763466</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hilliard</surname><given-names>F. A.</given-names></name><name><surname>Steele</surname><given-names>D. S.</given-names></name><name><surname>Laver</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Le Marchand</surname><given-names>S. J.</given-names></name><name><surname>Chopra</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>48</volume> (<issue>2</issue>), <fpage>293</fpage>–<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2009.10.005</pub-id>
<pub-id pub-id-type="pmid">19835880</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>B. F.</given-names></name><name><surname>Rosen</surname><given-names>M. R.</given-names></name></person-group> (<year>1981</year>). <article-title>Cellular mechanisms for cardiac arrhythmias</article-title>. <source/>Circ. Res.
<volume>49</volume> (<issue>1</issue>), <fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.49.1.1</pub-id>
<pub-id pub-id-type="pmid">7016362</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hopenfeld</surname><given-names>B.</given-names></name></person-group> (<year>2006</year>). <article-title>Mechanism for action potential alternans: the interplay between L-type calcium current and transient outward current</article-title>. <source/>Heart Rhythm
<volume>3</volume> (<issue>3</issue>), <fpage>345</fpage>–<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2005.11.016</pub-id>
<pub-id pub-id-type="pmid">16500310</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Horvath</surname><given-names>B.</given-names></name><name><surname>Banyasz</surname><given-names>T.</given-names></name><name><surname>Jian</surname><given-names>Z.</given-names></name><name><surname>Hegyi</surname><given-names>B.</given-names></name><name><surname>Kistamas</surname><given-names>K.</given-names></name><name><surname>Nanasi</surname><given-names>P. P.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Dynamics of the late Na(+) current during cardiac action potential and its contribution to afterdepolarizations</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>64</volume>, <fpage>59</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.08.010</pub-id>
<pub-id pub-id-type="pmid">24012538</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Horvath</surname><given-names>B.</given-names></name><name><surname>Hegyi</surname><given-names>B.</given-names></name><name><surname>Kistamas</surname><given-names>K.</given-names></name><name><surname>Vaczi</surname><given-names>K.</given-names></name><name><surname>Banyasz</surname><given-names>T.</given-names></name><name><surname>Magyar</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Cytosolic calcium changes affect the incidence of early afterdepolarizations in canine ventricular myocytes</article-title>. <source/>Can. J. Physiol. Pharmacol.
<volume>93</volume> (<issue>7</issue>), <fpage>527</fpage>–<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1139/cjpp-2014-0511</pub-id>
<pub-id pub-id-type="pmid">25928391</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Houle</surname><given-names>T. D.</given-names></name><name><surname>Ram</surname><given-names>M. L.</given-names></name><name><surname>Cala</surname><given-names>S. E.</given-names></name></person-group> (<year>2004</year>). <article-title>Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium</article-title>. <source/>Cardiovasc. Res.
<volume>64</volume> (<issue>2</issue>), <fpage>227</fpage>–<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardiores.2004.09.009</pub-id>
<pub-id pub-id-type="pmid">15485681</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hwang</surname><given-names>H. S.</given-names></name><name><surname>Hasdemir</surname><given-names>C.</given-names></name><name><surname>Laver</surname><given-names>D.</given-names></name><name><surname>Mehra</surname><given-names>D.</given-names></name><name><surname>Turhan</surname><given-names>K.</given-names></name><name><surname>Faggioni</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Circ. Arrhythm. Electrophysiol.
<volume>4</volume> (<issue>2</issue>), <fpage>128</fpage>–<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.110.959916</pub-id>
<pub-id pub-id-type="pmid">21270101</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hwang</surname><given-names>H. S.</given-names></name><name><surname>Baldo</surname><given-names>M. P.</given-names></name><name><surname>Rodriguez</surname><given-names>J. P.</given-names></name><name><surname>Faggioni</surname><given-names>M.</given-names></name><name><surname>Knollmann</surname><given-names>B. C.</given-names></name></person-group> (<year>2019</year>). <article-title>Efficacy of flecainide in catecholaminergic polymorphic ventricular tachycardia is mutation-independent but reduced by calcium overload</article-title>. <source/>Front. Physiol.
<volume>10</volume>, <elocation-id>992</elocation-id>. <pub-id pub-id-type="doi">10.3389/fphys.2019.00992</pub-id>
<pub-id pub-id-type="pmid">31456692</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>T.</given-names></name><name><surname>Uchida</surname><given-names>T.</given-names></name><name><surname>Hough</surname><given-names>D.</given-names></name><name><surname>Lee</surname><given-names>J. J.</given-names></name><name><surname>Fishbein</surname><given-names>M. C.</given-names></name><name><surname>Mandel</surname><given-names>W. J.</given-names></name><etal></etal></person-group> (<year>1996</year>). <article-title>Mechanism of spontaneous termination of functional reentry in isolated canine right atrium. Evidence for the presence of an excitable but nonexcited core</article-title>. <source/>Circulation
<volume>94</volume> (<issue>8</issue>), <fpage>1962</fpage>–<lpage>1973</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.94.8.1962</pub-id>
<pub-id pub-id-type="pmid">8873675</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ildarova</surname><given-names>R.</given-names></name><name><surname>Shkolnikova</surname><given-names>M. A.</given-names></name><name><surname>Kharlap</surname><given-names>M.</given-names></name><name><surname>Bereznitskaya</surname><given-names>V.</given-names></name><name><surname>Kalinin</surname><given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Sodium-channel blockers might contribute to the prevention of ventricular tachycardia in patients with long QT syndrome type 2: a description of 4 cases</article-title>. <source/>J. Electrocardiol.
<volume>45</volume> (<issue>3</issue>), <fpage>237</fpage>–<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1016/j.jelectrocard.2012.01.008</pub-id>
<pub-id pub-id-type="pmid">22402334</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>A.</given-names></name><name><surname>Knight</surname><given-names>B. P.</given-names></name><name><surname>McDonald</surname><given-names>K. T.</given-names></name><name><surname>Burke</surname><given-names>M. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Verapamil decreases ventricular tachyarrhythmias in a patient with timothy syndrome (LQT8)</article-title>. <source/>Heart Rhythm
<volume>3</volume> (<issue>8</issue>), <fpage>967</fpage>–<lpage>970</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2006.04.024</pub-id>
<pub-id pub-id-type="pmid">16876748</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jalife</surname><given-names>J.</given-names></name><name><surname>Delmar</surname><given-names>M.</given-names></name><name><surname>Anumonwo</surname><given-names>J.</given-names></name><name><surname>Berenfeld</surname><given-names>O.</given-names></name><name><surname>Kalifa</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Basic mechanisms of cardiac arrhythmias</article-title>. <source/>Basic Cardiac Electrophysiol. Clinician
<volume>2</volume>.
</mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>January</surname><given-names>C. T.</given-names></name><name><surname>Riddle</surname><given-names>J. M.</given-names></name></person-group> (<year>1989</year>). <article-title>Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current</article-title>. <source/>Circ. Res.
<volume>64</volume> (<issue>5</issue>), <fpage>977</fpage>–<lpage>990</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.64.5.977</pub-id>
<pub-id pub-id-type="pmid">2468430</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jensen</surname><given-names>H. H.</given-names></name><name><surname>Brohus</surname><given-names>M.</given-names></name><name><surname>Nyegaard</surname><given-names>M.</given-names></name><name><surname>Overgaard</surname><given-names>M. T.</given-names></name></person-group> (<year>2018</year>). <article-title>Human calmodulin mutations</article-title>. <source/>Front. Mol. Neurosci.
<volume>11</volume>, <elocation-id>396</elocation-id>. <pub-id pub-id-type="doi">10.3389/fnmol.2018.00396</pub-id>
<pub-id pub-id-type="pmid">30483049</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Xiao</surname><given-names>B.</given-names></name><name><surname>Kong</surname><given-names>H.</given-names></name><name><surname>Hunt</surname><given-names>D. J.</given-names></name><name><surname>Choi</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death</article-title>. <source/>Circ. Res.
<volume>97</volume> (<issue>11</issue>), <fpage>1173</fpage>–<lpage>1181</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000192146.85173.4b</pub-id>
<pub-id pub-id-type="pmid">16239587</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>S. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>104</volume> (<issue>46</issue>), <fpage>18309</fpage>–<lpage>18314</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0706573104</pub-id>
<pub-id pub-id-type="pmid">17984046</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnson</surname><given-names>D. M.</given-names></name><name><surname>Antoons</surname><given-names>G.</given-names></name></person-group> (<year>2018</year>). <article-title>Arrhythmogenic mechanisms in heart failure: linking beta-adrenergic stimulation, stretch, and calcium</article-title>. <source/>Front. Physiol.
<volume>9</volume>, <elocation-id>1453</elocation-id>. <pub-id pub-id-type="doi">10.3389/fphys.2018.01453</pub-id>
<pub-id pub-id-type="pmid">30374311</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jones</surname><given-names>P. P.</given-names></name><name><surname>Jiang</surname><given-names>D.</given-names></name><name><surname>Bolstad</surname><given-names>J.</given-names></name><name><surname>Hunt</surname><given-names>D. J.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Demaurex</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Endoplasmic reticulum Ca2+ measurements reveal that the cardiac ryanodine receptor mutations linked to cardiac arrhythmia and sudden death alter the threshold for store-overload-induced Ca2+ release</article-title>. <source/>Biochem. J.
<volume>412</volume> (<issue>1</issue>), <fpage>171</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20071287</pub-id>
<pub-id pub-id-type="pmid">18092949</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Joung</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>P. S.</given-names></name><name><surname>Lin</surname><given-names>S. F.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of the calcium and the voltage clocks in sinoatrial node dysfunction</article-title>. <source/>Yonsei Med. J.
<volume>52</volume> (<issue>2</issue>), <fpage>211</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.3349/ymj.2011.52.2.211</pub-id>
<pub-id pub-id-type="pmid">21319337</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kandel</surname><given-names>S. M.</given-names></name><name><surname>Roth</surname><given-names>B. J.</given-names></name></person-group> (<year>2015</year>). <article-title>The mechanism of reflection type reentry: a simulation study</article-title>. <source/>J. Cardiovasc. Electrophysiol.
<volume>26</volume> (<issue>12</issue>), <fpage>1370</fpage>–<lpage>1375</lpage>. <pub-id pub-id-type="doi">10.1111/jce.12815</pub-id>
<pub-id pub-id-type="pmid">26269355</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kang</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>X. L.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Ji</surname><given-names>J.</given-names></name><name><surname>Cheng</surname><given-names>H.</given-names></name><name><surname>Incardona</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel</article-title>. <source/>Mol. Pharmacol.
<volume>67</volume> (<issue>3</issue>), <fpage>827</fpage>–<lpage>836</lpage>. <pub-id pub-id-type="doi">10.1124/mol.104.006577</pub-id>
<pub-id pub-id-type="pmid">15548764</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kannankeril</surname><given-names>P. J.</given-names></name><name><surname>Moore</surname><given-names>J. P.</given-names></name><name><surname>Cerrone</surname><given-names>M.</given-names></name><name><surname>Priori</surname><given-names>S. G.</given-names></name><name><surname>Kertesz</surname><given-names>N. J.</given-names></name><name><surname>Ro</surname><given-names>P. S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial</article-title>. <source/>JAMA Cardiol.
<volume>2</volume> (<issue>7</issue>), <fpage>759</fpage>–<lpage>766</lpage>. <pub-id pub-id-type="doi">10.1001/jamacardio.2017.1320</pub-id>
<pub-id pub-id-type="pmid">28492868</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karagueuzian</surname><given-names>H. S.</given-names></name><name><surname>Pezhouman</surname><given-names>A.</given-names></name><name><surname>Angelini</surname><given-names>M.</given-names></name><name><surname>Olcese</surname><given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Enhanced late na and ca currents as effective antiarrhythmic drug targets</article-title>. <source/>Front. Pharmacol.
<volume>8</volume>, <elocation-id>36</elocation-id>. <pub-id pub-id-type="doi">10.3389/fphar.2017.00036</pub-id>
<pub-id pub-id-type="pmid">28220073</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kashimura</surname><given-names>T.</given-names></name><name><surname>Briston</surname><given-names>S. J.</given-names></name><name><surname>Trafford</surname><given-names>A. W.</given-names></name><name><surname>Napolitano</surname><given-names>C.</given-names></name><name><surname>Priori</surname><given-names>S. G.</given-names></name><name><surname>Eisner</surname><given-names>D. A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>In the RyR2(R4496C) mouse model of CPVT, beta-adrenergic stimulation induces Ca waves by increasing SR Ca content and not by decreasing the threshold for Ca waves</article-title>. <source/>Circ. Res.
<volume>107</volume> (<issue>12</issue>), <fpage>1483</fpage>–<lpage>1489</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.227744</pub-id>
<pub-id pub-id-type="pmid">20966392</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. A.</given-names></name><name><surname>Lopes</surname><given-names>C. M.</given-names></name><name><surname>Moss</surname><given-names>A. J.</given-names></name><name><surname>McNitt</surname><given-names>S.</given-names></name><name><surname>Barsheshet</surname><given-names>A.</given-names></name><name><surname>Robinson</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Trigger-specific risk factors and response to therapy in long QT syndrome type 2</article-title>. <source/>Heart Rhythm
<volume>7</volume> (<issue>12</issue>), <fpage>1797</fpage>–<lpage>1805</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2010.09.011</pub-id>
<pub-id pub-id-type="pmid">20850565</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kirchhof</surname><given-names>P.</given-names></name><name><surname>Benussi</surname><given-names>S.</given-names></name><name><surname>Kotecha</surname><given-names>D.</given-names></name><name><surname>Ahlsson</surname><given-names>A.</given-names></name><name><surname>Atar</surname><given-names>D.</given-names></name><name><surname>Casadei</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS</article-title>. <source/>Eur. J. Cardiothorac. Surg.
<volume>50</volume> (<issue>5</issue>), <fpage>e1</fpage>–<lpage>e88</lpage>. <pub-id pub-id-type="doi">10.1093/ejcts/ezw313</pub-id>
<pub-id pub-id-type="pmid">27663299</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kistamas</surname><given-names>K.</given-names></name><name><surname>Hegyi</surname><given-names>B.</given-names></name><name><surname>Vaczi</surname><given-names>K.</given-names></name><name><surname>Horvath</surname><given-names>B.</given-names></name><name><surname>Banyasz</surname><given-names>T.</given-names></name><name><surname>Magyar</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2015</year>a). <article-title>Oxidative shift in tissue redox potential increases beat-to-beat variability of action potential duration</article-title>. <source/>Can. J. Physiol. Pharmacol.
<volume>93</volume> (<issue>7</issue>), <fpage>563</fpage>–<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1139/cjpp-2014-0531</pub-id>
<pub-id pub-id-type="pmid">25996357</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kistamas</surname><given-names>K.</given-names></name><name><surname>Szentandrassy</surname><given-names>N.</given-names></name><name><surname>Hegyi</surname><given-names>B.</given-names></name><name><surname>Vaczi</surname><given-names>K.</given-names></name><name><surname>Ruzsnavszky</surname><given-names>F.</given-names></name><name><surname>Horvath</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2015</year>b). <article-title>Changes in intracellular calcium concentration influence beat-to-beat variability of action potential duration in canine ventricular myocytes</article-title>. <source/>J. Physiol. Pharmacol.
<volume>66</volume> (<issue>1</issue>), <fpage>73</fpage>–<lpage>81</lpage>.
<pub-id pub-id-type="pmid">25716967</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knollmann</surname><given-names>B. C.</given-names></name><name><surname>Chopra</surname><given-names>N.</given-names></name><name><surname>Hlaing</surname><given-names>T.</given-names></name><name><surname>Akin</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>T.</given-names></name><name><surname>Ettensohn</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>J. Clin. Invest.
<volume>116</volume> (<issue>9</issue>), <fpage>2510</fpage>–<lpage>2520</lpage>. <pub-id pub-id-type="doi">10.1172/JCI29128</pub-id>
<pub-id pub-id-type="pmid">16932808</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kohomoto</surname><given-names>O.</given-names></name><name><surname>Levi</surname><given-names>A. J.</given-names></name><name><surname>Bridge</surname><given-names>J. H.</given-names></name></person-group> (<year>1994</year>). <article-title>Relation between reverse sodium-calcium exchange and sarcoplasmic reticulum calcium release in guinea pig ventricular cells</article-title>. <source/>Circ. Res.
<volume>74</volume> (<issue>3</issue>), <fpage>550</fpage>–<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.74.3.550</pub-id>
<pub-id pub-id-type="pmid">8118963</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krause</surname><given-names>U.</given-names></name><name><surname>Gravenhorst</surname><given-names>V.</given-names></name><name><surname>Kriebel</surname><given-names>T.</given-names></name><name><surname>Ruschewski</surname><given-names>W.</given-names></name><name><surname>Paul</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>A rare association of long QT syndrome and syndactyly: Timothy syndrome (LQT 8)</article-title>. <source/>Clin. Res. Cardiol.
<volume>100</volume> (<issue>12</issue>), <fpage>1123</fpage>–<lpage>1127</lpage>. <pub-id pub-id-type="doi">10.1007/s00392-011-0358-4</pub-id>
<pub-id pub-id-type="pmid">21915623</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lahat</surname><given-names>H.</given-names></name><name><surname>Pras</surname><given-names>E.</given-names></name><name><surname>Olender</surname><given-names>T.</given-names></name><name><surname>Avidan</surname><given-names>N.</given-names></name><name><surname>Ben-Asher</surname><given-names>E.</given-names></name><name><surname>Man</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel</article-title>. <source/>Am. J. Hum. Genet.
<volume>69</volume> (<issue>6</issue>), <fpage>1378</fpage>–<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.1086/324565</pub-id>
<pub-id pub-id-type="pmid">11704930</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Laitinen</surname><given-names>P. J.</given-names></name><name><surname>Brown</surname><given-names>K. M.</given-names></name><name><surname>Piippo</surname><given-names>K.</given-names></name><name><surname>Swan</surname><given-names>H.</given-names></name><name><surname>Devaney</surname><given-names>J. M.</given-names></name><name><surname>Brahmbhatt</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia</article-title>. <source/>Circulation
<volume>103</volume> (<issue>4</issue>), <fpage>485</fpage>–<lpage>490</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.103.4.485</pub-id>
<pub-id pub-id-type="pmid">11157710</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lakatta</surname><given-names>E. G.</given-names></name><name><surname>DiFrancesco</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>What keeps us ticking: a funny current, a calcium clock, or both</article-title>? <source/>J. Mol. Cell. Cardiol.
<volume>47</volume> (<issue>2</issue>), <fpage>157</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2009.03.022</pub-id>
<pub-id pub-id-type="pmid">19361514</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lakatta</surname><given-names>E. G.</given-names></name><name><surname>Maltsev</surname><given-names>V. A.</given-names></name><name><surname>Vinogradova</surname><given-names>T. M.</given-names></name></person-group> (<year>2010</year>). <article-title>A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker</article-title>. <source/>Circ. Res.
<volume>106</volume> (<issue>4</issue>), <fpage>659</fpage>–<lpage>673</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.206078</pub-id>
<pub-id pub-id-type="pmid">20203315</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lakatta</surname><given-names>E. G.</given-names></name></person-group> (<year>2010</year>). <article-title>A paradigm shift for the heart's pacemaker</article-title>. <source/>Heart Rhythm
<volume>7</volume> (<issue>4</issue>), <fpage>559</fpage>–<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2009.12.013</pub-id>
<pub-id pub-id-type="pmid">20156611</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Landstrom</surname><given-names>A. P.</given-names></name><name><surname>Boczek</surname><given-names>N. J.</given-names></name><name><surname>Ye</surname><given-names>D.</given-names></name><name><surname>Miyake</surname><given-names>C. Y.</given-names></name><name><surname>De la Uz</surname><given-names>C. M.</given-names></name><name><surname>Allen</surname><given-names>H. D.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current</article-title>. <source/>Int. J. Cardiol.
<volume>220</volume>, <fpage>290</fpage>–<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2016.06.081</pub-id>
<pub-id pub-id-type="pmid">27390944</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Landstrom</surname><given-names>A. P.</given-names></name><name><surname>Dobrev</surname><given-names>D.</given-names></name><name><surname>Wehrens</surname><given-names>X. H. T.</given-names></name></person-group> (<year>2017</year>). <article-title>Calcium signaling and cardiac arrhythmias</article-title>. <source/>Circ. Res.
<volume>120</volume> (<issue>12</issue>), <fpage>1969</fpage>–<lpage>1993</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.310083</pub-id>
<pub-id pub-id-type="pmid">28596175</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lazrak</surname><given-names>A.</given-names></name><name><surname>Peres</surname><given-names>A.</given-names></name><name><surname>Giovannardi</surname><given-names>S.</given-names></name><name><surname>Peracchia</surname><given-names>C.</given-names></name></person-group> (<year>1994</year>). <article-title>Ca-mediated and independent effects of arachidonic acid on gap junctions and Ca-independent effects of oleic acid and halothane</article-title>. <source/>Biophys. J.
<volume>67</volume> (<issue>3</issue>), <fpage>1052</fpage>–<lpage>1059</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3495(94)80570-3</pub-id>
<pub-id pub-id-type="pmid">7811915</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lazzara</surname><given-names>R.</given-names></name></person-group> (<year>1988</year>). <article-title>Electrophysiological mechanisms for ventricular arrhythmias</article-title>. <source/>Clin. Cardiol.
<volume>11</volume> (<issue>3 Suppl 2</issue>), <fpage>II1</fpage>–<lpage>II4</lpage>.
</mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lazzerini</surname><given-names>P. E.</given-names></name><name><surname>Capecchi</surname><given-names>P. L.</given-names></name><name><surname>Laghi-Pasini</surname><given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>Long QT syndrome: an emerging role for inflammation and immunity</article-title>. <source/>Front. Cardiovasc. Med.
<volume>2</volume>, <elocation-id>26</elocation-id>. <pub-id pub-id-type="doi">10.3389/fcvm.2015.00026</pub-id>
<pub-id pub-id-type="pmid">26798623</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leenhardt</surname><given-names>A.</given-names></name><name><surname>Lucet</surname><given-names>V.</given-names></name><name><surname>Denjoy</surname><given-names>I.</given-names></name><name><surname>Grau</surname><given-names>F.</given-names></name><name><surname>Ngoc</surname><given-names>D. D.</given-names></name><name><surname>Coumel</surname><given-names>P.</given-names></name></person-group> (<year>1995</year>). <article-title>Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients</article-title>. <source/>Circulation
<volume>91</volume> (<issue>5</issue>), <fpage>1512</fpage>–<lpage>1519</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.91.5.1512</pub-id>
<pub-id pub-id-type="pmid">7867192</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lehnart</surname><given-names>S. E.</given-names></name><name><surname>Wehrens</surname><given-names>X. H.</given-names></name><name><surname>Laitinen</surname><given-names>P. J.</given-names></name><name><surname>Reiken</surname><given-names>S. R.</given-names></name><name><surname>Deng</surname><given-names>S. X.</given-names></name><name><surname>Cheng</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak</article-title>. <source/>Circulation
<volume>109</volume> (<issue>25</issue>), <fpage>3208</fpage>–<lpage>3214</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000132472.98675.EC</pub-id>
<pub-id pub-id-type="pmid">15197150</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Diaz</surname><given-names>M. E.</given-names></name><name><surname>Eisner</surname><given-names>D. A.</given-names></name><name><surname>O'Neill</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>The effects of membrane potential, SR Ca2+ content and RyR responsiveness on systolic Ca2+ alternans in rat ventricular myocytes</article-title>. <source/>J. Physiol.
<volume>587</volume> (<issue>Pt 6</issue>), <fpage>1283</fpage>–<lpage>1292</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2008.164368</pub-id>
<pub-id pub-id-type="pmid">19153161</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Limpitikul</surname><given-names>W. B.</given-names></name><name><surname>Dick</surname><given-names>I. E.</given-names></name><name><surname>Joshi-Mukherjee</surname><given-names>R.</given-names></name><name><surname>Overgaard</surname><given-names>M. T.</given-names></name><name><surname>George</surname><given-names>A. L.</given-names><suffix>Jr.</suffix></name><name><surname>Yue</surname><given-names>D. T.</given-names></name></person-group> (<year>2014</year>). <article-title>Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>74</volume>, <fpage>115</fpage>–<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2014.04.022</pub-id>
<pub-id pub-id-type="pmid">24816216</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lipp</surname><given-names>P.</given-names></name><name><surname>Niggli</surname><given-names>E.</given-names></name></person-group> (<year>1994</year>). <article-title>Modulation of Ca2+ release in cultured neonatal rat cardiac myocytes. Insight from subcellular release patterns revealed by confocal microscopy</article-title>. <source/>Circ. Res.
<volume>74</volume> (<issue>5</issue>), <fpage>979</fpage>–<lpage>990</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.74.5.979</pub-id>
<pub-id pub-id-type="pmid">8156645</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>D. W.</given-names></name><name><surname>Antzelevitch</surname><given-names>C.</given-names></name></person-group> (<year>1995</year>). <article-title>Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial, and endocardial myocytes. a weaker IKs contributes to the longer action potential of the M cell</article-title>. <source/>Circ. Res.
<volume>76</volume> (<issue>3</issue>), <fpage>351</fpage>–<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.76.3.351</pub-id>
<pub-id pub-id-type="pmid">7859382</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>N.</given-names></name><name><surname>Colombi</surname><given-names>B.</given-names></name><name><surname>Memmi</surname><given-names>M.</given-names></name><name><surname>Zissimopoulos</surname><given-names>S.</given-names></name><name><surname>Rizzi</surname><given-names>N.</given-names></name><name><surname>Negri</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model</article-title>. <source/>Circ. Res.
<volume>99</volume> (<issue>3</issue>), <fpage>292</fpage>–<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000235869.50747.e1</pub-id>
<pub-id pub-id-type="pmid">16825580</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>N.</given-names></name><name><surname>Rizzi</surname><given-names>N.</given-names></name><name><surname>Boveri</surname><given-names>L.</given-names></name><name><surname>Priori</surname><given-names>S. G.</given-names></name></person-group> (<year>2009</year>). <article-title>Ryanodine receptor and calsequestrin in arrhythmogenesis: what we have learnt from genetic diseases and transgenic mice</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>46</volume> (<issue>2</issue>), <fpage>149</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2008.10.012</pub-id>
<pub-id pub-id-type="pmid">19027025</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>N.</given-names></name><name><surname>Ruan</surname><given-names>Y.</given-names></name><name><surname>Denegri</surname><given-names>M.</given-names></name><name><surname>Bachetti</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Colombi</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2011</year>a). <article-title>Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>50</volume> (<issue>1</issue>), <fpage>214</fpage>–<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2010.10.001</pub-id>
<pub-id pub-id-type="pmid">20937285</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>N.</given-names></name><name><surname>Denegri</surname><given-names>M.</given-names></name><name><surname>Ruan</surname><given-names>Y.</given-names></name><name><surname>Avelino-Cruz</surname><given-names>J. E.</given-names></name><name><surname>Perissi</surname><given-names>A.</given-names></name><name><surname>Negri</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>b). <article-title>Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity</article-title>. <source/>Circ. Res.
<volume>109</volume> (<issue>3</issue>), <fpage>291</fpage>–<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.247338</pub-id>
<pub-id pub-id-type="pmid">21680895</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Chatel</surname><given-names>S.</given-names></name><name><surname>Simard</surname><given-names>C.</given-names></name><name><surname>Syam</surname><given-names>N.</given-names></name><name><surname>Salle</surname><given-names>L.</given-names></name><name><surname>Probst</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Molecular genetics and functional anomalies in a series of 248 Brugada cases with 11 mutations in the TRPM4 channel</article-title>. <source/>PLoS One
<volume>8</volume> (<issue>1</issue>), <elocation-id>e54131</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0054131</pub-id>
<pub-id pub-id-type="pmid">23382873</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Yan</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>KCNE2 modulates cardiac L-type Ca(2+) channel</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>72</volume>, <fpage>208</fpage>–<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2014.03.013</pub-id>
<pub-id pub-id-type="pmid">24681347</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>M. B.</given-names></name><name><surname>de Lange</surname><given-names>E.</given-names></name><name><surname>Garfinkel</surname><given-names>A.</given-names></name><name><surname>Weiss</surname><given-names>J. N.</given-names></name><name><surname>Qu</surname><given-names>Z.</given-names></name></person-group> (<year>2015</year>). <article-title>Delayed afterdepolarizations generate both triggers and a vulnerable substrate promoting reentry in cardiac tissue</article-title>. <source/>Heart Rhythm
<volume>12</volume> (<issue>10</issue>), <fpage>2115</fpage>–<lpage>2124</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2015.06.019</pub-id>
<pub-id pub-id-type="pmid">26072025</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Loughrey</surname><given-names>C. M.</given-names></name><name><surname>Otani</surname><given-names>N.</given-names></name><name><surname>Seidler</surname><given-names>T.</given-names></name><name><surname>Craig</surname><given-names>M. A.</given-names></name><name><surname>Matsuda</surname><given-names>R.</given-names></name><name><surname>Kaneko</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>K201 modulates excitation-contraction coupling and spontaneous Ca2+ release in normal adult rabbit ventricular cardiomyocytes</article-title>. <source/>Cardiovasc. Res.
<volume>76</volume> (<issue>2</issue>), <fpage>236</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardiores.2007.06.014</pub-id>
<pub-id pub-id-type="pmid">17644079</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Mahaut-Smith</surname><given-names>M. P.</given-names></name><name><surname>Huang</surname><given-names>C. L.</given-names></name><name><surname>Vandenberg</surname><given-names>J. I.</given-names></name></person-group> (<year>2003</year>). <article-title>Mutant MiRP1 subunits modulate HERG K+ channel gating: a mechanism for pro-arrhythmia in long QT syndrome type 6</article-title>. <source/>J. Physiol.
<volume>551</volume> (<issue>Pt 1</issue>), <fpage>253</fpage>–<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2003.046045</pub-id>
<pub-id pub-id-type="pmid">12923204</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lukas</surname><given-names>A.</given-names></name><name><surname>Antzelevitch</surname><given-names>C.</given-names></name></person-group> (<year>1996</year>). <article-title>Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia</article-title>. <source/>Cardiovasc. Res.
<volume>32</volume> (<issue>3</issue>), <fpage>593</fpage>–<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1016/S0008-6363(96)00115-0</pub-id>
<pub-id pub-id-type="pmid">8881520</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lukyanenko</surname><given-names>V.</given-names></name><name><surname>Subramanian</surname><given-names>S.</given-names></name><name><surname>Gyorke</surname><given-names>I.</given-names></name><name><surname>Wiesner</surname><given-names>T. F.</given-names></name><name><surname>Gyorke</surname><given-names>S.</given-names></name></person-group> (<year>1999</year>). <article-title>The role of luminal Ca2+ in the generation of Ca2+ waves in rat ventricular myocytes</article-title>. <source/>J. Physiol.
<volume>518</volume> (<issue>Pt 1</issue>), <fpage>173</fpage>–<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.1999.0173r.x</pub-id>
<pub-id pub-id-type="pmid">10373699</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Magyar</surname><given-names>J.</given-names></name><name><surname>Banyasz</surname><given-names>T.</given-names></name><name><surname>Szentandrassy</surname><given-names>N.</given-names></name><name><surname>Kistamas</surname><given-names>K.</given-names></name><name><surname>Nanasi</surname><given-names>P. P.</given-names></name><name><surname>Satin</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Role of gap junction channel in the development of beat-to-beat action potential repolarization variability and arrhythmias</article-title>. <source/>Curr. Pharma. Des.
<volume>21</volume> (<issue>8</issue>), <fpage>1042</fpage>–<lpage>1052</lpage>. <pub-id pub-id-type="doi">10.2174/1381612820666141029102443</pub-id>
</mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Magyar</surname><given-names>J.</given-names></name><name><surname>Kistamas</surname><given-names>K.</given-names></name><name><surname>Vaczi</surname><given-names>K.</given-names></name><name><surname>Hegyi</surname><given-names>B.</given-names></name><name><surname>Horvath</surname><given-names>B.</given-names></name><name><surname>Banyasz</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Concept of relative variability of cardiac action potential duration and its test under various experimental conditions</article-title>. <source/>Gen. Physiol. Biophys.
<volume>35</volume> (<issue>1</issue>), <fpage>55</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.4149/gpb_2015019</pub-id>
<pub-id pub-id-type="pmid">26492070</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mahajan</surname><given-names>A.</given-names></name><name><surname>Shiferaw</surname><given-names>Y.</given-names></name><name><surname>Sato</surname><given-names>D.</given-names></name><name><surname>Baher</surname><given-names>A.</given-names></name><name><surname>Olcese</surname><given-names>R.</given-names></name><name><surname>Xie</surname><given-names>L. H.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>A rabbit ventricular action potential model replicating cardiac dynamics at rapid heart rates</article-title>. <source/>Biophys. J.
<volume>94</volume> (<issue>2</issue>), <fpage>392</fpage>–<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1529/biophysj.106.98160</pub-id>
<pub-id pub-id-type="pmid">18160660</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maier</surname><given-names>L. S.</given-names></name><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart</article-title>. <source/>Cardiovasc. Res.
<volume>73</volume> (<issue>4</issue>), <fpage>631</fpage>–<lpage>640</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardiores.2006.11.005</pub-id>
<pub-id pub-id-type="pmid">17157285</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maltsev</surname><given-names>V. A.</given-names></name><name><surname>Vinogradova</surname><given-names>T. M.</given-names></name><name><surname>Lakatta</surname><given-names>E. G.</given-names></name></person-group> (<year>2006</year>). <article-title>The emergence of a general theory of the initiation and strength of the heartbeat</article-title>. <source/>J. Pharmacol. Sci.
<volume>100</volume> (<issue>5</issue>), <fpage>338</fpage>–<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1254/jphs.cr0060018</pub-id>
<pub-id pub-id-type="pmid">16799255</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marsman</surname><given-names>R. F.</given-names></name><name><surname>Barc</surname><given-names>J.</given-names></name><name><surname>Beekman</surname><given-names>L.</given-names></name><name><surname>Alders</surname><given-names>M.</given-names></name><name><surname>Dooijes</surname><given-names>D.</given-names></name><name><surname>van den Wijngaard</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence</article-title>. <source/>J. Am. Coll. Cardiol.
<volume>63</volume> (<issue>3</issue>), <fpage>259</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2013.07.091</pub-id>
<pub-id pub-id-type="pmid">24076290</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maruyama</surname><given-names>M.</given-names></name><name><surname>Joung</surname><given-names>B.</given-names></name><name><surname>Tang</surname><given-names>L.</given-names></name><name><surname>Shinohara</surname><given-names>T.</given-names></name><name><surname>On</surname><given-names>Y. K.</given-names></name><name><surname>Han</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Diastolic intracellular calcium-membrane voltage coupling gain and postshock arrhythmias: role of purkinje fibers and triggered activity</article-title>. <source/>Circ. Res.
<volume>106</volume> (<issue>2</issue>), <fpage>399</fpage>–<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.211292</pub-id>
<pub-id pub-id-type="pmid">19926871</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Mayer</surname><given-names>A. G.</given-names></name></person-group> (<year>1906</year>). <source/>Rhythmical Pulsation in Scyphomedusae (<publisher-loc>Washington DC</publisher-loc>: <publisher-name>Carnegie Institution of Washington</publisher-name>).
</mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mechmann</surname><given-names>S.</given-names></name><name><surname>Pott</surname><given-names>L.</given-names></name></person-group> (<year>1986</year>). <article-title>Identification of Na-Ca exchange current in single cardiac myocytes</article-title>. <source/>Nature
<volume>319</volume> (<issue>6054</issue>), <fpage>597</fpage>–<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1038/319597a0</pub-id>
<pub-id pub-id-type="pmid">2418367</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Medeiros-Domingo</surname><given-names>A.</given-names></name><name><surname>Kaku</surname><given-names>T.</given-names></name><name><surname>Tester</surname><given-names>D. J.</given-names></name><name><surname>Iturralde-Torres</surname><given-names>P.</given-names></name><name><surname>Itty</surname><given-names>A.</given-names></name><name><surname>Ye</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome</article-title>. <source/>Circulation
<volume>116</volume> (<issue>2</issue>), <fpage>134</fpage>–<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.659086</pub-id>
<pub-id pub-id-type="pmid">17592081</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meregalli</surname><given-names>P. G.</given-names></name><name><surname>Wilde</surname><given-names>A. A.</given-names></name><name><surname>Tan</surname><given-names>H. L.</given-names></name></person-group> (<year>2005</year>). <article-title>Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more</article-title>? <source/>Cardiovasc. Res.
<volume>67</volume> (<issue>3</issue>), <fpage>367</fpage>–<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardiores.2005.03.005</pub-id>
<pub-id pub-id-type="pmid">15913579</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Milberg</surname><given-names>P.</given-names></name><name><surname>Ramtin</surname><given-names>S.</given-names></name><name><surname>Monnig</surname><given-names>G.</given-names></name><name><surname>Osada</surname><given-names>N.</given-names></name><name><surname>Wasmer</surname><given-names>K.</given-names></name><name><surname>Breithardt</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Comparison of the <italic>in vitro</italic> electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block</article-title>. <source/>J. Cardiovasc. Pharmacol.
<volume>44</volume> (<issue>3</issue>), <fpage>278</fpage>–<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1097/01.fjc.0000129581.81508.78</pub-id>
<pub-id pub-id-type="pmid">15475823</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mines</surname><given-names>G. R.</given-names></name></person-group> (<year>1913</year>). <article-title>On dynamic equilibrium in the heart</article-title>. <source/>J. Physiol.
<volume>46</volume> (<issue>4-5</issue>), <fpage>349</fpage>–<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1913.sp001596</pub-id>
<pub-id pub-id-type="pmid">16993210</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mines</surname><given-names>G. R.</given-names></name></person-group> (<year>1914</year>). <article-title>On circulating excitations in heart muscle and their possible relation to tachycardia and fibrillation</article-title>. <source/>Trans. R Soc. Can.
<volume>8</volume>, <fpage>43</fpage>–<lpage>52</lpage>.
</mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>R. D.</given-names></name><name><surname>Simmerman</surname><given-names>H. K.</given-names></name><name><surname>Jones</surname><given-names>L. R.</given-names></name></person-group> (<year>1988</year>). <article-title>Ca2+ binding effects on protein conformation and protein interactions of canine cardiac calsequestrin</article-title>. <source/>J. Biol. Chem.
<volume>263</volume> (<issue>3</issue>), <fpage>1376</fpage>–<lpage>1381</lpage>.
<pub-id pub-id-type="pmid">3335548</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miura</surname><given-names>M.</given-names></name><name><surname>Ishide</surname><given-names>N.</given-names></name><name><surname>Oda</surname><given-names>H.</given-names></name><name><surname>Sakurai</surname><given-names>M.</given-names></name><name><surname>Shinozaki</surname><given-names>T.</given-names></name><name><surname>Takishima</surname><given-names>T.</given-names></name></person-group> (<year>1993</year>). <article-title>Spatial features of calcium transients during early and delayed afterdepolarizations</article-title>. <source/>Am. J. Physiol.
<volume>265</volume> (<issue>2 Pt 2</issue>), <fpage>H439</fpage>–<lpage>H444</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.1993.265.2.H439</pub-id>
<pub-id pub-id-type="pmid">8368346</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miura</surname><given-names>M.</given-names></name><name><surname>Ishide</surname><given-names>N.</given-names></name><name><surname>Numaguchi</surname><given-names>H.</given-names></name><name><surname>Takishima</surname><given-names>T.</given-names></name></person-group> (<year>1995</year>). <article-title>Diversity of early afterdepolarizations in guinea pig myocytes: spatial characteristics of intracellular Ca2+ concentration</article-title>. <source/>Heart Vessels
<volume>10</volume> (<issue>5</issue>), <fpage>266</fpage>–<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1007/BF01744906</pub-id>
<pub-id pub-id-type="pmid">8904002</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>U.</given-names></name><name><surname>Gollob</surname><given-names>M. H.</given-names></name><name><surname>Gow</surname><given-names>R. M.</given-names></name><name><surname>Krahn</surname><given-names>A. D.</given-names></name></person-group> (<year>2006</year>). <article-title>Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia</article-title>. <source/>Heart Rhythm
<volume>3</volume> (<issue>12</issue>), <fpage>1486</fpage>–<lpage>1489</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2006.08.018</pub-id>
<pub-id pub-id-type="pmid">17161793</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mohler</surname><given-names>P. J.</given-names></name><name><surname>Splawski</surname><given-names>I.</given-names></name><name><surname>Napolitano</surname><given-names>C.</given-names></name><name><surname>Bottelli</surname><given-names>G.</given-names></name><name><surname>Sharpe</surname><given-names>L.</given-names></name><name><surname>Timothy</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>A cardiac arrhythmia syndrome caused by loss of ankyrin-B function</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A.
<volume>101</volume> (<issue>24</issue>), <fpage>9137</fpage>–<lpage>9142</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0402546101</pub-id>
<pub-id pub-id-type="pmid">15178757</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mohler</surname><given-names>P. J.</given-names></name><name><surname>Schott</surname><given-names>J. J.</given-names></name><name><surname>Gramolini</surname><given-names>A. O.</given-names></name><name><surname>Dilly</surname><given-names>K. W.</given-names></name><name><surname>Guatimosim</surname><given-names>S.</given-names></name><name><surname>duBell</surname><given-names>W. H.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death</article-title>. <source/>Nature
<volume>421</volume> (<issue>6923</issue>), <fpage>634</fpage>–<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1038/nature01335</pub-id>
<pub-id pub-id-type="pmid">12571597</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morita</surname><given-names>H.</given-names></name><name><surname>Morita</surname><given-names>S. T.</given-names></name><name><surname>Nagase</surname><given-names>S.</given-names></name><name><surname>Banba</surname><given-names>K.</given-names></name><name><surname>Nishii</surname><given-names>N.</given-names></name><name><surname>Tani</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome</article-title>. <source/>J. Am. Coll. Cardiol.
<volume>42</volume> (<issue>9</issue>), <fpage>1624</fpage>–<lpage>1631</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2003.06.004</pub-id>
<pub-id pub-id-type="pmid">14607450</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moss</surname><given-names>A. J.</given-names></name><name><surname>Zareba</surname><given-names>W.</given-names></name><name><surname>Hall</surname><given-names>W. J.</given-names></name><name><surname>Schwartz</surname><given-names>P. J.</given-names></name><name><surname>Crampton</surname><given-names>R. S.</given-names></name><name><surname>Benhorin</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome</article-title>. <source/>Circulation
<volume>101</volume> (<issue>6</issue>), <fpage>616</fpage>–<lpage>623</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.101.6.616</pub-id>
<pub-id pub-id-type="pmid">10673253</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moss</surname><given-names>A. J.</given-names></name><name><surname>Windle</surname><given-names>J. R.</given-names></name><name><surname>Hall</surname><given-names>W. J.</given-names></name><name><surname>Zareba</surname><given-names>W.</given-names></name><name><surname>Robinson</surname><given-names>J. L.</given-names></name><name><surname>McNitt</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial</article-title>. <source/>Ann. Noninvasive Electrocardiol.
<volume>10</volume> (<issue>4 Suppl</issue>), <fpage>59</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1111/j.1542-474X.2005.00077.x</pub-id>
<pub-id pub-id-type="pmid">16274417</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moss</surname><given-names>A. J.</given-names></name><name><surname>Zareba</surname><given-names>W.</given-names></name><name><surname>Schwarz</surname><given-names>K. Q.</given-names></name><name><surname>Rosero</surname><given-names>S.</given-names></name><name><surname>McNitt</surname><given-names>S.</given-names></name><name><surname>Robinson</surname><given-names>J. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome</article-title>. <source/>J. Cardiovasc. Electrophysiol.
<volume>19</volume> (<issue>12</issue>), <fpage>1289</fpage>–<lpage>1293</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8167.2008.01246.x</pub-id>
<pub-id pub-id-type="pmid">18662191</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nanasi</surname><given-names>P. P.</given-names></name><name><surname>Magyar</surname><given-names>J.</given-names></name><name><surname>Varro</surname><given-names>A.</given-names></name><name><surname>Ordog</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Beat-to-beat variability of cardiac action potential duration: underlying mechanism and clinical implications</article-title>. <source/>Can. J. Physiol. Pharmacol.
<volume>95</volume> (<issue>10</issue>), <fpage>1230</fpage>–<lpage>1235</lpage>. <pub-id pub-id-type="doi">10.1139/cjpp-2016-0597</pub-id>
<pub-id pub-id-type="pmid">28746810</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nattel</surname><given-names>S.</given-names></name><name><surname>Dobrev</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation</article-title>. <source/>Nat. Rev. Cardiol.
<volume>13</volume> (<issue>10</issue>), <fpage>575</fpage>–<lpage>590</lpage>. <pub-id pub-id-type="doi">10.1038/nrcardio.2016.118</pub-id>
<pub-id pub-id-type="pmid">27489190</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nawathe</surname><given-names>P. A.</given-names></name><name><surname>Kryukova</surname><given-names>Y.</given-names></name><name><surname>Oren</surname><given-names>R. V.</given-names></name><name><surname>Milanesi</surname><given-names>R.</given-names></name><name><surname>Clancy</surname><given-names>C. E.</given-names></name><name><surname>Lu</surname><given-names>J. T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>An LQTS6 MiRP1 mutation suppresses pacemaker current and is associated with sinus bradycardia</article-title>. <source/>J. Cardiovasc. Electrophysiol.
<volume>24</volume> (<issue>9</issue>), <fpage>1021</fpage>–<lpage>1027</lpage>. <pub-id pub-id-type="doi">10.1111/jce.12163</pub-id>
<pub-id pub-id-type="pmid">23631727</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Neef</surname><given-names>S.</given-names></name><name><surname>Dybkova</surname><given-names>N.</given-names></name><name><surname>Sossalla</surname><given-names>S.</given-names></name><name><surname>Ort</surname><given-names>K. R.</given-names></name><name><surname>Fluschnik</surname><given-names>N.</given-names></name><name><surname>Neumann</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation</article-title>. <source/>Circ. Res.
<volume>106</volume> (<issue>6</issue>), <fpage>1134</fpage>–<lpage>1144</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.203836</pub-id>
<pub-id pub-id-type="pmid">20056922</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nolasco</surname><given-names>J. B.</given-names></name><name><surname>Dahlen</surname><given-names>R. W.</given-names></name></person-group> (<year>1968</year>). <article-title>A graphic method for the study of alternation in cardiac action potentials</article-title>. <source/>J. Appl. Physiol.
<volume>25</volume> (<issue>2</issue>), <fpage>191</fpage>–<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.1968.25.2.191</pub-id>
<pub-id pub-id-type="pmid">5666097</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nyegaard</surname><given-names>M.</given-names></name><name><surname>Overgaard</surname><given-names>M. T.</given-names></name><name><surname>Sondergaard</surname><given-names>M. T.</given-names></name><name><surname>Vranas</surname><given-names>M.</given-names></name><name><surname>Behr</surname><given-names>E. R.</given-names></name><name><surname>Hildebrandt</surname><given-names>L. L.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death</article-title>. <source/>Am. J. Hum. Genet.
<volume>91</volume> (<issue>4</issue>), <fpage>703</fpage>–<lpage>712</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.08.015</pub-id>
<pub-id pub-id-type="pmid">23040497</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ohgo</surname><given-names>T.</given-names></name><name><surname>Okamura</surname><given-names>H.</given-names></name><name><surname>Noda</surname><given-names>T.</given-names></name><name><surname>Satomi</surname><given-names>K.</given-names></name><name><surname>Suyama</surname><given-names>K.</given-names></name><name><surname>Kurita</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation</article-title>. <source/>Heart Rhythm
<volume>4</volume> (<issue>6</issue>), <fpage>695</fpage>–<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2007.02.014</pub-id>
<pub-id pub-id-type="pmid">17556186</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oosthoek</surname><given-names>P. W.</given-names></name><name><surname>Viragh</surname><given-names>S.</given-names></name><name><surname>Lamers</surname><given-names>W. H.</given-names></name><name><surname>Moorman</surname><given-names>A. F.</given-names></name></person-group> (<year>1993</year>). <article-title>Immunohistochemical delineation of the conduction system. II: The atrioventricular node and Purkinje fibers</article-title>. <source/>Circ. Res.
<volume>73</volume> (<issue>3</issue>), <fpage>482</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.73.3.482</pub-id>
<pub-id pub-id-type="pmid">8394224</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Overend</surname><given-names>C. L.</given-names></name><name><surname>Eisner</surname><given-names>D. A.</given-names></name><name><surname>O'Neill</surname><given-names>S. C.</given-names></name></person-group> (<year>1997</year>). <article-title>The effect of tetracaine on spontaneous Ca2+ release and sarcoplasmic reticulum calcium content in rat ventricular myocytes</article-title>. <source/>J. Physiol.
<volume>502</volume> (<issue>Pt 3</issue>), <fpage>471</fpage>–<lpage>479</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.1997.471bj.x</pub-id>
<pub-id pub-id-type="pmid">9279801</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pertsov</surname><given-names>A. M.</given-names></name><name><surname>Davidenko</surname><given-names>J. M.</given-names></name><name><surname>Salomonsz</surname><given-names>R.</given-names></name><name><surname>Baxter</surname><given-names>W. T.</given-names></name><name><surname>Jalife</surname><given-names>J.</given-names></name></person-group> (<year>1993</year>). <article-title>Spiral waves of excitation underlie reentrant activity in isolated cardiac muscle</article-title>. <source/>Circ. Res.
<volume>72</volume> (<issue>3</issue>), <fpage>631</fpage>–<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.72.3.631</pub-id>
<pub-id pub-id-type="pmid">8431989</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pflaumer</surname><given-names>A.</given-names></name><name><surname>Davis</surname><given-names>A. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Guidelines for the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Heart Lung Circ.
<volume>21</volume> (<issue>2</issue>), <fpage>96</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.hlc.2011.10.008</pub-id>
<pub-id pub-id-type="pmid">22119737</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Picht</surname><given-names>E.</given-names></name><name><surname>DeSantiago</surname><given-names>J.</given-names></name><name><surname>Blatter</surname><given-names>L. A.</given-names></name><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Cardiac alternans do not rely on diastolic sarcoplasmic reticulum calcium content fluctuations</article-title>. <source/>Circ. Res.
<volume>99</volume> (<issue>7</issue>), <fpage>740</fpage>–<lpage>748</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000244002.88813.91</pub-id>
<pub-id pub-id-type="pmid">16946134</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Plaster</surname><given-names>N. M.</given-names></name><name><surname>Tawil</surname><given-names>R.</given-names></name><name><surname>Tristani-Firouzi</surname><given-names>M.</given-names></name><name><surname>Canun</surname><given-names>S.</given-names></name><name><surname>Bendahhou</surname><given-names>S.</given-names></name><name><surname>Tsunoda</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome</article-title>. <source/>Cell
<volume>105</volume> (<issue>4</issue>), <fpage>511</fpage>–<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(01)00342-7</pub-id>
<pub-id pub-id-type="pmid">11371347</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pogwizd</surname><given-names>S. M.</given-names></name><name><surname>Schlotthauer</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Yuan</surname><given-names>W.</given-names></name><name><surname>Bers</surname><given-names>D. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness</article-title>. <source/>Circ. Res.
<volume>88</volume> (<issue>11</issue>), <fpage>1159</fpage>–<lpage>1167</lpage>. <pub-id pub-id-type="doi">10.1161/hh1101.091193</pub-id>
<pub-id pub-id-type="pmid">11397782</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Postma</surname><given-names>A. V.</given-names></name><name><surname>Denjoy</surname><given-names>I.</given-names></name><name><surname>Kamblock</surname><given-names>J.</given-names></name><name><surname>Alders</surname><given-names>M.</given-names></name><name><surname>Lupoglazoff</surname><given-names>J. M.</given-names></name><name><surname>Vaksmann</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients</article-title>. <source/>J. Med. Genet.
<volume>42</volume> (<issue>11</issue>), <fpage>863</fpage>–<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2004.028993</pub-id>
<pub-id pub-id-type="pmid">16272262</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pott</surname><given-names>C.</given-names></name><name><surname>Dechering</surname><given-names>D. G.</given-names></name><name><surname>Reinke</surname><given-names>F.</given-names></name><name><surname>Muszynski</surname><given-names>A.</given-names></name><name><surname>Zellerhoff</surname><given-names>S.</given-names></name><name><surname>Bittner</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature</article-title>. <source/>Europace
<volume>13</volume> (<issue>6</issue>), <fpage>897</fpage>–<lpage>901</lpage>. <pub-id pub-id-type="doi">10.1093/europace/euq517</pub-id>
<pub-id pub-id-type="pmid">21292648</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Priori</surname><given-names>S. G.</given-names></name><name><surname>Corr</surname><given-names>P. B.</given-names></name></person-group> (<year>1990</year>). <article-title>Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines</article-title>. <source/>Am. J. Physiol.
<volume>258</volume> (<issue>6 Pt 2</issue>), <fpage>H1796</fpage>–<lpage>H1805</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.1990.258.6.H1796</pub-id>
<pub-id pub-id-type="pmid">2163219</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Priori</surname><given-names>S. G.</given-names></name><name><surname>Napolitano</surname><given-names>C.</given-names></name><name><surname>Tiso</surname><given-names>N.</given-names></name><name><surname>Memmi</surname><given-names>M.</given-names></name><name><surname>Vignati</surname><given-names>G.</given-names></name><name><surname>Bloise</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Circulation
<volume>103</volume> (<issue>2</issue>), <fpage>196</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.103.2.196</pub-id>
<pub-id pub-id-type="pmid">11208676</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Priori</surname><given-names>S. G.</given-names></name><name><surname>Wilde</surname><given-names>A. A.</given-names></name><name><surname>Horie</surname><given-names>M.</given-names></name><name><surname>Cho</surname><given-names>Y.</given-names></name><name><surname>Behr</surname><given-names>E. R.</given-names></name><name><surname>Berul</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes</article-title>. <source/>Heart Rhythm
<volume>10</volume> (<issue>12</issue>), <fpage>e85</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2013.07.021</pub-id>
<pub-id pub-id-type="pmid">23916535</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qi</surname><given-names>X. Y.</given-names></name><name><surname>Yeh</surname><given-names>Y. H.</given-names></name><name><surname>Xiao</surname><given-names>L.</given-names></name><name><surname>Burstein</surname><given-names>B.</given-names></name><name><surname>Maguy</surname><given-names>A.</given-names></name><name><surname>Chartier</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current</article-title>. <source/>Circ. Res.
<volume>103</volume> (<issue>8</issue>), <fpage>845</fpage>–<lpage>854</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.175463</pub-id>
<pub-id pub-id-type="pmid">18723446</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qu</surname><given-names>Z.</given-names></name><name><surname>Weiss</surname><given-names>J. N.</given-names></name></person-group> (<year>2015</year>). <article-title>Mechanisms of ventricular arrhythmias: from molecular fluctuations to electrical turbulence</article-title>. <source/>Annu. Rev. Physiol.
<volume>77</volume>, <fpage>29</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-physiol-021014-071622</pub-id>
<pub-id pub-id-type="pmid">25340965</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qu</surname><given-names>Z.</given-names></name><name><surname>Shiferaw</surname><given-names>Y.</given-names></name><name><surname>Weiss</surname><given-names>J. N.</given-names></name></person-group> (<year>2007</year>). <article-title>Nonlinear dynamics of cardiac excitation-contraction coupling: an iterated map study</article-title>. <source/>Phys. Rev. E Stat. Nonlinear Soft Matter Phys.
<volume>75</volume> (<issue>1 Pt 1</issue>), <elocation-id>011927</elocation-id>. <pub-id pub-id-type="doi">10.1103/PhysRevE.75.011927</pub-id>
</mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Radwanski</surname><given-names>P. B.</given-names></name><name><surname>Ho</surname><given-names>H. T.</given-names></name><name><surname>Veeraraghavan</surname><given-names>R.</given-names></name><name><surname>Brunello</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Belevych</surname><given-names>A. E.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Neuronal Na(+) channels are integral components of pro-arrhythmic Na(+)/Ca(2+) signaling nanodomain that promotes cardiac arrhythmias during beta-adrenergic stimulation</article-title>. <source/>JACC Basic to Trans. Sci.
<volume>1</volume> (<issue>4</issue>), <fpage>251</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacbts.2016.04.004</pub-id>
</mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reid</surname><given-names>D. S.</given-names></name><name><surname>Tynan</surname><given-names>M.</given-names></name><name><surname>Braidwood</surname><given-names>L.</given-names></name><name><surname>Fitzgerald</surname><given-names>G. R.</given-names></name></person-group> (<year>1975</year>). <article-title>Bidirectional tachycardia in a child. a study using his bundle electrography</article-title>. <source/>Br. Heart J.
<volume>37</volume> (<issue>3</issue>), <fpage>339</fpage>–<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1136/hrt.37.3.339</pub-id>
<pub-id pub-id-type="pmid">1138739</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reiken</surname><given-names>S.</given-names></name><name><surname>Gaburjakova</surname><given-names>M.</given-names></name><name><surname>Guatimosim</surname><given-names>S.</given-names></name><name><surname>Gomez</surname><given-names>A. M.</given-names></name><name><surname>D'Armiento</surname><given-names>J.</given-names></name><name><surname>Burkhoff</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Protein kinase a phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol</article-title>. <source/>J. Biol. Chem.
<volume>278</volume> (<issue>1</issue>), <fpage>444</fpage>–<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M207028200</pub-id>
<pub-id pub-id-type="pmid">12401811</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ringer</surname><given-names>S.</given-names></name></person-group> (<year>1883</year>). <article-title>A further contribution regarding the influence of the different constituents of the blood on the contraction of the heart</article-title>. <source/>J. Physiol.
<volume>4</volume> (<issue>1</issue>), <fpage>29</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1883.sp000120</pub-id>
</mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rizzi</surname><given-names>N.</given-names></name><name><surname>Liu</surname><given-names>N.</given-names></name><name><surname>Napolitano</surname><given-names>C.</given-names></name><name><surname>Nori</surname><given-names>A.</given-names></name><name><surname>Turcato</surname><given-names>F.</given-names></name><name><surname>Colombi</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model</article-title>. <source/>Circ. Res.
<volume>103</volume> (<issue>3</issue>), <fpage>298</fpage>–<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.171660</pub-id>
<pub-id pub-id-type="pmid">18583715</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roden</surname><given-names>D. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Drug-induced prolongation of the QT interval</article-title>. <source/>New Engl. J. Med.
<volume>350</volume> (<issue>10</issue>), <fpage>1013</fpage>–<lpage>1022</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra032426</pub-id>
<pub-id pub-id-type="pmid">14999113</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roden</surname><given-names>D. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Long QT syndrome: reduced repolarization reserve and the genetic link</article-title>. <source/>J. Internal Med.
<volume>259</volume> (<issue>1</issue>), <fpage>59</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2796.2005.01589.x</pub-id>
<pub-id pub-id-type="pmid">16336514</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosen</surname><given-names>M. R.</given-names></name><name><surname>Gelband</surname><given-names>H.</given-names></name><name><surname>Merker</surname><given-names>C.</given-names></name><name><surname>Hoffman</surname><given-names>B. F.</given-names></name></person-group> (<year>1973</year>). <article-title>Mechanisms of digitalis toxicity. effects of ouabain on phase four of canine Purkinje fiber transmembrane potentials</article-title>. <source/>Circulation
<volume>47</volume> (<issue>4</issue>), <fpage>681</fpage>–<lpage>689</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.47.4.681</pub-id>
<pub-id pub-id-type="pmid">4696790</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosen</surname><given-names>M. R.</given-names></name><name><surname>Wit</surname><given-names>A. L.</given-names></name><name><surname>Hoffman</surname><given-names>B. F.</given-names></name></person-group> (<year>1975</year>). <article-title>Electrophysiology and pharmacology of cardiac arrhythmias. IV. Cardiac antiarrhythmic and toxic effects of digitalis</article-title>. <source/>Am. Heart J.
<volume>89</volume> (<issue>3</issue>), <fpage>391</fpage>–<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1016/0002-8703(75)90090-3</pub-id>
<pub-id pub-id-type="pmid">1090138</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosenbaum</surname><given-names>D. S.</given-names></name><name><surname>Jackson</surname><given-names>L. E.</given-names></name><name><surname>Smith</surname><given-names>J. M.</given-names></name><name><surname>Garan</surname><given-names>H.</given-names></name><name><surname>Ruskin</surname><given-names>J. N.</given-names></name><name><surname>Cohen</surname><given-names>R. J.</given-names></name></person-group> (<year>1994</year>). <article-title>Electrical alternans and vulnerability to ventricular arrhythmias</article-title>. <source/>New Engl. J. Med.
<volume>330</volume> (<issue>4</issue>), <fpage>235</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM199401273300402</pub-id>
<pub-id pub-id-type="pmid">8272084</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosenthal</surname><given-names>J. E.</given-names></name></person-group> (<year>1988</year>). <article-title>Reflected reentry in depolarized foci with variable conduction impairment in 1 day old infarcted canine cardiac tissue</article-title>. <source/>J. Am. Coll. Cardiol.
<volume>12</volume> (<issue>2</issue>), <fpage>404</fpage>–<lpage>411</lpage>. <pub-id pub-id-type="doi">10.1016/0735-1097(88)90413-5</pub-id>
<pub-id pub-id-type="pmid">3392334</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosero</surname><given-names>S. Z.</given-names></name><name><surname>Zareba</surname><given-names>W.</given-names></name><name><surname>Robinson</surname><given-names>J. L.</given-names></name><name><surname>Moss</surname><given-names>A. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Gene-Specific Therapy for Long QT Syndrome</article-title>. <source/>Ann. Noninvasive Electrocardiol.
<volume>2</volume> (<issue>3</issue>), <fpage>274</fpage>–<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1111/j.1542-474X.1997.tb00336.x</pub-id>
</mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosso</surname><given-names>R.</given-names></name><name><surname>Kalman</surname><given-names>J. M.</given-names></name><name><surname>Rogowski</surname><given-names>O.</given-names></name><name><surname>Diamant</surname><given-names>S.</given-names></name><name><surname>Birger</surname><given-names>A.</given-names></name><name><surname>Biner</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Heart Rhythm
<volume>4</volume> (<issue>9</issue>), <fpage>1149</fpage>–<lpage>1154</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2007.05.017</pub-id>
<pub-id pub-id-type="pmid">17765612</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosso</surname><given-names>R.</given-names></name><name><surname>Kogan</surname><given-names>E.</given-names></name><name><surname>Belhassen</surname><given-names>B.</given-names></name><name><surname>Rozovski</surname><given-names>U.</given-names></name><name><surname>Scheinman</surname><given-names>M. M.</given-names></name><name><surname>Zeltser</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance</article-title>. <source/>J. Am. Coll. Cardiol.
<volume>52</volume> (<issue>15</issue>), <fpage>1231</fpage>–<lpage>1238</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2008.07.010</pub-id>
<pub-id pub-id-type="pmid">18926326</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rozanski</surname><given-names>G. J.</given-names></name><name><surname>Lipsius</surname><given-names>S. L.</given-names></name></person-group> (<year>1985</year>). <article-title>Electrophysiology of functional subsidiary pacemakers in canine right atrium</article-title>. <source/>Am. J. Physiol.
<volume>249</volume> (<issue>3 Pt 2</issue>), <fpage>H594</fpage>–<lpage>H603</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.1985.249.3.H594</pub-id>
<pub-id pub-id-type="pmid">4037107</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sanguinetti</surname><given-names>M. C.</given-names></name><name><surname>Jiang</surname><given-names>C.</given-names></name><name><surname>Curran</surname><given-names>M. E.</given-names></name><name><surname>Keating</surname><given-names>M. T.</given-names></name></person-group> (<year>1995</year>). <article-title>A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel</article-title>. <source/>Cell
<volume>81</volume> (<issue>2</issue>), <fpage>299</fpage>–<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(95)90340-2</pub-id>
<pub-id pub-id-type="pmid">7736582</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sanguinetti</surname><given-names>M. C.</given-names></name><name><surname>Curran</surname><given-names>M. E.</given-names></name><name><surname>Zou</surname><given-names>A.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Spector</surname><given-names>P. S.</given-names></name><name><surname>Atkinson</surname><given-names>D. L.</given-names></name><etal></etal></person-group> (<year>1996</year>). <article-title>Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel</article-title>. <source/>Nature
<volume>384</volume> (<issue>6604</issue>), <fpage>80</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1038/384080a0</pub-id>
<pub-id pub-id-type="pmid">8900283</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sato</surname><given-names>D.</given-names></name><name><surname>Shiferaw</surname><given-names>Y.</given-names></name><name><surname>Garfinkel</surname><given-names>A.</given-names></name><name><surname>Weiss</surname><given-names>J. N.</given-names></name><name><surname>Qu</surname><given-names>Z.</given-names></name><name><surname>Karma</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Spatially discordant alternans in cardiac tissue: role of calcium cycling</article-title>. <source/>Circ. Res.
<volume>99</volume> (<issue>5</issue>), <fpage>520</fpage>–<lpage>527</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000240542.03986.e7</pub-id>
<pub-id pub-id-type="pmid">16902177</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saunders</surname><given-names>J. H.</given-names></name><name><surname>Ferrier</surname><given-names>G. R.</given-names></name><name><surname>Moe</surname><given-names>G. K.</given-names></name></person-group> (<year>1973</year>). <article-title>Conduction block associated with transient depolarizations induced by acetylstrophanthidin in isolated canine Purkinje fibers</article-title>. <source/>Circ. Res.
<volume>32</volume> (<issue>5</issue>), <fpage>610</fpage>–<lpage>617</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.32.5.610</pub-id>
<pub-id pub-id-type="pmid">4713203</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schotten</surname><given-names>U.</given-names></name><name><surname>Dobrev</surname><given-names>D.</given-names></name><name><surname>Platonov</surname><given-names>P. G.</given-names></name><name><surname>Kottkamp</surname><given-names>H.</given-names></name><name><surname>Hindricks</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Current controversies in determining the main mechanisms of atrial fibrillation</article-title>. <source/>J. Internal Med.
<volume>279</volume> (<issue>5</issue>), <fpage>428</fpage>–<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1111/joim.12492</pub-id>
<pub-id pub-id-type="pmid">26991914</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>P. J.</given-names></name><name><surname>Priori</surname><given-names>S. G.</given-names></name><name><surname>Locati</surname><given-names>E. H.</given-names></name><name><surname>Napolitano</surname><given-names>C.</given-names></name><name><surname>Cantu</surname><given-names>F.</given-names></name><name><surname>Towbin</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>1995</year>). <article-title>Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy</article-title>. <source/>Circulation
<volume>92</volume> (<issue>12</issue>), <fpage>3381</fpage>–<lpage>3386</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.92.12.3381</pub-id>
<pub-id pub-id-type="pmid">8521555</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>P. J.</given-names></name><name><surname>Crotti</surname><given-names>L.</given-names></name><name><surname>Insolia</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Long-QT syndrome: from genetics to management</article-title>. <source/>Circ. Arrhythmia Electrophysiol.
<volume>5</volume> (<issue>4</issue>), <fpage>868</fpage>–<lpage>877</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.111.962019</pub-id>
</mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shah</surname><given-names>D. P.</given-names></name><name><surname>Baez-Escudero</surname><given-names>J. L.</given-names></name><name><surname>Weisberg</surname><given-names>I. L.</given-names></name><name><surname>Beshai</surname><given-names>J. F.</given-names></name><name><surname>Burke</surname><given-names>M. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Ranolazine safely decreases ventricular and atrial fibrillation in timothy syndrome (LQT8)</article-title>. <source/>Pacing Clin. Electrophysiol.
<volume>35</volume> (<issue>3</issue>), <fpage>e62</fpage>–<lpage>e64</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8159.2010.02913.x</pub-id>
<pub-id pub-id-type="pmid">20883512</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shamgar</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Schmitt</surname><given-names>N.</given-names></name><name><surname>Haitin</surname><given-names>Y.</given-names></name><name><surname>Peretz</surname><given-names>A.</given-names></name><name><surname>Wiener</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations</article-title>. <source/>Circ. Res.
<volume>98</volume> (<issue>8</issue>), <fpage>1055</fpage>–<lpage>1063</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000218979.40770.69</pub-id>
<pub-id pub-id-type="pmid">16556865</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shan</surname><given-names>J.</given-names></name><name><surname>Xie</surname><given-names>W.</given-names></name><name><surname>Betzenhauser</surname><given-names>M.</given-names></name><name><surname>Reiken</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>B. X.</given-names></name><name><surname>Wronska</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Circ. Res.
<volume>111</volume> (<issue>6</issue>), <fpage>708</fpage>–<lpage>717</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.273342</pub-id>
<pub-id pub-id-type="pmid">22828895</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shiferaw</surname><given-names>Y.</given-names></name><name><surname>Watanabe</surname><given-names>M. A.</given-names></name><name><surname>Garfinkel</surname><given-names>A.</given-names></name><name><surname>Weiss</surname><given-names>J. N.</given-names></name><name><surname>Karma</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Model of intracellular calcium cycling in ventricular myocytes</article-title>. <source/>Biophys. J.
<volume>85</volume> (<issue>6</issue>), <fpage>3666</fpage>–<lpage>3686</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3495(03)74784-5</pub-id>
<pub-id pub-id-type="pmid">14645059</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>W.</given-names></name><name><surname>Kurita</surname><given-names>T.</given-names></name><name><surname>Matsuo</surname><given-names>K.</given-names></name><name><surname>Suyama</surname><given-names>K.</given-names></name><name><surname>Aihara</surname><given-names>N.</given-names></name><name><surname>Kamakura</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-QT syndrome</article-title>. <source/>Circulation
<volume>97</volume> (<issue>16</issue>), <fpage>1581</fpage>–<lpage>1588</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.97.16.1581</pub-id>
<pub-id pub-id-type="pmid">9593563</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>W.</given-names></name><name><surname>Antzelevitch</surname><given-names>C.</given-names></name><name><surname>Suyama</surname><given-names>K.</given-names></name><name><surname>Kurita</surname><given-names>T.</given-names></name><name><surname>Taguchi</surname><given-names>A.</given-names></name><name><surname>Aihara</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome</article-title>. <source/>J. Cardiovasc. Electrophysiol.
<volume>11</volume> (<issue>12</issue>), <fpage>1320</fpage>–<lpage>1329</lpage>. <pub-id pub-id-type="doi">10.1046/j.1540-8167.2000.01320.x</pub-id>
<pub-id pub-id-type="pmid">11196553</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shkryl</surname><given-names>V.</given-names></name><name><surname>Maxwell</surname><given-names>J.</given-names></name><name><surname>Domeier</surname><given-names>T.</given-names></name><name><surname>Blatter</surname><given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Refractoriness of sarcoplasmic reticulum Ca2+ release determines Ca2+ alternans in atrial myocytes</article-title>. <source/>Am. J. Physiol. Heart Circ. Physiol.
<volume>302</volume> (<issue>11</issue>), <fpage>H2310</fpage>–<lpage>H2320</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00079.2012</pub-id>
<pub-id pub-id-type="pmid">22467301</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sicouri</surname><given-names>S.</given-names></name><name><surname>Antzelevitch</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Mechanisms underlying the actions of antidepressant and antipsychotic drugs that cause sudden cardiac arrest</article-title>. <source/>Arrhythmia Electrophysiol. Rev.
<volume>7</volume> (<issue>3</issue>), <fpage>199</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.15420/aer.2018.29.2</pub-id>
</mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simard</surname><given-names>C.</given-names></name><name><surname>Hof</surname><given-names>T.</given-names></name><name><surname>Keddache</surname><given-names>Z.</given-names></name><name><surname>Launay</surname><given-names>P.</given-names></name><name><surname>Guinamard</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>The TRPM4 non-selective cation channel contributes to the mammalian atrial action potential</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>59</volume>, <fpage>11</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.01.019</pub-id>
<pub-id pub-id-type="pmid">23416167</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sipido</surname><given-names>K. R.</given-names></name><name><surname>Maes</surname><given-names>M.</given-names></name><name><surname>Van de Werf</surname><given-names>F.</given-names></name></person-group> (<year>1997</year>). <article-title>Low efficiency of Ca2+ entry through the Na(+)-Ca2+ exchanger as trigger for Ca2+ release from the sarcoplasmic reticulum. a comparison between L-type Ca2+ current and reverse-mode Na(+)-Ca2+ exchange</article-title>. <source/>Circ. Res.
<volume>81</volume> (<issue>6</issue>), <fpage>1034</fpage>–<lpage>1044</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.81.6.1034</pub-id>
<pub-id pub-id-type="pmid">9400385</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sipido</surname><given-names>K. R.</given-names></name><name><surname>Bito</surname><given-names>V.</given-names></name><name><surname>Antoons</surname><given-names>G.</given-names></name><name><surname>Volders</surname><given-names>P. G.</given-names></name><name><surname>Vos</surname><given-names>M. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Na/Ca exchange and cardiac ventricular arrhythmias</article-title>. <source/>Ann. N. Y. Acad. Sci.
<volume>1099</volume>, <fpage>339</fpage>–<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1196/annals.1387.066</pub-id>
<pub-id pub-id-type="pmid">17446474</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sondergaard</surname><given-names>M. T.</given-names></name><name><surname>Tian</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Chazin</surname><given-names>W. J.</given-names></name><name><surname>Chen</surname><given-names>S. R.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Arrhythmogenic calmodulin mutations affect the activation and termination of cardiac ryanodine receptor-mediated Ca2+ release</article-title>. <source/>J. Biol. Chem.
<volume>290</volume> (<issue>43</issue>), <fpage>26151</fpage>–<lpage>26162</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.676627</pub-id>
<pub-id pub-id-type="pmid">26309258</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sondergaard</surname><given-names>M. T.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Larsen</surname><given-names>K. T.</given-names></name><name><surname>Nani</surname><given-names>A.</given-names></name><name><surname>Tian</surname><given-names>X.</given-names></name><name><surname>Holt</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The Arrhythmogenic Calmodulin p.Phe142Leu mutation impairs c-domain ca2+ binding but not calmodulin-dependent inhibition of the cardiac ryanodine receptor</article-title>. <source/>J. Biol. Chem.
<volume>292</volume> (<issue>4</issue>), <fpage>1385</fpage>–<lpage>1395</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.766253</pub-id>
<pub-id pub-id-type="pmid">27927985</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Alcalai</surname><given-names>R.</given-names></name><name><surname>Arad</surname><given-names>M.</given-names></name><name><surname>Wolf</surname><given-names>C. M.</given-names></name><name><surname>Toka</surname><given-names>O.</given-names></name><name><surname>Conner</surname><given-names>D. A.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>J. Clin. Invest.
<volume>117</volume> (<issue>7</issue>), <fpage>1814</fpage>–<lpage>1823</lpage>. <pub-id pub-id-type="doi">10.1172/JCI31080</pub-id>
<pub-id pub-id-type="pmid">17607358</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sood</surname><given-names>S.</given-names></name><name><surname>Chelu</surname><given-names>M. G.</given-names></name><name><surname>van Oort</surname><given-names>R. J.</given-names></name><name><surname>Skapura</surname><given-names>D.</given-names></name><name><surname>Santonastasi</surname><given-names>M.</given-names></name><name><surname>Dobrev</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation</article-title>. <source/>Heart Rhythm
<volume>5</volume> (<issue>7</issue>), <fpage>1047</fpage>–<lpage>1054</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2008.03.030</pub-id>
<pub-id pub-id-type="pmid">18598963</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Splawski</surname><given-names>I.</given-names></name><name><surname>Tristani-Firouzi</surname><given-names>M.</given-names></name><name><surname>Lehmann</surname><given-names>M. H.</given-names></name><name><surname>Sanguinetti</surname><given-names>M. C.</given-names></name><name><surname>Keating</surname><given-names>M. T.</given-names></name></person-group> (<year>1997</year>). <article-title>Mutations in the hminK gene cause long QT syndrome and suppress IKs function</article-title>. <source/>Nat. Genet.
<volume>17</volume> (<issue>3</issue>), <fpage>338</fpage>–<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1038/ng1197-338</pub-id>
<pub-id pub-id-type="pmid">9354802</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Splawski</surname><given-names>I.</given-names></name><name><surname>Timothy</surname><given-names>K. W.</given-names></name><name><surname>Sharpe</surname><given-names>L. M.</given-names></name><name><surname>Decher</surname><given-names>N.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Bloise</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism</article-title>. <source/>Cell
<volume>119</volume> (<issue>1</issue>), <fpage>19</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2004.09.011</pub-id>
<pub-id pub-id-type="pmid">15454078</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Suetomi</surname><given-names>T.</given-names></name><name><surname>Yano</surname><given-names>M.</given-names></name><name><surname>Uchinoumi</surname><given-names>H.</given-names></name><name><surname>Fukuda</surname><given-names>M.</given-names></name><name><surname>Hino</surname><given-names>A.</given-names></name><name><surname>Ono</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Mutation-linked defective interdomain interactions within ryanodine receptor cause aberrant Ca(2)(+)release leading to catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Circulation
<volume>124</volume> (<issue>6</issue>), <fpage>682</fpage>–<lpage>694</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.023259</pub-id>
<pub-id pub-id-type="pmid">21768539</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sumitomo</surname><given-names>N.</given-names></name><name><surname>Nakamura</surname><given-names>T.</given-names></name><name><surname>Fukuhara</surname><given-names>J.</given-names></name><name><surname>Nakai</surname><given-names>T.</given-names></name><name><surname>Watanabe</surname><given-names>I.</given-names></name><name><surname>Mugishima</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Heart Vessels
<volume>25</volume> (<issue>5</issue>), <fpage>448</fpage>–<lpage>452</lpage>. <pub-id pub-id-type="doi">10.1007/s00380-009-1214-6</pub-id>
<pub-id pub-id-type="pmid">20676970</pub-id></mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sung</surname><given-names>R. J.</given-names></name><name><surname>Wu</surname><given-names>S. N.</given-names></name><name><surname>Wu</surname><given-names>J. S.</given-names></name><name><surname>Chang</surname><given-names>H. D.</given-names></name><name><surname>Luo</surname><given-names>C. H.</given-names></name></person-group> (<year>2006</year>). <article-title>Electrophysiological mechanisms of ventricular arrhythmias in relation to Andersen-Tawil syndrome under conditions of reduced IK1: a simulation study</article-title>. <source/>Am. J. Physiol. Heart Circ. Physiol.
<volume>291</volume> (<issue>6</issue>), <fpage>H2597</fpage>–<lpage>H2605</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00393.2006</pub-id>
<pub-id pub-id-type="pmid">16877549</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Surawicz</surname><given-names>B.</given-names></name></person-group> (<year>1998</year>). <article-title>U wave: facts, hypotheses, misconceptions, and misnomers</article-title>. <source/>J. Cardiovasc. Electrophysiol.
<volume>9</volume> (<issue>10</issue>), <fpage>1117</fpage>–<lpage>1128</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8167.1998.tb00890.x</pub-id>
<pub-id pub-id-type="pmid">9817564</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Swan</surname><given-names>H.</given-names></name><name><surname>Piippo</surname><given-names>K.</given-names></name><name><surname>Viitasalo</surname><given-names>M.</given-names></name><name><surname>Heikkila</surname><given-names>P.</given-names></name><name><surname>Paavonen</surname><given-names>T.</given-names></name><name><surname>Kainulainen</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts</article-title>. <source/>J. Am. Coll. Cardiol.
<volume>34</volume> (<issue>7</issue>), <fpage>2035</fpage>–<lpage>2042</lpage>. <pub-id pub-id-type="doi">10.1016/s0735-1097(99)00461-1</pub-id>
<pub-id pub-id-type="pmid">10588221</pub-id></mixed-citation>
</ref>
<ref id="B239">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Swan</surname><given-names>H.</given-names></name><name><surname>Laitinen</surname><given-names>P.</given-names></name><name><surname>Kontula</surname><given-names>K.</given-names></name><name><surname>Toivonen</surname><given-names>L.</given-names></name></person-group> (<year>2005</year>). <article-title>Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations</article-title>. <source/>J. Cardiovasc. Electrophysiol.
<volume>16</volume> (<issue>2</issue>), <fpage>162</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1046/j.1540-8167.2005.40516.x</pub-id>
<pub-id pub-id-type="pmid">15720454</pub-id></mixed-citation>
</ref>
<ref id="B240">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Szabo</surname><given-names>B.</given-names></name><name><surname>Sweidan</surname><given-names>R.</given-names></name><name><surname>Rajagopalan</surname><given-names>C. V.</given-names></name><name><surname>Lazzara</surname><given-names>R.</given-names></name></person-group> (<year>1994</year>). <article-title>Role of Na+:Ca2+ exchange current in Cs(+)-induced early afterdepolarizations in Purkinje fibers</article-title>. <source/>J. Cardiovasc. Electrophysiol.
<volume>5</volume> (<issue>11</issue>), <fpage>933</fpage>–<lpage>944</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8167.1994.tb01133.x</pub-id>
<pub-id pub-id-type="pmid">7889233</pub-id></mixed-citation>
</ref>
<ref id="B241">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Szabo</surname><given-names>G.</given-names></name><name><surname>Szentandrassy</surname><given-names>N.</given-names></name><name><surname>Biro</surname><given-names>T.</given-names></name><name><surname>Toth</surname><given-names>B. I.</given-names></name><name><surname>Czifra</surname><given-names>G.</given-names></name><name><surname>Magyar</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Asymmetrical distribution of ion channels in canine and human left-ventricular wall: epicardium versus midmyocardium</article-title>. <source/>Pflugers Archiv.
<volume>450</volume> (<issue>5</issue>), <fpage>307</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-005-1445-z</pub-id>
<pub-id pub-id-type="pmid">15952036</pub-id></mixed-citation>
</ref>
<ref id="B242">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Szabo</surname><given-names>L.</given-names></name><name><surname>Szentandrassy</surname><given-names>N.</given-names></name><name><surname>Kistamas</surname><given-names>K.</given-names></name><name><surname>Hegyi</surname><given-names>B.</given-names></name><name><surname>Ruzsnavszky</surname><given-names>F.</given-names></name><name><surname>Vaczi</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Effects of tacrolimus on action potential configuration and transmembrane ion currents in canine ventricular cells</article-title>. <source/>Naunyn-Schmiedeberg's Arch. Pharmacol.
<volume>386</volume> (<issue>3</issue>), <fpage>239</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1007/s00210-012-0823-2</pub-id>
<pub-id pub-id-type="pmid">23250339</pub-id></mixed-citation>
</ref>
<ref id="B243">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Szentandrassy</surname><given-names>N.</given-names></name><name><surname>Kistamas</surname><given-names>K.</given-names></name><name><surname>Hegyi</surname><given-names>B.</given-names></name><name><surname>Horvath</surname><given-names>B.</given-names></name><name><surname>Ruzsnavszky</surname><given-names>F.</given-names></name><name><surname>Vaczi</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Contribution of ion currents to beat-to-beat variability of action potential duration in canine ventricular myocytes</article-title>. <source/>Pflugers Archiv.
<volume>467</volume> (<issue>7</issue>), <fpage>1431</fpage>–<lpage>1443</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-014-1581-4</pub-id>
<pub-id pub-id-type="pmid">25081243</pub-id></mixed-citation>
</ref>
<ref id="B244">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takamatsu</surname><given-names>T.</given-names></name><name><surname>Wier</surname><given-names>W. G.</given-names></name></person-group> (<year>1990</year>). <article-title>Calcium waves in mammalian heart: quantification of origin, magnitude, waveform, and velocity</article-title>. <source/>FASEB J.
<volume>4</volume> (<issue>5</issue>), <fpage>1519</fpage>–<lpage>1525</lpage>. <pub-id pub-id-type="doi">10.1096/fasebj.4.5.2307330</pub-id>
<pub-id pub-id-type="pmid">2307330</pub-id></mixed-citation>
</ref>
<ref id="B245">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Terentyev</surname><given-names>D.</given-names></name><name><surname>Nori</surname><given-names>A.</given-names></name><name><surname>Santoro</surname><given-names>M.</given-names></name><name><surname>Viatchenko-Karpinski</surname><given-names>S.</given-names></name><name><surname>Kubalova</surname><given-names>Z.</given-names></name><name><surname>Gyorke</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death</article-title>. <source/>Circ. Res.
<volume>98</volume> (<issue>9</issue>), <fpage>1151</fpage>–<lpage>1158</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000220647.93982.08</pub-id>
<pub-id pub-id-type="pmid">16601229</pub-id></mixed-citation>
</ref>
<ref id="B246">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thiel</surname><given-names>W. H.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Hund</surname><given-names>T. J.</given-names></name><name><surname>Koval</surname><given-names>O. M.</given-names></name><name><surname>Purohit</surname><given-names>A.</given-names></name><name><surname>Song</surname><given-names>L. S.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Proarrhythmic defects in Timothy syndrome require calmodulin kinase II</article-title>. <source/>Circulation
<volume>118</volume> (<issue>22</issue>), <fpage>2225</fpage>–<lpage>2234</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.788067</pub-id>
<pub-id pub-id-type="pmid">19001023</pub-id></mixed-citation>
</ref>
<ref id="B247">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thomsen</surname><given-names>M. B.</given-names></name><name><surname>Verduyn</surname><given-names>S. C.</given-names></name><name><surname>Stengl</surname><given-names>M.</given-names></name><name><surname>Beekman</surname><given-names>J. D.</given-names></name><name><surname>de Pater</surname><given-names>G.</given-names></name><name><surname>van Opstal</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs</article-title>. <source/>Circulation
<volume>110</volume> (<issue>16</issue>), <fpage>2453</fpage>–<lpage>2459</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000145162.64183.C8</pub-id>
<pub-id pub-id-type="pmid">15477402</pub-id></mixed-citation>
</ref>
<ref id="B248">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trafford</surname><given-names>A. W.</given-names></name><name><surname>Sibbring</surname><given-names>G. C.</given-names></name><name><surname>Diaz</surname><given-names>M. E.</given-names></name><name><surname>Eisner</surname><given-names>D. A.</given-names></name></person-group> (<year>2000</year>). <article-title>The effects of low concentrations of caffeine on spontaneous Ca release in isolated rat ventricular myocytes</article-title>. <source/>Cell Calcium
<volume>28</volume> (<issue>4</issue>), <fpage>269</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1054/ceca.2000.0156</pub-id>
<pub-id pub-id-type="pmid">11032782</pub-id></mixed-citation>
</ref>
<ref id="B249">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tse</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Mechanisms of cardiac arrhythmias</article-title>. <source/>J. Arrhythmia
<volume>32</volume> (<issue>2</issue>), <fpage>75</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.joa.2015.11.003</pub-id>
</mixed-citation>
</ref>
<ref id="B250">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Uchinoumi</surname><given-names>H.</given-names></name><name><surname>Yano</surname><given-names>M.</given-names></name><name><surname>Suetomi</surname><given-names>T.</given-names></name><name><surname>Ono</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Tateishi</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor</article-title>. <source/>Circ. Res.
<volume>106</volume> (<issue>8</issue>), <fpage>1413</fpage>–<lpage>1424</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.209312</pub-id>
<pub-id pub-id-type="pmid">20224043</pub-id></mixed-citation>
</ref>
<ref id="B251">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van der Werf</surname><given-names>C.</given-names></name><name><surname>Kannankeril</surname><given-names>P. J.</given-names></name><name><surname>Sacher</surname><given-names>F.</given-names></name><name><surname>Krahn</surname><given-names>A. D.</given-names></name><name><surname>Viskin</surname><given-names>S.</given-names></name><name><surname>Leenhardt</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>J. Am. Coll. Cardiol.
<volume>57</volume> (<issue>22</issue>), <fpage>2244</fpage>–<lpage>2254</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2011.01.026</pub-id>
<pub-id pub-id-type="pmid">21616285</pub-id></mixed-citation>
</ref>
<ref id="B252">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Hemel</surname><given-names>N. M.</given-names></name><name><surname>Swenne</surname><given-names>C. A.</given-names></name><name><surname>De Bakker</surname><given-names>J. M.</given-names></name><name><surname>Defauw</surname><given-names>J. J.</given-names></name><name><surname>Guiraudon</surname><given-names>G. M.</given-names></name></person-group> (<year>1988</year>). <article-title>Epicardial reflection as a cause of incessant ventricular bigeminy</article-title>. <source/>Pacing Clin. Electrophysiol.
<volume>11</volume> (<issue>7</issue>), <fpage>1036</fpage>–<lpage>1044</lpage>. <pub-id pub-id-type="doi">10.1111/j.1540-8159.1988.tb03949.x</pub-id>
<pub-id pub-id-type="pmid">2457882</pub-id></mixed-citation>
</ref>
<ref id="B253">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vega</surname><given-names>A. L.</given-names></name><name><surname>Tester</surname><given-names>D. J.</given-names></name><name><surname>Ackerman</surname><given-names>M. J.</given-names></name><name><surname>Makielski</surname><given-names>J. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia</article-title>. <source/>Circ. Arrhythm. Electrophysiol.
<volume>2</volume> (<issue>5</issue>), <fpage>540</fpage>–<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.109.872309</pub-id>
<pub-id pub-id-type="pmid">19843922</pub-id></mixed-citation>
</ref>
<ref id="B254">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Venetucci</surname><given-names>L. A.</given-names></name><name><surname>Trafford</surname><given-names>A. W.</given-names></name><name><surname>Diaz</surname><given-names>M. E.</given-names></name><name><surname>O'Neill</surname><given-names>S. C.</given-names></name><name><surname>Eisner</surname><given-names>D. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Reducing ryanodine receptor open probability as a means to abolish spontaneous Ca2+ release and increase Ca2+ transient amplitude in adult ventricular myocytes</article-title>. <source/>Circ. Res.
<volume>98</volume> (<issue>10</issue>), <fpage>1299</fpage>–<lpage>1305</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000222000.35500.65</pub-id>
<pub-id pub-id-type="pmid">16614307</pub-id></mixed-citation>
</ref>
<ref id="B255">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Venetucci</surname><given-names>L. A.</given-names></name><name><surname>Trafford</surname><given-names>A. W.</given-names></name><name><surname>Eisner</surname><given-names>D. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves: threshold sarcoplasmic reticulum calcium content is required</article-title>. <source/>Circ. Res.
<volume>100</volume> (<issue>1</issue>), <fpage>105</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000252828.17939.00</pub-id>
<pub-id pub-id-type="pmid">17110597</pub-id></mixed-citation>
</ref>
<ref id="B256">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Venetucci</surname><given-names>L.</given-names></name><name><surname>Denegri</surname><given-names>M.</given-names></name><name><surname>Napolitano</surname><given-names>C.</given-names></name><name><surname>Priori</surname><given-names>S. G.</given-names></name></person-group> (<year>2012</year>). <article-title>Inherited calcium channelopathies in the pathophysiology of arrhythmias</article-title>. <source/>Nat. Rev. Cardiol.
<volume>9</volume> (<issue>10</issue>), <fpage>561</fpage>–<lpage>575</lpage>. <pub-id pub-id-type="doi">10.1038/nrcardio.2012.93</pub-id>
<pub-id pub-id-type="pmid">22733215</pub-id></mixed-citation>
</ref>
<ref id="B257">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vermeulen</surname><given-names>J. T.</given-names></name><name><surname>McGuire</surname><given-names>M. A.</given-names></name><name><surname>Opthof</surname><given-names>T.</given-names></name><name><surname>Coronel</surname><given-names>R.</given-names></name><name><surname>de Bakker</surname><given-names>J. M.</given-names></name><name><surname>Klopping</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>1994</year>). <article-title>Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts</article-title>. <source/>Cardiovasc. Res.
<volume>28</volume> (<issue>10</issue>), <fpage>1547</fpage>–<lpage>1554</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/28.10.1547</pub-id>
<pub-id pub-id-type="pmid">8001044</pub-id></mixed-citation>
</ref>
<ref id="B258">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Verrier</surname><given-names>R. L.</given-names></name><name><surname>Klingenheben</surname><given-names>T.</given-names></name><name><surname>Malik</surname><given-names>M.</given-names></name><name><surname>El-Sherif</surname><given-names>N.</given-names></name><name><surname>Exner</surname><given-names>D. V.</given-names></name><name><surname>Hohnloser</surname><given-names>S. H.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility–consensus guideline by international society for holter and noninvasive electrocardiology</article-title>. <source/>J. Am. Coll. Cardiol.
<volume>58</volume> (<issue>13</issue>), <fpage>1309</fpage>–<lpage>1324</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2011.06.029</pub-id>
<pub-id pub-id-type="pmid">21920259</pub-id></mixed-citation>
</ref>
<ref id="B259">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Viatchenko-Karpinski</surname><given-names>S.</given-names></name><name><surname>Terentyev</surname><given-names>D.</given-names></name><name><surname>Gyorke</surname><given-names>I.</given-names></name><name><surname>Terentyeva</surname><given-names>R.</given-names></name><name><surname>Volpe</surname><given-names>P.</given-names></name><name><surname>Priori</surname><given-names>S. G.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin</article-title>. <source/>Circ. Res.
<volume>94</volume> (<issue>4</issue>), <fpage>471</fpage>–<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000115944.10681.EB</pub-id>
<pub-id pub-id-type="pmid">14715535</pub-id></mixed-citation>
</ref>
<ref id="B260">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vinogradova</surname><given-names>T. M.</given-names></name><name><surname>Lyashkov</surname><given-names>A. E.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name><name><surname>Ruknudin</surname><given-names>A. M.</given-names></name><name><surname>Sirenko</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>High basal protein kinase a-dependent phosphorylation drives rhythmic internal Ca2+ store oscillations and spontaneous beating of cardiac pacemaker cells</article-title>. <source/>Circ. Res.
<volume>98</volume> (<issue>4</issue>), <fpage>505</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000204575.94040.d1</pub-id>
<pub-id pub-id-type="pmid">16424365</pub-id></mixed-citation>
</ref>
<ref id="B261">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Voigt</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Trafford</surname><given-names>A. W.</given-names></name><name><surname>Abu-Taha</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation</article-title>. <source/>Circulation
<volume>125</volume> (<issue>17</issue>), <fpage>2059</fpage>–<lpage>2070</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.067306</pub-id>
<pub-id pub-id-type="pmid">22456474</pub-id></mixed-citation>
</ref>
<ref id="B262">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Volders</surname><given-names>P. G.</given-names></name><name><surname>Kulcsar</surname><given-names>A.</given-names></name><name><surname>Vos</surname><given-names>M. A.</given-names></name><name><surname>Sipido</surname><given-names>K. R.</given-names></name><name><surname>Wellens</surname><given-names>H. J.</given-names></name><name><surname>Lazzara</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Similarities between early and delayed afterdepolarizations induced by isoproterenol in canine ventricular myocytes</article-title>. <source/>Cardiovasc. Res.
<volume>34</volume> (<issue>2</issue>), <fpage>348</fpage>–<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1016/s0008-6363(96)00270-2</pub-id>
<pub-id pub-id-type="pmid">9205549</pub-id></mixed-citation>
</ref>
<ref id="B263">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Volders</surname><given-names>P. G.</given-names></name><name><surname>Vos</surname><given-names>M. A.</given-names></name><name><surname>Szabo</surname><given-names>B.</given-names></name><name><surname>Sipido</surname><given-names>K. R.</given-names></name><name><surname>de Groot</surname><given-names>S. H.</given-names></name><name><surname>Gorgels</surname><given-names>A. P.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts</article-title>. <source/>Cardiovasc. Res.
<volume>46</volume> (<issue>3</issue>), <fpage>376</fpage>–<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1016/s0008-6363(00)00022-5</pub-id>
<pub-id pub-id-type="pmid">10912449</pub-id></mixed-citation>
</ref>
<ref id="B264">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vukmir</surname><given-names>R. B.</given-names></name><name><surname>Stein</surname><given-names>K. L.</given-names></name></person-group> (<year>1991</year>). <article-title>Torsades de pointes therapy with phenytoin</article-title>. <source/>Ann. Emerg. Med.
<volume>20</volume> (<issue>2</issue>), <fpage>198</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/s0196-0644(05)81223-5</pub-id>
<pub-id pub-id-type="pmid">1996806</pub-id></mixed-citation>
</ref>
<ref id="B265">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Splawski</surname><given-names>I.</given-names></name><name><surname>Atkinson</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Robinson</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>1995</year>). <article-title>SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome</article-title>. <source/>Cell
<volume>80</volume> (<issue>5</issue>), <fpage>805</fpage>–<lpage>811</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(95)90359-3</pub-id>
<pub-id pub-id-type="pmid">7889574</pub-id></mixed-citation>
</ref>
<ref id="B266">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Trumble</surname><given-names>W. R.</given-names></name><name><surname>Liao</surname><given-names>H.</given-names></name><name><surname>Wesson</surname><given-names>C. R.</given-names></name><name><surname>Dunker</surname><given-names>A. K.</given-names></name><name><surname>Kang</surname><given-names>C. H.</given-names></name></person-group> (<year>1998</year>). <article-title>Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum</article-title>. <source/>Nat. Struct. Biol.
<volume>5</volume> (<issue>6</issue>), <fpage>476</fpage>–<lpage>483</lpage>. <pub-id pub-id-type="doi">10.1038/nsb0698-476</pub-id>
<pub-id pub-id-type="pmid">9628486</pub-id></mixed-citation>
</ref>
<ref id="B267">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>H.</given-names></name><name><surname>Chopra</surname><given-names>N.</given-names></name><name><surname>Laver</surname><given-names>D.</given-names></name><name><surname>Hwang</surname><given-names>H. S.</given-names></name><name><surname>Davies</surname><given-names>S. S.</given-names></name><name><surname>Roach</surname><given-names>D. E.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans</article-title>. <source/>Nat. Med.
<volume>15</volume> (<issue>4</issue>), <fpage>380</fpage>–<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1038/nm.1942</pub-id>
<pub-id pub-id-type="pmid">19330009</pub-id></mixed-citation>
</ref>
<ref id="B268">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wegener</surname><given-names>F. T.</given-names></name><name><surname>Ehrlich</surname><given-names>J. R.</given-names></name><name><surname>Hohnloser</surname><given-names>S. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome</article-title>. <source/>Europace
<volume>10</volume> (<issue>1</issue>), <fpage>112</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1093/europace/eum252</pub-id>
<pub-id pub-id-type="pmid">18006559</pub-id></mixed-citation>
</ref>
<ref id="B269">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weiss</surname><given-names>J. N.</given-names></name><name><surname>Chen</surname><given-names>P. S.</given-names></name><name><surname>Qu</surname><given-names>Z.</given-names></name><name><surname>Karagueuzian</surname><given-names>H. S.</given-names></name><name><surname>Garfinkel</surname><given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>Ventricular fibrillation: how do we stop the waves from breaking</article-title>? <source/>Circ. Res.
<volume>87</volume> (<issue>12</issue>), <fpage>1103</fpage>–<lpage>1107</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.87.12.1103</pub-id>
<pub-id pub-id-type="pmid">11110766</pub-id></mixed-citation>
</ref>
<ref id="B270">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weiss</surname><given-names>J. N.</given-names></name><name><surname>Karma</surname><given-names>A.</given-names></name><name><surname>Shiferaw</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>P. S.</given-names></name><name><surname>Garfinkel</surname><given-names>A.</given-names></name><name><surname>Qu</surname><given-names>Z.</given-names></name></person-group> (<year>2006</year>). <article-title>From pulsus to pulseless: the saga of cardiac alternans</article-title>. <source/>Circ. Res.
<volume>98</volume> (<issue>10</issue>), <fpage>1244</fpage>–<lpage>1253</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000224540.97431.f0</pub-id>
<pub-id pub-id-type="pmid">16728670</pub-id></mixed-citation>
</ref>
<ref id="B271">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weiss</surname><given-names>J. N.</given-names></name><name><surname>Garfinkel</surname><given-names>A.</given-names></name><name><surname>Karagueuzian</surname><given-names>H. S.</given-names></name><name><surname>Nguyen</surname><given-names>T. P.</given-names></name><name><surname>Olcese</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>P. S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Perspective: a dynamics-based classification of ventricular arrhythmias</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>82</volume>, <fpage>136</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.02.017</pub-id>
<pub-id pub-id-type="pmid">25769672</pub-id></mixed-citation>
</ref>
<ref id="B272">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wier</surname><given-names>W. G.</given-names></name><name><surname>Cannell</surname><given-names>M. B.</given-names></name><name><surname>Berlin</surname><given-names>J. R.</given-names></name><name><surname>Marban</surname><given-names>E.</given-names></name><name><surname>Lederer</surname><given-names>W. J.</given-names></name></person-group> (<year>1987</year>). <article-title>Cellular and subcellular heterogeneity of [Ca2+]i in single heart cells revealed by fura-2</article-title>. <source/>Science
<volume>235</volume> (<issue>4786</issue>), <fpage>325</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1126/science.3798114</pub-id>
<pub-id pub-id-type="pmid">3798114</pub-id></mixed-citation>
</ref>
<ref id="B273">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wilders</surname><given-names>R.</given-names></name><name><surname>Verkerk</surname><given-names>A. O.</given-names></name></person-group> (<year>2018</year>). <article-title>Long QT syndrome and sinus bradycardia-a mini review</article-title>. <source/>Front. Cardiovasc. Med.
<volume>5</volume>, <elocation-id>106</elocation-id>. <pub-id pub-id-type="doi">10.3389/fcvm.2018.00106</pub-id>
<pub-id pub-id-type="pmid">30123799</pub-id></mixed-citation>
</ref>
<ref id="B274">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wit</surname><given-names>A. L.</given-names></name><name><surname>Cranefield</surname><given-names>P. F.</given-names></name></person-group> (<year>1977</year>). <article-title>Triggered and automatic activity in the canine coronary sinus</article-title>. <source/>Circ. Res.
<volume>41</volume> (<issue>4</issue>), <fpage>434</fpage>–<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.41.4.434</pub-id>
<pub-id pub-id-type="pmid">902353</pub-id></mixed-citation>
</ref>
<ref id="B275">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wit</surname><given-names>A. L.</given-names></name><name><surname>Hoffman</surname><given-names>B. F.</given-names></name><name><surname>Cranefield</surname><given-names>P. F.</given-names></name></person-group> (<year>1972</year>). <article-title>Slow conduction and reentry in the ventricular conducting system. I. return extrasystole in canine purkinje fibers</article-title>. <source/>Circ. Res.
<volume>30</volume> (<issue>1</issue>), <fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.30.1.1</pub-id>
<pub-id pub-id-type="pmid">5007524</pub-id></mixed-citation>
</ref>
<ref id="B276">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wren</surname><given-names>L. M.</given-names></name><name><surname>Jimenez-Jaimez</surname><given-names>J.</given-names></name><name><surname>Al-Ghamdi</surname><given-names>S.</given-names></name><name><surname>Al-Aama</surname><given-names>J. Y.</given-names></name><name><surname>Bdeir</surname><given-names>A.</given-names></name><name><surname>Al-Hassnan</surname><given-names>Z. N.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Genetic mosaicism in calmodulinopathy</article-title>. <source/>Circ. Genom. Precis. Med.
<volume>12</volume> (<issue>9</issue>), <fpage>375</fpage>–<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCGEN.119.002581</pub-id>
<pub-id pub-id-type="pmid">31454269</pub-id></mixed-citation>
</ref>
<ref id="B277">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>T. J.</given-names></name><name><surname>Lin</surname><given-names>S. F.</given-names></name><name><surname>Weiss</surname><given-names>J. N.</given-names></name><name><surname>Ting</surname><given-names>C. T.</given-names></name><name><surname>Chen</surname><given-names>P. S.</given-names></name></person-group> (<year>2002</year>). <article-title>Two types of ventricular fibrillation in isolated rabbit hearts: importance of excitability and action potential duration restitution</article-title>. <source/>Circulation
<volume>106</volume> (<issue>14</issue>), <fpage>1859</fpage>–<lpage>1866</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.0000031334.49170.fb</pub-id>
<pub-id pub-id-type="pmid">12356642</pub-id></mixed-citation>
</ref>
<ref id="B278">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>G.</given-names></name><name><surname>Ai</surname><given-names>T.</given-names></name><name><surname>Kim</surname><given-names>J. J.</given-names></name><name><surname>Mohapatra</surname><given-names>B.</given-names></name><name><surname>Xi</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>alpha-1-syntrophin mutation and the long-QT syndrome: a disease of sodium channel disruption</article-title>. <source/>Circ. Arrhythmia Electrophysiol.
<volume>1</volume> (<issue>3</issue>), <fpage>193</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.108.769224</pub-id>
</mixed-citation>
</ref>
<ref id="B279">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xie</surname><given-names>L. H.</given-names></name><name><surname>Sato</surname><given-names>D.</given-names></name><name><surname>Garfinkel</surname><given-names>A.</given-names></name><name><surname>Qu</surname><given-names>Z.</given-names></name><name><surname>Weiss</surname><given-names>J. N.</given-names></name></person-group> (<year>2008</year>). <article-title>Intracellular Ca alternans: coordinated regulation by sarcoplasmic reticulum release, uptake, and leak</article-title>. <source/>Biophys. J.
<volume>95</volume> (<issue>6</issue>), <fpage>3100</fpage>–<lpage>3110</lpage>. <pub-id pub-id-type="doi">10.1529/biophysj.108.130955</pub-id>
<pub-id pub-id-type="pmid">18539635</pub-id></mixed-citation>
</ref>
<ref id="B280">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xie</surname><given-names>L. H.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Karagueuzian</surname><given-names>H. S.</given-names></name><name><surname>Weiss</surname><given-names>J. N.</given-names></name></person-group> (<year>2009</year>). <article-title>Oxidative-stress-induced afterdepolarizations and calmodulin kinase II signaling</article-title>. <source/>Circ. Res.
<volume>104</volume> (<issue>1</issue>), <fpage>79</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.183475</pub-id>
<pub-id pub-id-type="pmid">19038865</pub-id></mixed-citation>
</ref>
<ref id="B281">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Yano</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Uchinoumi</surname><given-names>H.</given-names></name><name><surname>Tateishi</surname><given-names>H.</given-names></name><name><surname>Mochizuki</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts</article-title>. <source/>Circulation
<volume>117</volume> (<issue>6</issue>), <fpage>762</fpage>–<lpage>772</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.718957</pub-id>
<pub-id pub-id-type="pmid">18227387</pub-id></mixed-citation>
</ref>
<ref id="B282">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yan</surname><given-names>G. X.</given-names></name><name><surname>Antzelevitch</surname><given-names>C.</given-names></name></person-group> (<year>1999</year>). <article-title>Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation</article-title>. <source/>Circulation
<volume>100</volume> (<issue>15</issue>), <fpage>1660</fpage>–<lpage>1666</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.100.15.1660</pub-id>
<pub-id pub-id-type="pmid">10517739</pub-id></mixed-citation>
</ref>
<ref id="B283">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Liang</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Grunnet</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Identification of a Kir3.4 mutation in congenital long QT syndrome</article-title>. <source/>Am. J. Hum. Genet.
<volume>86</volume> (<issue>6</issue>), <fpage>872</fpage>–<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2010.04.017</pub-id>
<pub-id pub-id-type="pmid">20560207</pub-id></mixed-citation>
</ref>
<ref id="B284">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>T.</given-names></name><name><surname>Chun</surname><given-names>Y. W.</given-names></name><name><surname>Stroud</surname><given-names>D. M.</given-names></name><name><surname>Mosley</surname><given-names>J. D.</given-names></name><name><surname>Knollmann</surname><given-names>B. C.</given-names></name><name><surname>Hong</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Screening for acute IKr block is insufficient to detect torsades de pointes liability: role of late sodium current</article-title>. <source/>Circulation
<volume>130</volume> (<issue>3</issue>), <fpage>224</fpage>–<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.007765</pub-id>
<pub-id pub-id-type="pmid">24895457</pub-id></mixed-citation>
</ref>
<ref id="B285">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yano</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Kobayashi</surname><given-names>S.</given-names></name><name><surname>Matsuzaki</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Role of ryanodine receptor as a Ca(2)(+) regulatory center in normal and failing hearts</article-title>. <source/>J. Cardiol.
<volume>53</volume> (<issue>1</issue>), <fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jjcc.2008.10.008</pub-id>
<pub-id pub-id-type="pmid">19167631</pub-id></mixed-citation>
</ref>
<ref id="B286">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yarotskyy</surname><given-names>V.</given-names></name><name><surname>Gao</surname><given-names>G.</given-names></name><name><surname>Du</surname><given-names>L.</given-names></name><name><surname>Ganapathi</surname><given-names>S. B.</given-names></name><name><surname>Peterson</surname><given-names>B. Z.</given-names></name><name><surname>Elmslie</surname><given-names>K. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation</article-title>. <source/>J. Biol. Chem.
<volume>285</volume> (<issue>1</issue>), <fpage>43</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.076448</pub-id>
<pub-id pub-id-type="pmid">19887376</pub-id></mixed-citation>
</ref>
<ref id="B287">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yazawa</surname><given-names>M.</given-names></name><name><surname>Hsueh</surname><given-names>B.</given-names></name><name><surname>Jia</surname><given-names>X.</given-names></name><name><surname>Pasca</surname><given-names>A. M.</given-names></name><name><surname>Bernstein</surname><given-names>J. A.</given-names></name><name><surname>Hallmayer</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome</article-title>. <source/>Nature
<volume>471</volume> (<issue>7337</issue>), <fpage>230</fpage>–<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1038/nature09855</pub-id>
<pub-id pub-id-type="pmid">21307850</pub-id></mixed-citation>
</ref>
<ref id="B288">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zaza</surname><given-names>A.</given-names></name><name><surname>Belardinelli</surname><given-names>L.</given-names></name><name><surname>Shryock</surname><given-names>J. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Pathophysiology and pharmacology of the cardiac “late sodium current</article-title>.” <source/>Pharmacol. Ther.
<volume>119</volume> (<issue>3</issue>), <fpage>326</fpage>–<lpage>339</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2008.06.001</pub-id>
<pub-id pub-id-type="pmid">18662720</pub-id></mixed-citation>
</ref>
<ref id="B289">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Q.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Jiang</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Vembaiyan</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release</article-title>. <source/>Nat. Med.
<volume>17</volume> (<issue>8</issue>), <fpage>1003</fpage>–<lpage>1009</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2406</pub-id>
<pub-id pub-id-type="pmid">21743453</pub-id></mixed-citation>
</ref>
<ref id="B290">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Z. I.</given-names></name><name><surname>Clancy</surname><given-names>C. E.</given-names></name></person-group> (<year>2007</year>). <article-title>L-type Ca2+ channel mutations and T-wave alternans: a model study</article-title>. <source/>Am. J. Physiol. Heart Circulatory Physiol.
<volume>293</volume> (<issue>6</issue>), <fpage>H3480</fpage>–<lpage>H3489</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00476.2007</pub-id>
</mixed-citation>
</ref>
<ref id="B291">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zygmunt</surname><given-names>A. C.</given-names></name><name><surname>Eddlestone</surname><given-names>G. T.</given-names></name><name><surname>Thomas</surname><given-names>G. P.</given-names></name><name><surname>Nesterenko</surname><given-names>V. V.</given-names></name><name><surname>Antzelevitch</surname><given-names>C.</given-names></name></person-group> (<year>2001</year>). <article-title>Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle</article-title>. <source/>Am. J. Physiol. Heart Circulatory Physiol.
<volume>281</volume> (<issue>2</issue>), <fpage>H689</fpage>–<lpage>H697</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.2001.281.2.H689</pub-id>
</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>